-
A network meta-analysis of therapies for previously untreated chronic lymphocytic leukemia.
Cancer treatment reviews 20121201
-
Comparison on therapeutic effects of RFT and RCTVP regimen in the treatment of patients with indolent B-cell lymphoma in China.
Medical oncology (Northwood, London, England) 20121201
-
Busulfan, fludarabine, and alemtuzumab as a reduced toxicity regimen for children with malignant and nonmalignant diseases improves engraftment and graft-versus-host disease without delaying immune reconstitution.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20121101
-
Heat shock protein-90 inhibitor, NVP-AUY922, is effective in combination with fludarabine against chronic lymphocytic leukemia cells cultured on CD40L-stromal layer and inhibits their activated/proliferative phenotype.
Leukemia & lymphoma 20121101
-
Cyclophosphamide promotes engraftment of gene-modified cells in a mouse model of Fanconi anemia without causing cytogenetic abnormalities.
Journal of molecular medicine (Berlin, Germany) 20121101
-
The cytotoxic activity of Aplidin in chronic lymphocytic leukemia (CLL) is mediated by a direct effect on leukemic cells and an indirect effect on monocyte-derived cells.
Investigational new drugs 20121001
-
Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen.
Bone marrow transplantation 20121001
-
Allo-SCT for AML and MDS with treosulfan compared with BU-based regimens: reduced toxicity vs reduced intensity.
Bone marrow transplantation 20121001
-
Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance in untreated elderly patients with mantle cell lymphoma: a prospective study by the Finnish Lymphoma Group.
Leukemia & lymphoma 20121001
-
Assessment of 285 cases of chronic lymphocytic leukemia seen at single large tertiary center in Northern India.
Leukemia & lymphoma 20121001
-
N-(4-hydroxyphenyl)retinamide promotes apoptosis of resting and proliferating B-cell chronic lymphocytic leukemia cells and potentiates fludarabine and ABT-737 cytotoxicity.
Leukemia 20121001
-
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study.
Haematologica 20121001
-
Efficacy and safety of yttrium-90 ibritumomab tiuxetan in Japanese patients with non-Hodgkin lymphoma.
Japanese journal of radiology 20121001
-
Rituximab in combination with high-dose dexamethasone for the treatment of relapsed/refractory chronic lymphocytic leukemia.
Leukemia research 20121001
-
Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial.
British journal of haematology 20121001
-
Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial.
The Lancet. Oncology 20121001
-
Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia.
The Cochrane database of systematic reviews 20120912
-
Fludarabine and cladribine induce changes in surface proteins on human B-lymphoid cell lines involved with apoptosis, cell survival, and antitumor immunity.
Journal of proteome research 20120907
-
Comprehensive assessment of prognostic factors predicting outcome in Chinese patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide.
Medical oncology (Northwood, London, England) 20120901
-
Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning.
Bone marrow transplantation 20120901
-
Unrelated cord blood transplantation for newly diagnosed patients with severe acquired aplastic anemia using a reduced-intensity conditioning: high graft rejection, but good survival.
Bone marrow transplantation 20120901
-
A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenita.
Bone marrow transplantation 20120901
-
Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study.
Leukemia & lymphoma 20120901
-
Radiation-free allogeneic conditioning with fludarabine, carmustine, and thiotepa for acute lymphoblastic leukemia and other hematologic malignancies necessitating enhanced central nervous system activity.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120901
-
High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003-2007.
Haematologica 20120901
-
Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response.
Haematologica 20120901
-
A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome.
Annals of hematology 20120901
-
Long-term follow-up of reduced-intensity allogeneic hematopoietic stem cell transplantation for refractory or relapsed follicular lymphoma.
American journal of hematology 20120901
-
Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis.
Leukemia research 20120901
-
Cyclophosphamide-based in vivo T-cell depletion for HLA-haploidentical transplantation in Fanconi anemia.
Pediatric hematology and oncology 20120901
-
Allogeneic stem cell transplantation for patients with chronic myeloid leukemia: risk stratified approach with a long-term follow-up.
American journal of hematology 20120901
-
Outcome of allogeneic haematopoietic stem cell transplantation in aplastic anaemia.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20120901
-
Hematopoietic stem cell transplantation for thalassemia.
Immunotherapy 20120901
-
Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas: phase 2 study of the Italian Lymphoma Foundation.
Cancer 20120815
-
ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol.
Blood 20120809
-
Treatment of older patients with mantle-cell lymphoma.
The New England journal of medicine 20120809
-
Escalated lymphodepletion followed by donor lymphocyte infusion can induce a graft-versus-host response without overwhelming toxicity.
Bone marrow transplantation 20120801
-
Risk factors for molecular detection of adenovirus in pediatric hematopoietic stem cell transplantation recipients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120801
-
Keratinocyte dysplasia in hematopoietic stem cell transplantation recipients in the day-28-to-84 posttransplantation period.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120801
-
Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120801
-
Phase II prospective study of treosulfan-based reduced-intensity conditioning in allogeneic HSCT for hematological malignancies from 10/10 HLA-identical unrelated donor.
Annals of hematology 20120801
-
Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients.
Leukemia 20120801
-
Twice-daily fludarabine and cytarabine combination with or without gentuzumab ozogamicin is effective in patients with relapsed/refractory acute myeloid leukemia, high-risk myelodysplastic syndrome, and blast- phase chronic myeloid leukemia.
Clinical lymphoma, myeloma & leukemia 20120801
-
Functional analysis of the ATM-p53-p21 pathway in the LRF CLL4 trial: blockade at the level of p21 is associated with short response duration.
Clinical cancer research : an official journal of the American Association for Cancer Research 20120801
-
In vivo antitumor activity of intratumoral fludarabine phosphate in refractory tumors expressing E. coli purine nucleoside phosphorylase.
Cancer chemotherapy and pharmacology 20120801
-
Ofatumumab, the first human anti-CD20 monoclonal antibody for the treatment of B cell hematologic malignancies.
Annals of the New York Academy of Sciences 20120801
-
Glucocorticoid resistance in chronic lymphocytic leukaemia is associated with a failure of upregulated Bim/Bcl-2 complexes to activate Bax and Bak.
Cell death & disease 20120801
-
[Clinical analysis of haploidentical or unrelated donor hematopoietic stem cell transplantation for patients with severe aplastic anemia].
Zhongguo shi yan xue ye xue za zhi 20120801
-
[Alleviation of palmoplantar pustulosis associated with adult T cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20120801
-
Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan.
Blood 20120712
-
Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120710
-
[Modern times: back to past, back to future].
Medicina clinica 20120707
-
The Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory disease.
Leukemia & lymphoma 20120701
-
Quality of life in chronic lymphocytic leukemia: 5-year results from the multicenter randomized LRF CLL4 trial.
Leukemia & lymphoma 20120701
-
Maximally tolerated busulfan systemic exposure in combination with fludarabine as conditioning before allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120701
-
Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy.
Annals of hematology 20120701
-
Fludarabine combined with radiotherapy in patients with locally advanced NSCLC lung carcinoma: a phase I study.
Journal of cancer research and clinical oncology 20120701
-
Phosphorylation of deoxycytidine kinase on Ser-74: impact on kinetic properties and nucleoside analog activation in cancer cells.
Biochemical pharmacology 20120701
-
Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120701
-
miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
Carcinogenesis 20120701
-
Dietary polyphenols in cancer prevention: the example of the flavonoid quercetin in leukemia.
Annals of the New York Academy of Sciences 20120701
-
Sequential arabinosylcytosin with or without fludarabine in paracmastic patients with acute myeloid leukemia.
Die Pharmazie 20120701
-
T-cell large granular lymphocytic leukemia: treatment experience with fludarabine.
Clinics (Sao Paulo, Brazil) 20120701
-
Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results.
Blood 20120628
-
Impact of terminal dimethylation on the resistance profile of α-N-heterocyclic thiosemicarbazones.
Biochemical pharmacology 20120615
-
Lytic bone disease as the presenting feature of Philadelphia-positive monosomy 7 myelodysplasia progressing to acute myeloid leukaemia.
Gene 20120615
-
Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes.
Blood 20120607
-
A Phase III trial of fludarabine, cyclophosphamide, and rituximab vs. pentostatin, cyclophosphamide, and rituximab in B-cell chronic lymphocytic leukemia.
Investigational new drugs 20120601
-
Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 20120601
-
Highly variable pharmacokinetics of once-daily intravenous busulfan when combined with fludarabine in pediatric patients: phase I clinical study for determination of optimal once-daily busulfan dose using pharmacokinetic modeling.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120601
-
Enhancement of fludarabine sensitivity by all-trans-retinoic acid in chronic lymphocytic leukemia cells.
Haematologica 20120601
-
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells.
Haematologica 20120601
-
Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignancies.
Experimental hematology 20120601
-
Fatal outcome despite full lympho-hematopoietic reconstitution after allogeneic stem cell transplantation in atypical ataxia telangiectasia.
Journal of clinical immunology 20120601
-
Matched sibling donor stem cell transplantation for Fanconi anemia patients with T-cell somatic mosaicism.
Pediatric transplantation 20120601
-
T-cell replete fludarabine/cyclophosphamide reduced intensity allogeneic stem cell transplantation for lymphoid malignancies.
British journal of haematology 20120601
-
Reduced-intensity conditioning in unrelated donor cord blood transplantation for familial hemophagocytic lymphohistiocytosis.
American journal of hematology 20120601
-
Cotransplantation of allogeneic mesenchymal and hematopoietic stem cells in children with aplastic anemia.
Pediatrics 20120601
-
Fludarabine nucleoside induces accumulations of p53, p63 and p73 in the nuclei of human B-lymphoid cell lines, with cytosolic and mitochondrial increases in p53.
Proteomics. Clinical applications 20120601
-
A Canadian perspective on bendamustine for the treatment of chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Current oncology (Toronto, Ont.) 20120601
-
[Clinical analysis on 40 patients with chronic lymphocytic leukemia].
Zhongguo shi yan xue ye xue za zhi 20120601
-
[Salvaged allogeneic hematopoietic stem cell transplantation for refractory/recurrent acute myeloid leukemia].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20120601
-
Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial.
Blood 20120531
-
Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120510
-
Risk categories and refractory CLL in the era of chemoimmunotherapy.
Blood 20120503
-
Oral cryotherapy can significantly reduce oral mucositis but not acute GVHD incidence in Flu/Mel conditioning allo-SCT.
Bone marrow transplantation 20120501
-
Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation.
Bone marrow transplantation 20120501
-
Successful treatment of IgM-monoclonal gammopathy of undetermined significance associated with cryoglobulinemia and cold agglutinin disease with immunochemotherapy with rituximab, fludarabine, and cyclophosphamide.
Annals of hematology 20120501
-
Fludarabine, melphalan, thiotepa and anti-thymocyte globulin conditioning for unrelated cord blood transplant.
Leukemia & lymphoma 20120501
-
The value of rituximab for the treatment of fludarabine-refractory chronic lymphocytic leukemia: a systematic review and qualitative analysis of the literature.
Leukemia & lymphoma 20120501
-
Protein phosphatase-2A activation is a critical step for enzastaurin activity in chronic lymphoid leukemia cells.
Leukemia & lymphoma 20120501
-
Synergistic cytotoxicity of the DNA alkylating agent busulfan, nucleoside analogs and suberoylanilide hydroxamic acid in lymphoma cell lines.
Leukemia & lymphoma 20120501
-
Oral high-dose glucocorticoids and ofatumumab in fludarabine-resistant chronic lymphocytic leukemia.
Leukemia 20120501
-
Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors.
Naunyn-Schmiedeberg's archives of pharmacology 20120501
-
Nonmyeloablative conditioning regimen to increase engraftment of gene-modified hematopoietic stem cells in young rhesus monkeys.
Molecular therapy : the journal of the American Society of Gene Therapy 20120501
-
The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT.
Bone marrow transplantation 20120501
-
Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia.
Blood reviews 20120501
-
Excellent outcome of matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy: a United Kingdom multicentre retrospective experience.
British journal of haematology 20120501
-
Audit of peripheral stem cell transplantation for aplastic anemia in multitransfused infected patients.
Transplantation proceedings 20120501
-
[Pretreatment doses of antithymocyte globubin-fresenius for allogeneic hematopoietic stem cell transplantation for beta-thalassemia major].
Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20120501
-
The Hsp90 inhibitor NVP-AUY922-AG inhibits NF-κB signaling, overcomes microenvironmental cytoprotection and is highly synergistic with fludarabine in primary CLL cells.
Oncotarget 20120501
-
[Successful treatment with low-dose etoposide for hemophagocytic syndrome following reduced-intensity conditioning for cord blood transplantation in a patient with acute myelgenous leukemia].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20120501
-
Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy.
Blood cancer journal 20120501
-
Fludarabine may overcome resistance to rituximab in IgM-related neuropathy.
Journal of the neurological sciences 20120415
-
Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation.
Bone marrow transplantation 20120401
-
Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donors.
Bone marrow transplantation 20120401
-
Role of HCT-comorbidity index, age and disease status at transplantation in predicting survival and non-relapse mortality in patients with myelodysplasia and leukemia undergoing reduced-intensity-conditioning hemopoeitic progenitor cell transplantation.
Bone marrow transplantation 20120401
-
The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120401
-
SIE, SIES, GITMO updated clinical recommendations for the management of chronic lymphocytic leukemia.
Leukemia research 20120401
-
AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments.
Haematologica 20120401
-
LBH-589 (panobinostat) potentiates fludarabine anti-leukemic activity through a JNK- and XIAP-dependent mechanism.
Leukemia research 20120401
-
Fludarabine and a histone deacetylase inhibitor - strange bedfellows.
Leukemia research 20120401
-
Exhaustion of cytotoxic effector systems may limit monoclonal antibody-based immunotherapy in cancer patients.
Journal of immunology (Baltimore, Md. : 1950) 20120401
-
Rituximab for chronic lymphocytic leukemia.
Expert opinion on biological therapy 20120401
-
FLAG-liposomal doxorubicin (Myocet) regimen for refractory or relapsed acute leukemia pediatric patients.
Journal of pediatric hematology/oncology 20120401
-
Are reduced-intensity transplants safe in older patients with hematologic malignancies?
Expert review of hematology 20120401
-
Waldenström macroglobulinemia.
Hematology (Amsterdam, Netherlands) 20120401
-
Incidence and mortality trends of leukemia and lymphoma in Croatia, 1988-2009.
Croatian medical journal 20120401
-
Long-term results of chemoimmunotherapy with low-dose fludarabine, cyclophosphamide and high-dose rituximab as initial treatment for patients with chronic lymphocytic leukemia.
Blood 20120329
-
Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lymphocytic leukemia: a multivariate analysis from the randomized GCLLSG CLL8 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120320
-
Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120310
-
Successful second bone marrow transplantation in Omenn's syndrome after bone marrow aplasia: a case report.
Pediatric transplantation 20120301
-
Salvage haploidentical transplantation for graft failure using reduced-intensity conditioning.
Bone marrow transplantation 20120301
-
FAME, a novel conditioning regimen for allogeneic stem cell transplantation for lymphoma, does not earn fame.
Hematological oncology 20120301
-
Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo.
Bone marrow transplantation 20120301
-
The effect of zinc sulfate in the prevention of high-dose chemotherapy-induced mucositis: a double-blind, randomized, placebo-controlled study.
Hematological oncology 20120301
-
Endoscopic diagnosis of acute intestinal GVHD following allogeneic hematopoietic SCT: a retrospective analysis in 175 patients.
Bone marrow transplantation 20120301
-
Successful cord blood transplantation with reduced-intensity conditioning for childhood cerebral X-linked adrenoleukodystrophy at advanced and early stages.
Pediatric transplantation 20120301
-
Post-remission intervention with alemtuzumab or rituximab to eradicate minimal residual disease in chronic lymphocytic leukemia: where do we stand?
Leukemia & lymphoma 20120301
-
Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results.
Leukemia & lymphoma 20120301
-
Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia.
Leukemia & lymphoma 20120301
-
Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect.
Leukemia 20120301
-
Low dose alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia.
Leukemia & lymphoma 20120301
-
Upfront allogeneic blood stem cell transplantation for patients with high-risk myelodysplastic syndrome or secondary acute myeloid leukemia using a FLAMSA-based high-dose sequential conditioning regimen.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120301
-
Systematic review of purine analog treatment for chronic lymphocytic leukemia: lessons for future trials.
Haematologica 20120301
-
Efficacy of combining dasatinib and FLAG-IDA for patients with chronic myeloid leukemia in blastic transformation.
Haematologica 20120301
-
Fludarabine and rituximab for relapsed or refractory hairy cell leukemia.
Blood 20120301
-
Characteristics of translocation (16;16)(p13;q22) acute myeloid leukemia.
American journal of hematology 20120301
-
Recipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia.
Human immunology 20120301
-
Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma).
Annals of oncology : official journal of the European Society for Medical Oncology 20120301
-
Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia.
Nature cell biology 20120301
-
Feasibility of non-TBI conditioning with busulfan and fludarabine for allogeneic stem cell transplantation in lymphoid malignancy.
The Korean journal of internal medicine 20120301
-
A case of therapy-related acute myeloid leukemia following 5-fluorouracil chemotherapy.
The Korean journal of internal medicine 20120301
-
Bendamustine: inadequate or outdated data.
Prescrire international 20120301
-
Epidemiology of astrovirus infection in children.
Korean journal of pediatrics 20120301
-
Treatment strategies for Hodgkin lymphoma recurring following autologous hematopoietic stem cell transplantation.
The Korean journal of hematology 20120301
-
Factors influencing lymphocyte reconstitution after allogeneic hematopoietic stem cell transplantation in children.
The Korean journal of hematology 20120301
-
[Allogeneic hematopoietic stem cell transplantation with fludarabine, melphalan, and total body irradiation as a conditioning for elderly patients with myeloid malignancies].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20120301
-
Weekly gemcitabine and docetaxel in refractory soft tissue sarcoma: a retrospective analysis.
Cancer research and treatment : official journal of Korean Cancer Association 20120301
-
[Allogeneic peripheral blood stem cell transplantation from sibling donors for 10 patients with multiple myeloma].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20120301
-
Alemtuzumab for patients with chronic lymphocytic leukaemia.
The Cochrane database of systematic reviews 20120215
-
Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR.
Bone marrow transplantation 20120201
-
Single center retrospective analysis of BU-based conditioning regimens in allogeneic transplantation.
Bone marrow transplantation 20120201
-
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology 20120201
-
Immune hemolysis after fludarabine-based reduced intensity conditioning and allogeneic PBSC transplantation for CML with minor ABO incompatibility.
Annals of hematology 20120201
-
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results.
Annals of oncology : official journal of the European Society for Medical Oncology 20120201
-
Accurate targeting of daily intravenous busulfan with 8-hour blood sampling in hospitalized adult hematopoietic cell transplant recipients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120201
-
Oral fludarabine in combination with doxorubicin and dexamethasone as first-line therapy for nodal peripheral T-cell lymphomas: early results of a prospective multicenter study.
Cancer chemotherapy and pharmacology 20120201
-
Development and validation of a test dose strategy for once-daily i.v. busulfan: importance of fixed infusion rate dosing.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120201
-
Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for the treatment of previously untreated chronic lymphocytic leukemia.
Leukemia & lymphoma 20120201
-
Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia.
Leukemia & lymphoma 20120201
-
Anti-T lymphocyte globulin (ATG) induces generation of regulatory T cells, at least part of them express activated CD44.
Journal of clinical immunology 20120201
-
CD69 is independently prognostic in chronic lymphocytic leukemia: a comprehensive clinical and biological profiling study.
Haematologica 20120201
-
Risk factors for Pneumocystis jirovecii pneumonia in patients with lymphoproliferative disorders.
Clinical lymphoma, myeloma & leukemia 20120201
-
Plerixafor for autologous peripheral blood stem cell mobilization in patients previously treated with fludarabine or lenalidomide.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120201
-
DNA building blocks: keeping control of manufacture.
Critical reviews in biochemistry and molecular biology 20120201
-
Therapy-related myeloid neoplasms following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20120201
-
Individualized fludarabine-based regimen in elderly patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Advances in therapy 20120201
-
MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia.
Oncotarget 20120201
-
Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates interleukin-6 (IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart.
The Journal of biological chemistry 20120120
-
Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease.
Cancer 20120115
-
Leflunomide induces apoptosis in fludarabine-resistant and clinically refractory CLL cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 20120115
-
Tipping the Noxa/Mcl-1 balance overcomes ABT-737 resistance in chronic lymphocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 20120115
-
Reduced-intensity allogeneic hematopoietic cell transplantation using fludarabine-melphalan conditioning for treatment of mature T-cell lymphomas.
Bone marrow transplantation 20120101
-
Early allo-SCT for AML with a complex aberrant karyotype--results from a prospective pilot study.
Bone marrow transplantation 20120101
-
Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike.
Bone marrow transplantation 20120101
-
Second line chemotherapy in patients with enteropathy-associated T cell lymphoma: a retrospective single center analysis.
Annals of hematology 20120101
-
Comparable outcome after related or unrelated allogeneic stem cell transplant following reduced conditioning with fludarabine, busulfan and antithymocyte globulin.
Leukemia & lymphoma 20120101
-
Oral fludarabine and rituximab as initial therapy for chronic lymphocytic leukemia or small lymphocytic lymphoma: population-based experience matches clinical trials.
Leukemia & lymphoma 20120101
-
Prostate-specific membrane antigen-based therapeutics.
Advances in urology 20120101
-
Progressive multifocal leukoencephalopathy after treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia.
Leukemia & lymphoma 20120101
-
Engineered T cells for the adoptive therapy of B-cell chronic lymphocytic leukaemia.
Advances in hematology 20120101
-
A pilot pharmacologic biomarker study of busulfan and fludarabine in hematopoietic cell transplant recipients.
Cancer chemotherapy and pharmacology 20120101
-
The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias.
Advances in hematology 20120101
-
Sorafenib-induced apoptosis of chronic lymphocytic leukemia cells is associated with downregulation of RAF and myeloid cell leukemia sequence 1 (Mcl-1).
Molecular medicine (Cambridge, Mass.) 20120101
-
FLAGIDA-lite is an effective regimen for patients between 70 and 80 years with acute myeloid leukemia or refractory anemia with excess blasts-2 and is feasible as outpatient treatment.
American journal of hematology 20120101
-
Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature.
British journal of haematology 20120101
-
Degree of mucositis and duration of neutropenia are the major risk factors for early post-transplant febrile neutropenia and severe bacterial infections after reduced-intensity conditioning.
European journal of haematology 20120101
-
Pulmonary function testing prior to reduced intensity conditioning allogeneic stem cell transplantation in an unselected patient cohort predicts posttransplantation pulmonary complications and outcome.
American journal of hematology 20120101
-
Synergistic antitumor activity of anti-CD25 recombinant immunotoxin LMB-2 with chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 20120101
-
Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease.
The Journal of allergy and clinical immunology 20120101
-
Low incidence and severity of oral mucositis in allogeneic stem cell transplantation after conditioning with treosulfan and fludarabine.
European journal of haematology 20120101
-
Estimation of Abbreviated Cyclosporine A Area under the Concentration-Time Curve in Allogenic Stem Cell Transplantation after Oral Administration.
Journal of transplantation 20120101
-
Removal of uracil by uracil DNA glycosylase limits pemetrexed cytotoxicity: overriding the limit with methoxyamine to inhibit base excision repair.
Cell death & disease 20120101
-
Multipotent Mesenchymal Stromal Cells for the Prophylaxis of Acute Graft-versus-Host Disease-A Phase II Study.
Stem cells international 20120101
-
Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature.
Diagnostic pathology 20120101
-
IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia.
Journal of translational medicine 20120101
-
Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in ovarian cancer.
Oncotarget 20120101
-
The kinetics of early T and B cell immune recovery after bone marrow transplantation in RAG-2-deficient SCID patients.
PloS one 20120101
-
Potentiation of anticancer drugs: effects of pentoxifylline on neoplastic cells.
International journal of molecular sciences 20120101
-
Serial measurements of cardiac biomarkers in patients after allogeneic hematopoietic stem cell transplantation.
Journal of experimental & clinical cancer research : CR 20120101
-
The co-presence of deletion 7q, 20q and inversion 16 in therapy-related acute myeloid leukemia developed secondary to treatment of breast cancer with cyclophosphamide, doxorubicin, and radiotherapy: a case report.
Journal of medical case reports 20120101
-
Emerging pharmacotherapies for adult patients with acute lymphoblastic leukemia.
Clinical Medicine Insights. Oncology 20120101
-
Mannose-binding lectin 2 polymorphisms do not influence frequency or type of infection in adults with chemotherapy induced neutropaenia.
PloS one 20120101
-
A genome-wide study of cytogenetic changes in colorectal cancer using SNP microarrays: opportunities for future personalized treatment.
PloS one 20120101
-
TCR gene transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 epitopes as melanoma-specific immune targets.
Clinical & developmental immunology 20120101
-
Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go.
Journal of hematology & oncology 20120101
-
Does fludarabine increase the incidence of sinusoidal obstruction syndrome when combined with Bu/Cy during conditioning?
Clinical transplantation 20120101
-
Chlamydia psittaci in ocular adnexa MALT lymphoma: a possible role in lymphomagenesis and a different geographical distribution.
Infectious agents and cancer 20120101
-
State-of-the-Art Management of Patients Suffering from Chronic Lymphocytic Leukemia.
Clinical Medicine Insights. Oncology 20120101
-
18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Management of Aggressive Non-Hodgkin's B-Cell Lymphoma.
ISRN hematology 20120101
-
Interferon-α regulates glutaminase 1 promoter through STAT1 phosphorylation: relevance to HIV-1 associated neurocognitive disorders.
PloS one 20120101
-
Longitudinal analysis of tetanus- and influenza-specific IgG antibodies in myeloma patients.
Clinical & developmental immunology 20120101
-
Modulation of Wnt5a expression by periodontopathic bacteria.
PloS one 20120101
-
Cytokines in tear fluid of patients with ocular graft-versus-host disease after allogeneic stem cell transplantation.
Molecular vision 20120101
-
Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a man with AIDS.
International journal of general medicine 20120101
-
Novel therapies for aggressive B-cell lymphoma.
Advances in hematology 20120101
-
Relapsed and/or Refractory Mantle Cell Lymphoma: What Role for Temsirolimus?
Clinical Medicine Insights. Oncology 20120101
-
Ginkgo biloba extract reduces high-glucose-induced endothelial adhesion by inhibiting the redox-dependent interleukin-6 pathways.
Cardiovascular diabetology 20120101
-
The HIV matrix protein p17 subverts nuclear receptors expression and induces a STAT1-dependent proinflammatory phenotype in monocytes.
PloS one 20120101
-
Immunotherapy for B-cell lymphoma: current status and prospective advances.
Frontiers in immunology 20120101
-
Novel regulatory therapies for prevention of Graft-versus-host disease.
BMC medicine 20120101
-
Therapy of elderly/comorbid patients with chronic lymphocytic leukemia.
Current pharmaceutical design 20120101
-
Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics.
International journal of molecular sciences 20120101
-
Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosis.
PloS one 20120101
-
Immunotherapy targets in pediatric cancer.
Frontiers in oncology 20120101
-
Acute myeloid leukemia: focus on novel therapeutic strategies.
Clinical Medicine Insights. Oncology 20120101
-
Viral infection in renal transplant recipients.
TheScientificWorldJournal 20120101
-
Apoptotic gene expression under influence of fludarabine and cladribine in chronic lymphocytic leukemia-microarray study.
Pharmacological reports : PR 20120101
-
Pan-pathway based interaction profiling of FDA-approved nucleoside and nucleobase analogs with enzymes of the human nucleotide metabolism.
PloS one 20120101
-
Chromosomal aberrations associated with clonal evolution and leukemic transformation in fanconi anemia: clinical and biological implications.
Anemia 20120101
-
Review of salvage therapy for biochemically recurrent prostate cancer: the role of imaging and rationale for systemic salvage targeted anti-prostate-specific membrane antigen radioimmunotherapy.
Advances in urology 20120101
-
Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation.
Stem cells international 20120101
-
Hematopoietic stem cell function in a murine model of sickle cell disease.
Anemia 20120101
-
Epstein-Barr virus-negative classical Hodgkin's lymphoma in a patient with T-cell prolymphocytic leukemia treated with fludarabine.
Journal of clinical and experimental hematopathology : JCEH 20120101
-
Cytomegalovirus oesophagitis following treatment with fludarabine for refractory lymphoplasmacytic lymphoma.
BMJ case reports 20120101
-
Bendamustine versus chlorambucil for the first-line treatment of chronic lymphocytic leukemia in England and Wales: a cost-utility analysis.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20120101
-
Successful treatment of γ-heavy-chain disease with rituximab and fludarabine.
Acta haematologica 20120101
-
Rituximab and new regimens for indolent lymphoma: a brief update from 2012 ASCO Annual Meeting.
Cancer cell international 20120101
-
Heterogeneity of p53-pathway Protein Expression in Chemosensitive Chronic Lymphocytic Leukemia: A Pilot Study.
Journal of Cancer 20120101
-
Bing and neel syndrome.
Case reports in hematology 20120101
-
Preclinical antitumor activity of thiarabine in human leukemia and lymphoma xenograft models.
Nucleosides, nucleotides & nucleic acids 20120101
-
[Invasive mycoses during hematopoietic stem cell transplantation].
Terapevticheskii arkhiv 20120101
-
Chemotherapy: New FluCam combination therapy has familiar limitations.
Nature reviews. Clinical oncology 20111206
-
FLANG salvage chemotherapy is an effective regimen that offers a safe bridge to transplantation for patients with relapsed or refractory acute myeloid leukemia.
Medical oncology (Northwood, London, England) 20111201
-
(90)Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphoma.
Bone marrow transplantation 20111201
-
Successful reduced-intensity SCT from unrelated cord blood in three patients with X-linked SCID.
Bone marrow transplantation 20111201
-
Treosulfan-based preparative regimens for allo-HSCT in childhood hematological malignancies: a retrospective study on behalf of the EBMT pediatric diseases working party.
Bone marrow transplantation 20111201
-
Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioning.
Hematological oncology 20111201
-
Non-gastric marginal zone B cell lymphoma: clinicopathologic features and treatment results.
Annals of hematology 20111201
-
Waldenström's macroglobulinemia and nephrotic syndrome with membranous nephropathy.
Scandinavian journal of urology and nephrology 20111201
-
Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20111201
-
Safety and efficacy of combination therapy with fludarabine, mitoxantrone, and rituximab followed by yttrium-90 ibritumomab tiuxetan and maintenance rituximab as front-line therapy for patients with follicular or marginal zone lymphoma.
Clinical lymphoma, myeloma & leukemia 20111201
-
Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia.
Leukemia & lymphoma 20111201
-
Chronic lymphocytic leukemia in less fit patients: 'slow-go'.
Leukemia & lymphoma 20111201
-
IL-17A upregulates keratin 17 expression in keratinocytes through STAT1- and STAT3-dependent mechanisms.
The Journal of investigative dermatology 20111201
-
Gastric mucosa-associated lymphoid tissue lymphoma: how to attack the T… for two?
Leukemia & lymphoma 20111201
-
A prospective phase II study of RICE re-induction, then high-dose fludarabine and busulfan, followed by autologous or allogeneic blood stem cell transplantation for indolent b-cell lymphoma.
Clinical lymphoma, myeloma & leukemia 20111201
-
Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with fludarabine: effect on tumor microenvironment.
Leukemia & lymphoma 20111201
-
The effects of chemotherapeutic agents on differentiated chordoma cells.
Journal of neurosurgery. Spine 20111201
-
Drug dosing and monitoring in obese patients undergoing allogenic stem cell transplantation.
International journal of clinical pharmacy 20111201
-
Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial.
The Lancet. Oncology 20111201
-
Targeted expression of Escherichia coli purine nucleoside phosphorylase and Fludara® for prostate cancer therapy.
The journal of gene medicine 20111201
-
Nonnecrobiotic necrobiotic xanthogranuloma as an initial manifestation of paraproteinemia and small lymphocytic lymphoma in a patient with Sjögren syndrome.
The American Journal of dermatopathology 20111201
-
Fludarabine nucleoside modulates nuclear 'survival and death' proteins in resistant chronic lymphocytic leukemia cells.
Nucleosides, nucleotides & nucleic acids 20111201
-
Structural insights into the inhibition of cytosolic 5'-nucleotidase II (cN-II) by ribonucleoside 5'-monophosphate analogues.
PLoS computational biology 20111201
-
Radioimmunotherapy of non-Hodgkin's lymphoma: from the 'magic bullets' to 'radioactive magic bullets'.
The Yale journal of biology and medicine 20111201
-
Progressive multifocal leukoencephalopathy following fludarabine treatment in a chronic lymphocytic leukemia patient.
Experimental oncology 20111201
-
[Recent advances of transplantation from bone marrow derived stem cells].
Nihon rinsho. Japanese journal of clinical medicine 20111201
-
Clinical implications of chimerism after allogeneic hematopoietic stem cell transplantation in children with non-malignant diseases.
The Korean journal of hematology 20111201
-
Comparison of new flu-bu12-tg conditioning with the standard bu-cy myeloablative regimen in patients undergoing allogeneic stem cell transplantation for acute myeloid leukemia.
Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 20111201
-
[HLA haploidentical peripheral blood stem cells transplantation for β thalassemia major].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20111201
-
Pixantrone dimaleate in combination with fludarabine, dexamethasone, and rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: phase 1 study with a dose-expansion cohort.
Cancer 20111115
-
Ofatumumab is active in patients with fludarabine-refractory CLL irrespective of prior rituximab: results from the phase 2 international study.
Blood 20111110
-
Anti-CD20: tales of identical twins?
Blood 20111110
-
Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies.
JAMA 20111102
-
Overcoming the age barrier in hematopoietic stem cell transplantation: progress, but still a long way to go.
JAMA 20111102
-
Severe pulmonary toxicity after myeloablative conditioning using total body irradiation: an assessment of risk factors.
International journal of radiation oncology, biology, physics 20111101
-
Pharmacokinetic targeting of i.v. BU with fludarabine as conditioning before hematopoietic cell transplant: the effect of first-dose area under the concentration time curve on transplant-related outcomes.
Bone marrow transplantation 20111101
-
Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia.
Annals of hematology 20111101
-
Fludarabine, antithymocyte globulin, and very low-dose busulfan for reduced-intensity conditioning before allogeneic stem cell transplantation in patients with lymphoid malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20111101
-
Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20111101
-
Economic impact of disease progression in follicular non-Hodgkin lymphoma.
Leukemia & lymphoma 20111101
-
Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia.
European journal of haematology 20111101
-
The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality.
Haematologica 20111101
-
Therapeutic in vivo selection of thymic-derived natural T regulatory cells following non-myeloablative hematopoietic stem cell transplant for IPEX.
Clinical immunology (Orlando, Fla.) 20111101
-
Retroviral gene therapy for X-linked chronic granulomatous disease: results from phase I/II trial.
Molecular therapy : the journal of the American Society of Gene Therapy 20111101
-
Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings.
Journal of medical virology 20111101
-
rILYd4, a human CD59 inhibitor, enhances complement-dependent cytotoxicity of ofatumumab against rituximab-resistant B-cell lymphoma cells and chronic lymphocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 20111101
-
Therapy-related myeloid neoplasms.
Current opinion in oncology 20111101
-
Normal levels of peripheral CD19(+) CD5(+) CLL-like cells: toward a defined threshold for CLL follow-up -- a GEIL-GOELAMS study.
Cytometry. Part B, Clinical cytometry 20111101
-
Chronic lymphocytic leukaemia cells drive the global CD4+ T cell repertoire towards a regulatory phenotype and leads to the accumulation of CD4+ forkhead box P3+ T cells.
Clinical and experimental immunology 20111101
-
Successful allogeneic hematopoietic stem cell transplantation for chronic granulomatous disease with inflammatory complications and severe infection.
International journal of hematology 20111101
-
Isolation and characterization of a murine P388 leukemia line resistant to clofarabine.
Nucleosides, nucleotides & nucleic acids 20111101
-
Application of high-dose rate (60)Co remote after-loading system for local recurrent neuroblastoma.
Journal of pediatric surgery 20111101
-
Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience.
Oncotarget 20111101
-
[Clinical study of kangai injection plus FLAG regimen for refractory/relapsed acute leukemia].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20111101
-
Anthracyclines: a cornerstone in the management of non-Hodgkin's lymphoma.
Hematology reports 20111028
-
Ongoing trials in low-grade lymphoma.
Hematology reports 20111028
-
Case studies of elderly patients with non-Hodgkin's lymphoma.
Hematology reports 20111028
-
Therapy related acute myeloid leukemia with t(10:16): a rare entity.
Hematology reports 20111019
-
An open-label, pilot study of fludarabine, cyclophosphamide, and alemtuzumab in relapsed/refractory patients with B-cell chronic lymphocytic leukemia.
Blood 20111013
-
Waldenström's macroglobulinemia. An overview of its clinical, biochemical, immunological and therapeutic features and our series of 121 patients collected in a single center.
Critical reviews in oncology/hematology 20111001
-
Comorbidity index does not predict outcome in allogeneic myeloablative transplants conditioned with fludarabine/i.v. busulfan (FluBu4).
Bone marrow transplantation 20111001
-
Long-term follow-up of a pilot study using a chemotherapy-alone protocol for killer Ig-like receptor-ligand-mismatched haploidentical haematopoietic SCT.
Bone marrow transplantation 20111001
-
Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20111001
-
Fludarabine and pharmacokinetic-targeted busulfan before allografting for adults with acute lymphoid leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20111001
-
Prolonged progression-free survival in patients with chronic lymphocytic leukemia receiving granulocyte colony-stimulating factor during treatment with fludarabine, cyclophosphamide, and rituximab.
Annals of hematology 20111001
-
Association between single nucleotide polymorphism-genotype and outcome of patients with chronic lymphocytic leukemia in a randomized chemotherapy trial.
Haematologica 20111001
-
Alterations of hemostatic parameters in the early development of allogeneic hematopoietic stem cell transplantation-related complications.
Annals of hematology 20111001
-
Poor-risk cytogenetics may be associated with inferior outcome after fludarabine, cytarabine, and amsacrine reduced intensity conditioning in patients with high-risk acute myeloid leukemia.
Leukemia & lymphoma 20111001
-
Multicenter study of subcutaneous alemtuzumab administered at reduced dose in patients with fludarabine-relapsed/refractory chronic lymphocytic leukemia: final analysis.
Leukemia & lymphoma 20111001
-
Treatment strategies in patients with core-binding factor acute myeloid leukemia.
Current oncology reports 20111001
-
Chronic lymphocytic leukemia: an update on biology and treatment.
Current oncology reports 20111001
-
A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients.
British journal of haematology 20111001
-
Ofatumumab: a novel anti-CD20 monoclonal antibody for treatment of refractory chronic lymphocytic leukemia.
The Annals of pharmacotherapy 20111001
-
Single-agent rituximab in treatment-refractory or poor prognosis patients with chronic lymphocytic leukemia.
Current medical research and opinion 20111001
-
Strategy for bone marrow transplantation in eculizumab-treated paroxysmal nocturnal hemoglobinuria.
International journal of hematology 20111001
-
Synergistic effects of combination with fludarabine and carboplatin depend on fludarabine-mediated inhibition of enhanced nucleotide excision repair in leukemia.
International journal of hematology 20111001
-
Changes in renal function after different tandem hematopoietic stem-cell transplantation approaches in patients with multiple myeloma.
Journal of Korean medical science 20111001
-
Acute abdomen after allogenic hematopoietic stem cell transplantation.
Pediatric reports 20110930
-
Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997.
Blood 20110929
-
Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency.
Blood 20110929
-
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients.
Blood 20110922
-
Bendamustine combined with rituximab in patients with relapsed and/or refractory chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110910
-
A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients.
Cancer chemotherapy and pharmacology 20110901
-
Bone marrow transplantation for Fanconi anemia using fludarabine-based conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110901
-
Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110901
-
T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110901
-
Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110901
-
Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1.
Leukemia & lymphoma 20110901
-
Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trial.
Haematologica 20110901
-
Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome.
Blood 20110901
-
Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance Study.
British journal of haematology 20110901
-
Prognostic implications of the NIH consensus criteria in children with chronic graft-versus-host disease.
Yonsei medical journal 20110901
-
Hematopoietic stem cell transplantation with reduced intensity conditioning from a family haploidentical donor in an infant with familial hemophagocytic lymphohistocytosis.
International journal of hematology 20110901
-
Tubulinosema sp. microsporidian myositis in immunosuppressed patient.
Emerging infectious diseases 20110901
-
Optimizing the conditioning regimen for allogeneic stem-cell transplantation in acute myeloid leukemia; dose intensity is still in need.
Best practice & research. Clinical haematology 20110901
-
Progress in the treatment of chronic lymphocytic leukemia: results of the German CLL8 trial.
Expert review of anticancer therapy 20110901
-
Umbilical cord blood: current status & promise for the future.
The Indian journal of medical research 20110901
-
Comment on research report by Gruson and colleagues, this issue.
Journal of the peripheral nervous system : JPNS 20110901
-
Long-term response to rituximab and fludarabine combination in IgM anti-myelin-associated glycoprotein neuropathy.
Journal of the peripheral nervous system : JPNS 20110901
-
Low-grade lymphoma: Beyond fludarabine-single therapy.
The Korean journal of hematology 20110901
-
Fortuitous detection of esophageal pneumatosis in a neutropenic patient.
The Korean journal of hematology 20110901
-
Fludarabine-containing chemotherapy for patients with previously untreated low-grade non-Hodgkin's lymphoma.
The Korean journal of hematology 20110901
-
Tricuspid regurgitant velocity elevation in a three-year old child with sickle cell anemia and recurrent acute chest syndromes reversed not by hydroxyurea but by bone marrow transplantation.
Hematology reports 20110831
-
Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia.
Blood 20110825
-
Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia.
Blood 20110825
-
Frontline chemoimmunotherapy with fludarabine, cyclophosphamide, alemtuzumab, and rituximab for high-risk chronic lymphocytic leukemia.
Blood 20110825
-
[Scrotal ulcers revealing pulmonary and genitourinary tuberculosis].
Dermatology online journal 20110815
-
Influence of comorbidities on transplant outcomes in patients aged 50 years or more after myeloablative conditioning incorporating fludarabine, BU and ATG.
Bone marrow transplantation 20110801
-
Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110801
-
Influence of GST gene polymorphisms on the clearance of intravenous busulfan in adult patients undergoing hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110801
-
NOD2/CARD15 variants are not a risk factor for clinical outcome after nonmyeloablative allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110801
-
A prospective dose-finding trial using a modified continual reassessment method for optimization of fludarabine plus melphalan conditioning for marrow transplantation from unrelated donors in patients with hematopoietic malignancies.
Annals of oncology : official journal of the European Society for Medical Oncology 20110801
-
Fludarabine, cyclophosphamide, doxorubicin (FCD), and rituximab: a remission induction therapy for aggressive pediatric post-transplant lymphoproliferative disease (PTLD).
Pediatric blood & cancer 20110801
-
Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia.
Haematologica 20110801
-
Proliferative glomerulonephritis with monoclonal IgG deposits secondary to chronic lymphocytic leukemia. Report of two cases.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20110801
-
Armed and targeted measles virus for chemovirotherapy of pancreatic cancer.
Cancer gene therapy 20110801
-
Alemtuzumab based reduced intensity conditioning allogeneic haematopoietic stem cell transplantation for myelofibrosis.
Leukemia research 20110801
-
Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110801
-
STAT1 as a novel therapeutical target in pro-atherogenic signal integration of IFNγ, TLR4 and IL-6 in vascular disease.
Cytokine & growth factor reviews 20110801
-
Therapy-related myelodysplastic syndrome and acute myeloid leukemia in patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20110801
-
[The comparison of fludarabine or antithymocyte globulin based non-myeloablative conditioning regimen for haematologic diseases with graft-versus-host disease].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20110801
-
⁹⁰Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphoma.
Blood 20110728
-
Killing of chronic lymphocytic leukemia by the combination of fludarabine and oxaliplatin is dependent on the activity of XPF endonuclease.
Clinical cancer research : an official journal of the American Association for Cancer Research 20110715
-
Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts.
Blood 20110714
-
Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation.
British journal of cancer 20110712
-
High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110701
-
Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110701
-
Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110701
-
Unrelated donor transplantation for acute myelogenous leukemia in first remission.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110701
-
Reduced intensity allogeneic hematopoietic cell transplantation can induce durable remission in heavily pretreated relapsed Hodgkin lymphoma.
Annals of hematology 20110701
-
Fludarabine and cytarabine in patients with acute myeloid leukemia refractory to two different courses of front-line chemotherapy.
Leukemia research 20110701
-
Non-myeloablative hematopoietic stem cell transplantation in the treatment of severe idiopathic CD4+ lymphocytopenia.
European journal of haematology 20110701
-
Targeting the disturbed redox equilibrium in chronic lymphocytic leukemia by novel reactive oxygen species-catalytic 'sensor/effector' compounds.
Leukemia & lymphoma 20110701
-
New sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem-cell transplantation in very high-risk acute myeloid leukemia.
American journal of hematology 20110701
-
A pilot monocentric analysis of efficacy and safety of Fludarabine-Campath combination (Flucam) as first line treatment in elderly patients with chronic lymphocytic leukaemia and Tp53 disfunction.
British journal of haematology 20110701
-
Pathology consultation on drug-induced hemolytic anemia.
American journal of clinical pathology 20110701
-
Death receptor 4 is preferentially recruited to lipid rafts in chronic lymphocytic leukemia cells contributing to tumor necrosis related apoptosis inducing ligand-induced synergistic apoptotic responses.
Leukemia & lymphoma 20110701
-
Genomic and phenotypic characterization of nurse-like cells that promote drug resistance in chronic lymphocytic leukemia.
Leukemia & lymphoma 20110701
-
Rituximab in chronic lymphocytic leukemia.
Advances in therapy 20110701
-
Treatment of elderly patients with mantle cell lymphoma.
Seminars in hematology 20110701
-
Proteins with complex architecture as potential targets for drug design: a case study of Mycobacterium tuberculosis.
PLoS computational biology 20110701
-
Combination antifungal therapy and surgery for the treatment of invasive pulmonary aspergillosis after hematopoietic stem cell transplantation.
Pediatric reports 20110630
-
Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
Blood 20110623
-
Reduced intensity transplantation for primary immunodeficiency disorders.
Pediatric reports 20110622
-
HLA-mismatched hematopoietic stem cell tranplantation for pediatric solid tumors.
Pediatric reports 20110622
-
T cell-depleted hla-haploidentical stem cell transplantation in thalassemia young patients.
Pediatric reports 20110622
-
T cell depleted haploidentical transplantation: positive selection.
Pediatric reports 20110622
-
Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide.
Pediatric reports 20110622
-
Fanconi anemia - learning from children.
Pediatric reports 20110622
-
Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia.
Blood 20110616
-
[Practical considerations and questions in the treatment of chronic lymphocytic leukemia].
Orvosi hetilap 20110612
-
Autologous stem cell transplantation as a first-line treatment strategy for chronic lymphocytic leukemia: a multicenter, randomized, controlled trial from the SFGM-TC and GFLLC.
Blood 20110609
-
MHC class II deficiency cured by unrelated mismatched umbilical cord blood transplantation: case report and review of 68 cases in the literature.
Pediatric transplantation 20110601
-
A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescents.
Bone marrow transplantation 20110601
-
Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy.
Bone marrow transplantation 20110601
-
Feasibility of reduced-intensity cord blood transplantation as salvage therapy for graft failure: results of a nationwide survey of adult patients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110601
-
Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110601
-
Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110601
-
CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL.
Leukemia research 20110601
-
Identification of potential surrogate end points in randomized clinical trials of aggressive and indolent non-Hodgkin's lymphoma: correlation of complete response, time-to-event and overall survival end points.
Annals of oncology : official journal of the European Society for Medical Oncology 20110601
-
STAT1-mediated signal integration between IFNγ and LPS leads to increased EC and SMC activation and monocyte adhesion.
American journal of physiology. Cell physiology 20110601
-
Allogeneic haematopoietic stem cell transplantation as therapy for chronic granulomatous disease--single centre experience.
Journal of clinical immunology 20110601
-
Effect of expression of adenine phosphoribosyltransferase on the in vivo anti-tumor activity of prodrugs activated by E. coli purine nucleoside phosphorylase.
Cancer gene therapy 20110601
-
Purine analog toxicity in patients with hairy cell leukemia.
Leukemia & lymphoma 20110601
-
Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110601
-
Prolonged disease-free survival and overall survival with CVP alternating with fludarabine in advanced follicular lymphoma.
American journal of hematology 20110601
-
Dose-dense high-dose methylprednisolone and rituximab in the treatment of relapsed or refractory high-risk chronic lymphocytic leukemia.
Leukemia & lymphoma 20110601
-
Allogeneic stem cell transplantation in follicular lymphoma.
Best practice & research. Clinical haematology 20110601
-
Evidence-based guidelines for empirical therapy of neutropenic fever in Korea.
The Korean journal of internal medicine 20110601
-
Chlorambucil--still not bad: a reappraisal.
Clinical lymphoma, myeloma & leukemia 20110601
-
Fludarabine versus chlorambucil: is the debate over?
Clinical lymphoma, myeloma & leukemia 20110601
-
Immunotoxins and other conjugates containing saporin-s6 for cancer therapy.
Toxins 20110601
-
[Allogeneic hematopoietic stem cell transplantation for acute leukemias of ambiguous lineage in adults: a comparison between the conditioning of different intensities].
Zhonghua yi xue za zhi 20110531
-
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens.
Journal of immunology (Baltimore, Md. : 1950) 20110515
-
Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse.
Cancer 20110515
-
Impact of cranial irradiation added to intrathecal conditioning in hematopoietic cell transplantation in adult acute myeloid leukemia with central nervous system involvement.
International journal of radiation oncology, biology, physics 20110501
-
Enhancing the action of rituximab by adding fresh frozen plasma for the treatment of fludarabine refractory chronic lymphocytic leukemia.
International journal of cancer 20110501
-
Tacrolimus and mycofenolate mofetil as GvHD prophylaxis following nonmyeloablative conditioning and unrelated hematopoietic SCT for adult patients with advanced hematologic diseases.
Bone marrow transplantation 20110501
-
EPOCH-F: a novel salvage regimen for multiple myeloma before reduced-intensity allogeneic hematopoietic SCT.
Bone marrow transplantation 20110501
-
Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis.
Bone marrow transplantation 20110501
-
Cyclosporine levels and rate of graft rejection following non-myeloablative conditioning for allogeneic hematopoietic SCT.
Bone marrow transplantation 20110501
-
Targeted i.v. BU and fludarabine (t-i.v. BU/Flu) provides effective control of AML in adults with reduced toxicity.
Bone marrow transplantation 20110501
-
Evaluating the impact of antithymocyte globulin on lung function at 1 year after allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110501
-
Fludarabine-based conditioning chemotherapy for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110501
-
Diagnostic and therapeutic challenges.
Retina (Philadelphia, Pa.) 20110501
-
The pentostatin plus cyclophosphamide nonmyeloablative regimen induces durable host T cell functional deficits and prevents murine marrow allograft rejection.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110501
-
EBV related cerebral lymphoma in a leukemia patient treated with alemtuzumab.
Journal of neurology 20110501
-
Chronic lymphocytic leukemia and autoimmunity: a systematic review.
Haematologica 20110501
-
Zalypsis has in vitro activity in acute myeloid blasts and leukemic progenitor cells through the induction of a DNA damage response.
Haematologica 20110501
-
[Specific palatal infiltration in B-cell chronic lymphocytic leukemia].
Actas dermo-sifiliograficas 20110501
-
How I manage cold agglutinin disease.
British journal of haematology 20110501
-
Prognostic value of the International Scoring System and response in patients with advanced Waldenstrom macroglobulinemia.
Haematologica 20110501
-
Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21).
Leukemia 20110501
-
Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 20110501
-
Assessment of ovarian function after preparative chemotherapy and total body radiation for adoptive cell therapy.
Journal of immunotherapy (Hagerstown, Md. : 1997) 20110501
-
Fludarabine, cyclophosphamide, and rituximab chemotherapy followed by rituximab maintenance in follicular lymphoma: high efficacy may come at a cost?
Leukemia & lymphoma 20110501
-
Clinical effect of reduced-intensity conditioning regimen containing antithymocyte globulin for hematopoietic cell transplantation from unrelated-donors.
American journal of hematology 20110501
-
Mouse models of graft-versus-host disease: advances and limitations.
Disease models & mechanisms 20110501
-
Ofatumumab in the treatment of low-grade non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
Expert review of clinical immunology 20110501
-
Ofatumumab for the treatment of chronic lymphocytic leukaemia in patients who are refractory to fludarabine and alemtuzumab: a critique of the submission from GSK.
Health technology assessment (Winchester, England) 20110501
-
Alemtuzumab: what is the secret to safe therapy?
Clinical advances in hematology & oncology : H&O 20110501
-
Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience.
Blood 20110421
-
Treatment of Fanconi anemia patients using fludarabine and low-dose TBI, followed by unrelated donor hematopoietic cell transplantation.
Bone marrow transplantation 20110401
-
Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation.
Bone marrow transplantation 20110401
-
T-cell prolymphocytic leukaemia: spontaneous immunophenotypical switch from CD4 to CD8 expression.
Annals of hematology 20110401
-
Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for patients with hematologic malignancies who relapse following autologous transplantation: a multi-institutional prospective study from the Cancer and Leukemia Group B (CALGB trial 100002).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110401
-
Relationship between deoxycytidine kinase (DCK) genotypic variants and fludarabine toxicity in patients with follicular lymphoma.
Leukemia research 20110401
-
Further evidences for pharmacogenetic assessment of nucleoside analogue-treated patients.
Leukemia research 20110401
-
Allogeneic hematopoietic cell transplant with fludarabine-based reduced-intensity conditioning as treatment for advanced chronic lymphocytic leukemia.
Leukemia & lymphoma 20110401
-
Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up of CALGB study 9712.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110401
-
Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60-78 years of age.
British journal of haematology 20110401
-
Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals.
British journal of haematology 20110401
-
Reduced-intensity conditioning by fludarabine/busulfan without additional irradiation or T-cell depletion leads to low non-relapse mortality in unrelated bone marrow transplantation.
International journal of hematology 20110401
-
H275Y mutant pandemic (H1N1) 2009 virus in immunocompromised patients.
Emerging infectious diseases 20110401
-
BAG3: a multifaceted protein that regulates major cell pathways.
Cell death & disease 20110401
-
The effect of mitoxantrone as an anticancer drug on hepatocytes nuclei and chromatin: Selective release of histone proteins.
Indian journal of pharmacology 20110401
-
Treatment of indolent lymphoma in Germany - results of a representative population-based survey.
Clinical lymphoma, myeloma & leukemia 20110401
-
Inhibitory effect of leptin on rosiglitazone-induced differentiation of primary adipocytes prepared from TallyHO/Jng mice.
Biochemical and biophysical research communications 20110325
-
Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL.
Blood 20110317
-
Comprehensive proteomic analysis of the effects of purine analogs on human Raji B-cell lymphoma.
Journal of proteome research 20110304
-
Risk of birth abnormalities in the offspring of men with a history of cancer: a cohort study using Danish and Swedish national registries.
Journal of the National Cancer Institute 20110302
-
Toxic leukoencephalopathy following fludarabine-associated hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110301
-
Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110301
-
Phase II fludarabine and cyclophosphamide for the treatment of indolent B cell non-follicular lymphomas: final results of the LL02 trial of the Gruppo Italiano per lo Studio dei Linfomi (GISL).
Annals of hematology 20110301
-
APR-246 exhibits anti-leukemic activity and synergism with conventional chemotherapeutic drugs in acute myeloid leukemia cells.
European journal of haematology 20110301
-
Monitoring of WT1 expression in PB and CD34(+) donor chimerism of BM predicts early relapse in AML and MDS patients after hematopoietic cell transplantation with reduced-intensity conditioning.
Leukemia 20110301
-
Nucleoside analogs induce proteasomal down-regulation of p21 in chronic lymphocytic leukemia cell lines.
Biochemical pharmacology 20110301
-
A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia.
British journal of haematology 20110301
-
Frontline treatment of follicular lymphoma with fludarabine, cyclophosphamide, and rituximab followed by rituximab maintenance: toxicities overcome its high antilymphoma effect. Results from a Spanish Cooperative Trial (LNHF-03).
Leukemia & lymphoma 20110301
-
Antithymocyte globulin-induced acute lung injury during transplantation for aplastic anemia.
Journal of pediatric hematology/oncology 20110301
-
Early initial therapy of advanced follicular lymphoma: the need for vigilance.
Leukemia & lymphoma 20110301
-
Optimal pharmacotherapeutic management of chronic lymphocytic leukaemia: considerations in the elderly.
Drugs & aging 20110301
-
Recent advances in anti-angiogenic therapy of cancer.
Oncotarget 20110301
-
NK cell-based immunotherapy for treating cancer: will it be promising?
The Korean journal of hematology 20110301
-
[Successful combination therapy by meropenem and colistin for multi-drug-resistant Pseudomonas aeruginosa infection after allogeneic bone marrow transplantation].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20110301
-
Depressogenic effects of medications: a review.
Dialogues in clinical neuroscience 20110301
-
The treatment of pediatric chronic myelogenous leukemia in the imatinib era.
Korean journal of pediatrics 20110301
-
Prophylaxis and therapy of viral infections in pediatric patients treated for malignancy.
Pediatric reports 20110224
-
Twelfth biannual report of the Cochrane Haematological Malignancies Group--focus on tyrosine kinase inhibitors.
Journal of the National Cancer Institute 20110216
-
ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia.
Oncogene 20110210
-
Engraftment of unrelated cord blood after reduced-intensity conditioning regimen in children with refractory neuroblastoma: a feasibility trial.
Bone marrow transplantation 20110201
-
Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia.
Annals of hematology 20110201
-
Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age.
Haematologica 20110201
-
Alloreactive natural killer cells promote haploidentical hematopoietic stem cell transplantation by expansion of recipient-derived CD4(+) CD25(+) regulatory T cells.
Transplant international : official journal of the European Society for Organ Transplantation 20110201
-
Identification of patients with acute myeloblastic leukemia who benefit from the addition of gemtuzumab ozogamicin: results of the MRC AML15 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110201
-
Spotlight on rituximab in chronic lymphocytic leukemia, low-grade or follicular lymphoma, and diffuse large B-cell lymphoma.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20110201
-
The RNA activator ds-p21 potentiates the cytotoxicity induced by fludarabine in Dohh2 cells.
Oligonucleotides 20110201
-
Targeted IV busulfan and fludarabine followed by post-allogeneic hematopoietic cell transplantation rituximab demonstrate encouraging activity in CD20+ lymphoid malignancies without increased risk of infectious complications.
International journal of hematology 20110201
-
Allogeneic hematopoietic stem cell transplant after intravenous busulfan and fludarabine conditioning.
Leukemia & lymphoma 20110201
-
Personalizing treatment for chronic lymphocytic leukemia.
Expert review of hematology 20110201
-
Ofatumumab for newly diagnosed and relapsed/refractory chronic lymphocytic leukemia.
Expert review of anticancer therapy 20110201
-
[A preliminary study on efficacy of allogeneic hematopoietic stem cell transplantation by myeloablative conditioning regimen with fludarabine for high risk leukemia patients].
Zhongguo shi yan xue ye xue za zhi 20110201
-
[A case of chronic myeloid leukemia occurring during treatment for chronic lymphocytic leukemia].
Gan to kagaku ryoho. Cancer & chemotherapy 20110201
-
Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110120
-
The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodeling.
Biochemical pharmacology 20110115
-
Systemic absorption of topical lidocaine in a bone marrow transplant recipient with hepatic sinusoidal obstruction syndrome.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110115
-
Synthesis and biological properties of the cytotoxic 14-membered macrolides aspergillide A and B.
Chemistry (Weinheim an der Bergstrasse, Germany) 20110110
-
Phase 1/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies.
Blood 20110106
-
Homoharringtonine reduced Mcl-1 expression and induced apoptosis in chronic lymphocytic leukemia.
Blood 20110106
-
Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT.
Bone marrow transplantation 20110101
-
High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation.
Bone marrow transplantation 20110101
-
Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita.
Bone marrow transplantation 20110101
-
Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection.
Bone marrow transplantation 20110101
-
Linearity and stability of intravenous busulfan pharmacokinetics and the role of glutathione in busulfan elimination.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110101
-
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome.
Annals of hematology 20110101
-
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer.
Cytotherapy 20110101
-
Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia.
Cancer immunology, immunotherapy : CII 20110101
-
Fludarabine, cyclophosphamide, and antithymocyte globulin for matched related and unrelated allogeneic stem cell transplant in severe aplastic anemia.
Leukemia & lymphoma 20110101
-
Refractory Bartonella quintana bacillary angiomatosis following chemotherapy for chronic lymphocytic leukaemia.
Journal of medical microbiology 20110101
-
The Role of Allogeneic Stem Cell Transplantation in Relapsed/Refractory Hodgkin's Lymphoma Patients.
Advances in hematology 20110101
-
Rationale for possible targeting of histone deacetylase signaling in cancer diseases with a special reference to pancreatic cancer.
Journal of biomedicine & biotechnology 20110101
-
Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis.
Journal of oncology 20110101
-
Cord blood transplantation in children with relapsed or refractory severe aplastic anemia.
Journal of pediatric hematology/oncology 20110101
-
U.S. Food and drug administration approval: rituximab in combination with fludarabine and cyclophosphamide for the treatment of patients with chronic lymphocytic leukemia.
The oncologist 20110101
-
Systematic review of medical treatment in melanoma: current status and future prospects.
The oncologist 20110101
-
A transient IgE monoclonal protein in a child.
Annals of clinical biochemistry 20110101
-
FCR (Fludarabine, Cyclophosphamide, Rituximab) regimen followed by 90Yttrium ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma: a report of 9 cases.
Journal of experimental & clinical cancer research : CR 20110101
-
Immunotherapy for lung cancers.
Journal of biomedicine & biotechnology 20110101
-
The role of HDACs inhibitors in childhood and adolescence acute leukemias.
Journal of biomedicine & biotechnology 20110101
-
Immune-based therapies for sarcoma.
Sarcoma 20110101
-
Chromosomal minimal critical regions in therapy-related leukemia appear different from those of de novo leukemia by high-resolution aCGH.
PloS one 20110101
-
Role of rituximab in first-line treatment of chronic lymphocytic leukemia.
Therapeutics and clinical risk management 20110101
-
Treatment of limited stage follicular lymphoma with Rituximab immunotherapy and involved field radiotherapy in a prospective multicenter Phase II trial-MIR trial.
BMC cancer 20110101
-
Aggressive cutaneous vasculitis in a patient with chronic lymphatic leukemia following granulocyte colony stimulating factor injection: a case report.
Journal of medical case reports 20110101
-
Allogeneic hematopoietic stem cell transplantation for acute leukemia with Gilbert's syndrome.
Journal of hematology & oncology 20110101
-
Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia.
Diagnostic pathology 20110101
-
Reduced-intensity conditioning regimen combined with low-dose total body irradiation in the treatment of myelodysplastic syndrome.
Acta haematologica 20110101
-
[Efficacy of chemoimmunotherapy with fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20110101
-
Therapeutics formulated to target cancer stem cells: Is it in our future?
Cancer cell international 20110101
-
An illustrative case of subcutaneous panniculitis-like T-cell lymphoma.
Journal of skin cancer 20110101
-
A patient with splenic marginal zone lymphoma presenting with spastic paraplegia as the initial symptom.
Case reports in neurology 20110101
-
Factors that contribute to long-term survival in patients with leukemia not in remission at allogeneic hematopoietic cell transplantation.
Journal of experimental & clinical cancer research : CR 20110101
-
Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis.
BMC medicine 20110101
-
Apoptotic sphingolipid ceramide in cancer therapy.
Journal of lipids 20110101
-
Promising cytotoxic activity profile of fermented wheat germ extract (Avemar®) in human cancer cell lines.
Journal of experimental & clinical cancer research : CR 20110101
-
The emerging role of ofatumumab in the treatment of chronic lymphocytic leukemia.
Clinical Medicine Insights. Oncology 20110101
-
Frequency analysis of TRBV subfamily sjTRECs to characterize T-cell reconstitution in acute leukemia patients after allogeneic hematopoietic stem cell transplantation.
Journal of hematology & oncology 20110101
-
Immunological and clinical effects of vaccines targeting p53-overexpressing malignancies.
Journal of biomedicine & biotechnology 20110101
-
Rhizomucor and scedosporium infection post hematopoietic stem-cell transplant.
Case reports in medicine 20110101
-
A Case of Drug-Induced Hepatitis due to Lenalidomide.
Case reports in gastroenterology 20110101
-
Congenital neutropenia: diagnosis, molecular bases and patient management.
Orphanet journal of rare diseases 20110101
-
SULFs in human neoplasia: implication as progression and prognosis factors.
Journal of translational medicine 20110101
-
Risk factors and options to improve engraftment in unrelated cord blood transplantation.
Stem cells international 20110101
-
MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines.
BMC cancer 20110101
-
What are fungal infections?
Mediterranean journal of hematology and infectious diseases 20110101
-
Myelodysplastic syndrome and histone deacetylase inhibitors: 'to be or not to be acetylated'?
Journal of biomedicine & biotechnology 20110101
-
[Economic evaluation of rituximab added to fludarabine plus cyclophosphamide versus fludarabine plus cyclophosphamide for the treatment of chronic lymphocytic leukemia].
Gaceta sanitaria 20110101
-
Circulating microRNAs: potential biomarkers for cancer.
International journal of molecular sciences 20110101
-
Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: Case Report and systematic literature review.
BMC blood disorders 20110101
-
The Management of Classical Hodgkin's Lymphoma: Past, Present, and Future.
Advances in hematology 20110101
-
Clearing the complexity: immune complexes and their treatment in lupus nephritis.
International journal of nephrology and renovascular disease 20110101
-
Bendamustine: safety and efficacy in the management of indolent non-hodgkins lymphoma.
Clinical Medicine Insights. Oncology 20110101
-
Therapeutic potential and challenges of targeting receptor tyrosine kinase ROR1 with monoclonal antibodies in B-cell malignancies.
PloS one 20110101
-
Immune Reactions following Cord Blood Transplantations in Adults.
Stem cells international 20110101
-
Adoptive cell therapy for patients with melanoma.
Journal of Cancer 20110101
-
T cell therapy for nasopharyngeal carcinoma.
Journal of Cancer 20110101
-
Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC).
Journal of Cancer 20110101
-
Simultaneous clinical resolution of focal segmental glomerulosclerosis associated with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab.
BMC nephrology 20110101
-
Evolving role of high dose stem cell therapy in multiple myeloma.
Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 20110101
-
Summit on cell therapy for cancer: The importance of the interaction of multiple disciplines to advance clinical therapy.
Journal of translational medicine 20110101
-
Long-term results of allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
Neoplasma 20110101
-
Therapeutic strategies to enhance the anticancer efficacy of histone deacetylase inhibitors.
Journal of biomedicine & biotechnology 20110101
-
Peripheral T-Cell lymphoma manifested as gingival enlargement in a patient with chronic lymphocytic leukemia.
Journal of Indian Society of Periodontology 20110101
-
Clinical relevance and treatment of nonautoimmune anemia in chronic lymphocytic leukemia.
Cancer management and research 20110101
-
Haploidentical allogeneic haematopoietic stem cell transplantation as salvage therapy for engraftment failure after unrelated and autologous stem cell transplantation: a case report and review of the literature.
The Journal of international medical research 20110101
-
Mesenchymal stem cells: angels or demons?
Journal of biomedicine & biotechnology 20110101
-
Holoclone forming cells from pancreatic cancer cells enrich tumor initiating cells and represent a novel model for study of cancer stem cells.
PloS one 20110101
-
The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1.
Molecular cancer 20110101
-
Legionella pneumophila serogroup 3 pneumonia in a patient with low-grade 4 non-Hodgkin lymphoma: a case report.
Journal of medical case reports 20110101
-
Quercetin suppresses cyclooxygenase-2 expression and angiogenesis through inactivation of P300 signaling.
PloS one 20110101
-
Mechanisms of resistance to decitabine in the myelodysplastic syndrome.
PloS one 20110101
-
Combination immunotherapy and active-specific tumor cell vaccination augments anti-cancer immunity in a mouse model of gastric cancer.
Journal of translational medicine 20110101
-
Purine Nucleoside Phosphorylase mediated molecular chemotherapy and conventional chemotherapy: a tangible union against chemoresistant cancer.
BMC cancer 20110101
-
Therapy-Related Myeloid Neoplasms in Chronic Lymphocytic Leukemia and Waldenstrom's Macroglobulinemia.
Mediterranean journal of hematology and infectious diseases 20110101
-
Significant oral graft-versus-host disease after allogeneic stem cell transplantation with the FLU/MEL conditioning regimen.
Medical science monitor : international medical journal of experimental and clinical research 20110101
-
Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells.
PloS one 20110101
-
Fermented wheat germ extract--nutritional supplement or anticancer drug?
Nutrition journal 20110101
-
Atypical cytogenetics in therapy-related myelodysplastic syndrome secondary to indolent B-cell lymphoma.
Clinical laboratory science : journal of the American Society for Medical Technology 20110101
-
Timing is critical for an effective anti-metastatic immunotherapy: the decisive role of IFNγ/STAT1-mediated activation of autophagy.
PloS one 20110101
-
Systematic in-vitro evaluation of the NCI/NIH Developmental Therapeutics Program Approved Oncology Drug Set for the identification of a candidate drug repertoire for MLL-rearranged leukemia.
OncoTargets and therapy 20110101
-
Persisting right-sided chylothorax in a patient with chronic lymphocytic leukemia: a case report.
Journal of medical case reports 20110101
-
Combination treatment of flag with non-pegylated liposomal doxorubicin (MYOCET(TM)) in elderly patients with acute myeloid leukemia: a single center experience.
International journal of immunopathology and pharmacology 20110101
-
Long-term results of non-fludarabine versus fludarabine-based stem cell transplantation without total body irradiation in Fanconi anemia patients.
Hematology/oncology and stem cell therapy 20110101
-
Activation-induced cytidine deaminase (AID)-associated multigene signature to assess impact of AID in etiology of diseases with inflammatory component.
PloS one 20110101
-
Mucositis after reduced intensity conditioning and allogeneic stem cell transplantation.
Onkologie 20110101
-
Drug sensitivity patterns of HHV8 carrying body cavity lymphoma cell lines.
BMC cancer 20110101
-
Concurrent nephrotic syndrome and acute renal failure caused by chronic lymphocytic leukemia (CLL): a case report and literature review.
Diagnostic pathology 20110101
-
Differentiation of chronic lymphocytic leukemia B cells into immunoglobulin secreting cells decreases LEF-1 expression.
PloS one 20110101
-
Association of reactive oxygen species-mediated signal transduction with in vitro apoptosis sensitivity in chronic lymphocytic leukemia B cells.
PloS one 20110101
-
Recent advance in antigen-specific immunotherapy for acute myeloid leukemia.
Clinical & developmental immunology 20110101
-
Parallel screening of FDA-approved antineoplastic drugs for identifying sensitizers of TRAIL-induced apoptosis in cancer cells.
BMC cancer 20110101
-
Immune recovery after cyclophosphamide treatment in multiple myeloma: implication for maintenance immunotherapy.
Bone marrow research 20110101
-
Haploidentical hematopoietic stem-cell transplantation in adults.
Bone marrow research 20110101
-
Transplantation for congenital bone marrow failure syndromes.
Bone marrow research 20110101
-
Antibody-based therapies in multiple myeloma.
Bone marrow research 20110101
-
Small interfering RNA targeting mcl-1 enhances proteasome inhibitor-induced apoptosis in various solid malignant tumors.
BMC cancer 20110101
-
A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome.
Journal of hematology & oncology 20110101
-
Coexisting pulmonary tuberculosis and mucormycosis in a patient with aplastic anemia post allogenic stem cell transplantation.
Mediterranean journal of hematology and infectious diseases 20110101
-
A Systematic Review and Meta-Analysis of Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell Lymphoma.
ISRN hematology 20110101
-
IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase I/II study.
PloS one 20110101
-
Successful Handling of Disseminated BCG Disease in a Child with Severe Combined Immunodeficiency.
Case reports in medicine 20110101
-
Clinical characteristics and outcomes of Mycobacterium tuberculosis disease in adult patients with hematological malignancies.
BMC infectious diseases 20110101
-
Regulation of suppressors of cytokine signaling as a therapeutic approach in autoimmune diseases, with an emphasis on multiple sclerosis.
Journal of signal transduction 20110101
-
Dosimetric considerations in radioimmunotherapy and systemic radionuclide therapies: a review.
World journal of nuclear medicine 20110101
-
Using the biology of chronic lymphocytic leukemia to choose treatment.
Hematology. American Society of Hematology. Education Program 20110101
-
The treatment of relapsed refractory chronic lymphocytic leukemia.
Hematology. American Society of Hematology. Education Program 20110101
-
Alemtuzumab use in relapsed and refractory chronic lymphocytic leukemia. [corrected].
Hematology. American Society of Hematology. Education Program 20110101
-
Targeted treatment for chronic lymphocytic leukemia.
OncoTargets and therapy 20110101
-
Aleukemic leukemia cutis manifesting with disseminated nodular eruptions and a plaque preceding acute monocytic leukemia: a case report.
Case reports in oncology 20110101
-
Clinical Application of Mesenchymal Stem Cells in the Treatment and Prevention of Graft-versus-Host Disease.
Advances in hematology 20110101
-
The immune response to tumors as a tool toward immunotherapy.
Clinical & developmental immunology 20110101
-
Preliminary experience with the use of bendamustine: a peculiar skin rash as the commonest side effect.
Hematology/oncology and stem cell therapy 20110101
-
Therapy-related myeloid neoplasm in non-hodgkin lymphoma survivors.
Mediterranean journal of hematology and infectious diseases 20110101
-
Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells.
Clinical epigenetics 20110101
-
Synovial tissue response to treatment in psoriatic arthritis.
The open rheumatology journal 20110101
-
Role of ofatumumab in treatment of chronic lymphocytic leukemia.
Journal of blood medicine 20110101
-
Infectious complications in cord blood and T-cell depleted haploidentical stem cell transplantation.
American journal of blood research 20110101
-
Population pharmacokinetics of oral high-dose busulfan in adult patients undergoing hematopoietic stem cell transplantation.
Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20110101
-
Cell death signaling and anticancer therapy.
Frontiers in oncology 20110101
-
Development of real-time quantitative polymerase chain reaction assays to track treatment response in retinoid resistant acute promyelocytic leukemia.
Frontiers in oncology 20110101
-
Ribonucleotide reductase inhibitors: a new look at an old target for radiosensitization.
Frontiers in oncology 20110101
-
Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation.
Blood 20101223
-
Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial.
Lancet (London, England) 20101211
-
Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review.
British journal of cancer 20101207
-
CD34+ cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignancies.
Bone marrow transplantation 20101201
-
Carbon monoxide from CORM-2 reduces HMGB1 release through regulation of IFN-β/JAK2/STAT-1/INOS/NO signaling but not COX-2 in TLR-activated macrophages.
Shock (Augusta, Ga.) 20101201
-
Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories.
Annals of oncology : official journal of the European Society for Medical Oncology 20101201
-
Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics.
Gene therapy 20101201
-
Mesenchymal stem cell as salvage treatment for refractory chronic GVHD.
Bone marrow transplantation 20101201
-
Chronic lymphoid leukemia cells are highly sensitive to the combination of prednisolone and daunorubicin, but much less to doxorubicin or epirubicin.
Experimental hematology 20101201
-
PCR diagnostics and monitoring of adenoviral infections in hematopoietic stem cell transplantation recipients.
Archives of virology 20101201
-
Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignancies.
Experimental hematology 20101201
-
Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
Human pathology 20101201
-
Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease.
Leukemia & lymphoma 20101201
-
Rituximab-induced life-threatening coagulopathy occurring in a patient with Waldenström macroglobulinemia treated with fludarabine, cyclophosphamide, and rituximab combination.
Leukemia & lymphoma 20101201
-
Fludarabine based combinations are highly effective as first-line or salvage treatment in patients with Waldenström macroglobulinemia.
Leukemia & lymphoma 20101201
-
Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy.
Leukemia 20101201
-
Graft failure in cord blood transplantation successfully treated with short-term reduced-intensity conditioning regimen and second allogeneic transplantation.
International journal of hematology 20101201
-
Increasing the dose intensity of the conditioning regimen prior to allogeneic hematopoietic stem cell transplant: the role of pharmacokinetic monitoring.
Leukemia & lymphoma 20101201
-
Continuous sequential infusion of fludarabine and cytarabine for elderly patients with acute myeloid leukaemia secondary to a previously diagnosed myelodysplastic syndrome.
Hematological oncology 20101201
-
The DAC system and associations with acute leukemias and myelodysplastic syndromes.
Investigational new drugs 20101201
-
The European Medicines Agency review of ofatumumab (Arzerra®) for the treatment of chronic lymphocytic leukemia in patients refractory to fludarabine and alemtuzumab: summary of the scientific assessment of the European medicines agency committee for medicinal products for human use.
The oncologist 20101201
-
Histoplasma capsulatum reactivation with haemophagocytic syndrome in a patient with chronic lymphocytic leukaemia.
The Netherlands journal of medicine 20101201
-
DNA-PK, ATM and MDR proteins inhibitors in overcoming fludarabine resistance in CLL cells.
Experimental oncology 20101201
-
Novel agents for the treatment of chronic lymphocytic leukemia.
Clinical advances in hematology & oncology : H&O 20101201
-
[Umbilical cord blood cell transplantation from an unrelated donor: dual transplantation].
Methods and findings in experimental and clinical pharmacology 20101201
-
The JAK3-selective inhibitor PF-956980 reverses the resistance to cytotoxic agents induced by interleukin-4 treatment of chronic lymphocytic leukemia cells: potential for reversal of cytoprotection by the microenvironment.
Blood 20101125
-
Effect of FCGR2A and FCGR3A variants on CLL outcome.
Blood 20101118
-
The clinical application of monoclonal antibodies in chronic lymphocytic leukemia.
Blood 20101111
-
The role of allogeneic SCT in primary myelofibrosis: a British Society for Blood and Marrow Transplantation study.
Bone marrow transplantation 20101101
-
Simvastatin and purine analogs have a synergic effect on apoptosis of chronic lymphocytic leukemia cells.
Annals of hematology 20101101
-
Antiapoptotic effect of interleukin-2 (IL-2) in B-CLL cells with low and high affinity IL-2 receptors.
Annals of hematology 20101101
-
Standard- versus high-dose lenograstim in adults with hematologic malignancies for peripheral blood progenitor cell mobilization.
Transfusion 20101101
-
Single-unit umbilical cord blood transplantation from unrelated donors in adult patients with chronic myelogenous leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20101101
-
Cross-talk between STAT1 and PI3K/AKT signaling in HIV-1-induced blood-brain barrier dysfunction: role of CCR5 and implications for viral neuropathogenesis.
Journal of neuroscience research 20101101
-
Lycorine sensitizes CD40 ligand-protected chronic lymphocytic leukemia cells to bezafibrate- and medroxyprogesterone acetate-induced apoptosis but dasatanib does not overcome reported CD40-mediated drug resistance.
Haematologica 20101101
-
Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
The Journal of allergy and clinical immunology 20101101
-
Allogeneic natural killer cells for refractory lymphoma.
Cancer immunology, immunotherapy : CII 20101101
-
Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20101101
-
The addition of rituximab to fludarabine and cyclophosphamide improves progression-free survival in patients with previously treated chronic lymphocytic leukemia.
Current oncology reports 20101101
-
B-chronic lymphocytic leukemia chemoresistance involves innate and acquired leukemic side population cells.
Leukemia 20101101
-
A phase I study of lenalidomide in combination with fludarabine and rituximab in previously untreated CLL/SLL.
Leukemia 20101101
-
Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients.
Leukemia & lymphoma 20101101
-
Therapy-related myelodysplasia and fludarabine combination therapy - do the benefits justify the risk?
Leukemia & lymphoma 20101101
-
Thalidomide enhances cyclophosphamide and dexamethasone-mediated cytotoxicity towards cultured chronic lymphocytic leukaemia cells.
Oncology reports 20101101
-
Allogeneic hematopoietic cell transplantation for myelofibrosis: a 10-year experience at single institution.
American journal of hematology 20101101
-
Feasibility of second hematopoietic stem cell transplantation using reduced-intensity conditioning with fludarabine and melphalan after a failed autologous hematopoietic stem cell transplantation.
Transplantation proceedings 20101101
-
Human health risk assessment of pharmaceuticals in water: issues and challenges ahead.
International journal of environmental research and public health 20101101
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20101101
-
Does minor histocompatibility antigen HA-1 disparity affect the occurrence of graft-versus-host disease in tunisian recipients of hematopoietic stem cells?
Clinics (Sao Paulo, Brazil) 20101101
-
Refractory chronic lymphocytic leukemia--new therapeutic strategies.
Oncotarget 20101101
-
High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease.
Blood 20101028
-
Heating up cold agglutinins.
Blood 20101028
-
Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution.
Blood 20101021
-
Beyond hairy cell: the activity of cladribine in other hematologic malignancies.
Blood 20101021
-
Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101010
-
Reconstitution of PTEN activity by CK2 inhibitors and interference with the PI3-K/Akt cascade counteract the antiapoptotic effect of human stromal cells in chronic lymphocytic leukemia.
Blood 20101007
-
Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial.
Blood 20101007
-
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.
Lancet (London, England) 20101002
-
HLA-matched sibling transplantation with BM and CD34(+)-purified PBSCs in adult patients with high-risk severe aplastic anemia to overcome graft rejection without an increase in GVHD.
Bone marrow transplantation 20101001
-
Degree of predicted minor histocompatibility antigen mismatch correlates with poorer clinical outcomes in nonmyeloablative allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20101001
-
Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method.
Annals of hematology 20101001
-
Immunotherapy in high-risk chemotherapy-resistant patients with metastatic solid tumors and hematological malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: a phase I study.
Cancer immunology, immunotherapy : CII 20101001
-
Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates.
Diabetes 20101001
-
HBV reactivation after fludarabine chemotherapy identified on investigation of suspected transfusion-transmitted Hepatitis B virus.
Journal of hepatology 20101001
-
Fludarabine, cytarabine, granulocyte colony-stimulating factor, and idarubicin (FLAG-IDA) for the treatment of children with poor-prognosis acute leukemia: the Hacettepe experience.
Pediatric hematology and oncology 20101001
-
Successful treatment of melanoma brain metastases with adoptive cell therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 20101001
-
The microenvironment differentially impairs passive and active immunotherapy in chronic lymphocytic leukaemia - CXCR4 antagonists as potential adjuvants for monoclonal antibodies.
British journal of haematology 20101001
-
Review of clinical trials conducted in Waldenstrom macroglobulinemia and recommendations for reporting clinical trial responses in these patients.
Leukemia & lymphoma 20101001
-
Targeting base excision repair suggests a new therapeutic strategy of fludarabine for the treatment of chronic lymphocytic leukemia.
Leukemia 20101001
-
Current immunochemotherapy strategies in follicular lymphoma.
Advances in therapy 20101001
-
What's new in Waldenström macroglobulinemia.
Leukemia & lymphoma 20101001
-
Unresolved issues in the comparison of therapies and determination of responses in Waldenström macroglobulinemia.
Leukemia & lymphoma 20101001
-
Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
Expert review of anticancer therapy 20101001
-
Chronic lymphocytic leukemia.
Annals of oncology : official journal of the European Society for Medical Oncology 20101001
-
Ofatumumab: a new CD20 monoclonal antibody therapy for B-cell chronic lymphocytic leukemia.
Clinical lymphoma, myeloma & leukemia 20101001
-
Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia.
Health technology assessment (Winchester, England) 20101001
-
The clinical effectiveness and cost-effectiveness of rituximab for the first-line treatment of chronic lymphocytic leukaemia: an evidence review of the submission from Roche.
Health technology assessment (Winchester, England) 20101001
-
Stem cell transplantation using non-myeloablative conditioning regimen with fludarabine for hematological malignancies.
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 20101001
-
Ofatumumab: chronic lymphocytic leukaemia: a last resort.
Prescrire international 20101001
-
Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab-naive, recurrent/refractory follicular non-Hodgkin lymphoma with high tumor burden: a multicenter phase 2 trial by the Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Groupe Ouest Est des Leucémies et Autres Maladies du Sang (GOELAMS).
Cancer 20100915
-
Modifying akt signaling in B-cell chronic lymphocytic leukemia cells.
Cancer research 20100915
-
Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 study.
Blood 20100909
-
Elevations of tumor necrosis factor receptor 1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Bone marrow transplantation 20100901
-
Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT.
Bone marrow transplantation 20100901
-
MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblings.
Bone marrow transplantation 20100901
-
Rapid vision loss associated with fludarabine administration.
Retina (Philadelphia, Pa.) 20100901
-
Induction of indoleamine 2,3-dioxygenase by interferon-gamma in human lens epithelial cells: apoptosis through the formation of 3-hydroxykynurenine.
The international journal of biochemistry & cell biology 20100901
-
Progressive multifocal leukoencephalopathy and promyelocytic leukemia nuclear bodies: a review of clinical, neuropathological, and virological aspects of JC virus-induced demyelinating disease.
Acta neuropathologica 20100901
-
Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene.
Cancer gene therapy 20100901
-
U.S. Food and Drug Administration approval: ofatumumab for the treatment of patients with chronic lymphocytic leukemia refractory to fludarabine and alemtuzumab.
Clinical cancer research : an official journal of the American Association for Cancer Research 20100901
-
Chemoimmunotherapy of chronic lymphocytic leukemia.
Nature reviews. Clinical oncology 20100901
-
LMP-420: a novel purine nucleoside analog with potent cytotoxic effects for CLL cells and minimal toxicity for normal hematopoietic cells.
Leukemia 20100901
-
Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia: feasibility, toxicity, and therapeutic results.
American journal of hematology 20100901
-
Impact of 3 different short-term chemotherapy regimens on lymphocyte-depletion and reconstitution in melanoma patients.
Journal of immunotherapy (Hagerstown, Md. : 1997) 20100901
-
Favorable outcomes of intravenous busulfan, fludarabine, and 400 cGy total body irradiation-based reduced-intensity conditioning allogeneic stem cell transplantation for acute myelogenous leukemia with old age and/or co-morbidities.
International journal of hematology 20100901
-
Non-gastric marginal zone B-cell lymphoma in Korea: clinical features, treatment, and prognostic factors.
The Korean journal of internal medicine 20100901
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20100901
-
Early central nervous system complications after allogeneic hematopoietic stem cell transplantation in children.
The Korean journal of hematology 20100901
-
Quercetin induced apoptosis in association with death receptors and fludarabine in cells isolated from chronic lymphocytic leukaemia patients.
British journal of cancer 20100824
-
The impact of hepatitis viruses on chronic lymphoproliferative disorders--preliminary results.
Journal of medicine and life 20100815
-
Phase 2 and pharmacodynamic study of oral forodesine in patients with advanced, fludarabine-treated chronic lymphocytic leukemia.
Blood 20100812
-
T-cell-depleted reduced-intensity transplantation followed by donor leukocyte infusions to promote graft-versus-lymphoma activity results in excellent long-term survival in patients with multiply relapsed follicular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100810
-
Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines.
Cancer chemotherapy and pharmacology 20100801
-
Progressive multifocal leukencephalopathy and cerebral toxoplasmosis in a patient with CLL.
American journal of hematology 20100801
-
Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia.
Bone marrow transplantation 20100801
-
High-dose methylprednisolone can induce remissions in patients with fludarabine-refractory chronic lymphocytic leukaemia.
European journal of cancer (Oxford, England : 1990) 20100801
-
Auer rod-like inclusions in a low-grade B-cell leukemia.
Annals of diagnostic pathology 20100801
-
[Successful treatment of B-cell prolymphocytic leukemia (B-PLL) with FCR-Lite (fludarabine, cyclophosphamide, rituximab) protocol].
Orvosi hetilap 20100801
-
Chronic lymphocytic leukemia and focusing on epidemiology and management in everyday hematologic practice: recent data from the Czech Leukemia Study Group for Life (CELL).
Clinical lymphoma, myeloma & leukemia 20100801
-
Peripheral blasts on day 21 of induction chemotherapy in a patient with core binding factor acute myeloid leukemia: more than meets the eye.
Clinical lymphoma, myeloma & leukemia 20100801
-
[Incidence and risk factors of hemorrhagic cystitis after hematopoietic stem cell transplantation].
Zhongguo shi yan xue ye xue za zhi 20100801
-
[Bone marrow failure due to telomere associated gene mutation].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20100801
-
Diffusion-weighted magnetic resonance imaging in acute reversible toxic leukoencephalopathy: A report of two cases.
The Indian journal of radiology & imaging 20100801
-
Clinical roundtable monograph. New alternatives in CLL therapy: managing adverse events.
Clinical advances in hematology & oncology : H&O 20100801
-
Rituximab: a review of its use in chronic lymphocytic leukaemia, low-grade or follicular lymphoma and diffuse large B-cell lymphoma.
Drugs 20100730
-
Successful engraftment after reduced-intensity umbilical cord blood transplantation for myelofibrosis.
Blood 20100729
-
Hypomethylation and induction of retinoic acid receptor beta 2 by concurrent action of adenosine analogues and natural compounds in breast cancer cells.
European journal of pharmacology 20100725
-
Ofatumumab, a novel anti-CD20 monoclonal antibody for the treatment of B-cell malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100720
-
Allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies after dose-escalated treosulfan/fludarabine conditioning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100710
-
Inhibition of STAT1 accelerates bone fracture healing.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20100701
-
Reduced intensity conditioning HLA identical sibling donor allogeneic stem cell transplantation for patients with follicular lymphoma: long-term follow-up from two prospective multicenter trials.
Haematologica 20100701
-
Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients.
Leukemia research 20100701
-
Prognostic factor and quality of life analysis in 160 patients aged > or =60 years with hematologic neoplasias treated with allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100701
-
Donor-derived second hematologic malignancies after cord blood transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100701
-
Combination of fludarabine and imatinib induces apoptosis synergistically through loss of mitochondrial membrane potential and increases in caspase-3 enzyme activity in human K562 chronic myleloid leukemia cells.
Cancer investigation 20100701
-
Haemophagocytic syndrome and Hodgkin's disease variant of Richter's syndrome after fludarabine for CLL.
European journal of haematology 20100701
-
Co-transfusion of haplo-identical hematopoietic and mesenchymal stromal cells to treat a patient with severe aplastic.
Cytotherapy 20100701
-
Rhodococcus equi pneumonia in a patient with fludarabine-treated chronic lymphocytic leukemia and CD4-lymphopenia.
The American journal of the medical sciences 20100701
-
Immune recovery after fludarabine-cyclophosphamide-rituximab treatment in B-chronic lymphocytic leukemia: implication for maintenance immunotherapy.
Leukemia 20100701
-
Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomas.
British journal of haematology 20100701
-
Cytotoxic activity of 2-Fluoro-ara-AMP and 2-Fluoro-ara-AMP-loaded erythrocytes against human breast carcinoma cell lines.
International journal of oncology 20100701
-
Treatment of patients with fludarabine-refractory chronic lymphocytic leukemia: need for new treatment options.
Leukemia & lymphoma 20100701
-
Allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning for a child with recurrent anaplastic large cell lymphoma.
International journal of hematology 20100701
-
The vascular endothelial growth factor receptor tyrosine kinase inhibitors vatalanib and pazopanib potently induce apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 20100701
-
Interstrand crosslink inducing agents in pretransplant conditioning therapy for hematologic malignancies.
Environmental and molecular mutagenesis 20100701
-
Ofatumumab in the treatment of chronic lymphocytic leukemia.
Drugs of today (Barcelona, Spain : 1998) 20100701
-
New trends in nucleoside biotechnology.
Acta naturae 20100701
-
HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning.
Blood 20100624
-
Renal excretion of clofarabine: assessment of dose-linearity and role of renal transport systems on drug excretion.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20100614
-
Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100610
-
Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.
Blood 20100603
-
T-cell large granular lymphocytic (T-LGL) leukemia: a single institution experience.
Medical oncology (Northwood, London, England) 20100601
-
Aggregation of spectrin and PKCtheta is an early hallmark of fludarabine/mitoxantrone/dexamethasone-induced apoptosis in Jurkat T and HL60 cells.
Molecular and cellular biochemistry 20100601
-
Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: hematologic malignancy outcomes are not impaired in advanced age.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100601
-
Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100601
-
Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100601
-
Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab.
British journal of haematology 20100601
-
Regulatory T cell as a target for cancer therapy.
Archivum immunologiae et therapiae experimentalis 20100601
-
Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party.
Haematologica 20100601
-
Inefficient dystrophin expression after cord blood transplantation in Duchenne muscular dystrophy.
Muscle & nerve 20100601
-
Role of CD20 monoclonal antibodies in previously untreated chronic lymphocytic leukemia.
Clinical lymphoma, myeloma & leukemia 20100601
-
The effect of different ATG preparations on immune recovery after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia.
Hematology (Amsterdam, Netherlands) 20100601
-
[Research advance on fludarabine resistance mechanisms in chronic lymphocytic leukemia cells].
Zhongguo shi yan xue ye xue za zhi 20100601
-
Paramyxovirus entry and targeted vectors for cancer therapy.
PLoS pathogens 20100601
-
Allogeneic hematopoietic cell transplantation for acute leukemia in first relapse or second remission.
The Korean journal of hematology 20100601
-
Fludarabine-based myeloablative regimen as pretransplant conditioning therapy in adult acute leukemia/myelodysplastic syndrome: comparison with oral or intravenous busulfan with cyclophosphamide.
The Korean journal of hematology 20100601
-
Ofatumumab.
Drugs 20100528
-
Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100510
-
The FMCA-GM assays, high throughput non-clonogenic alternatives to CFU-GM in preclinical hematotoxicity testing.
Toxicology letters 20100504
-
Outcome of hematopoietic cell transplantation in children with sickle cell disease, a single center's experience.
Bone marrow transplantation 20100501
-
Fludarabine-based reduced intensity conditioning transplants have a higher incidence of cytomegalovirus reactivation compared with myeloablative transplants.
Bone marrow transplantation 20100501
-
Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer.
Journal of cellular physiology 20100501
-
Hematopoietic stem cell transplantation after posttransplant lymphoproliferative disorder.
Journal of Korean medical science 20100501
-
Enteroviral encephalitis in a patient with a marginal zone lymphomatreated with rituximab.
The Netherlands journal of medicine 20100501
-
Medical applications and toxicities of gallium compounds.
International journal of environmental research and public health 20100501
-
First siRNA library screening in hard-to-transfect HUVEC cells.
Journal of RNAi and gene silencing : an international journal of RNA and gene targeting research 20100501
-
A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy.
Cell death & disease 20100501
-
All-trans-retinoic acid promotes trafficking of human concentrative nucleoside transporter-3 (hCNT3) to the plasma membrane by a TGF-beta1-mediated mechanism.
The Journal of biological chemistry 20100430
-
Comparison of cladribine plus cyclophosphamide with fludarabine plus cyclophosphamide as first-line therapy for chronic lymphocytic leukemia: a phase III randomized study by the Polish Adult Leukemia Group (PALG-CLL3 Study).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100410
-
A new, validated HPLC-MS/MS method for the simultaneous determination of the anti-cancer agent capecitabine and its metabolites: 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, 5-fluorouracil and 5-fluorodihydrouracil, in human plasma.
Biomedical chromatography : BMC 20100401
-
[Brucella bacteremia reactivation 70 years after the primary infection].
Medecine et maladies infectieuses 20100401
-
Allogenic bone marrow transplantation with fludarabine/busulfan16 conditioning regimen and dasatinib maintenance therapy for elderly Philadelphia-positive acute/advanced leukemia patients.
Leukemia research 20100401
-
Keratotic vascular papules over the feet: a case of Waldenström's macroglobulinaemia-associated cutaneous macroglobulinosis.
Clinical and experimental dermatology 20100401
-
The addition of 400 cGY total body irradiation to a regimen incorporating once-daily intravenous busulfan, fludarabine, and antithymocyte globulin reduces relapse without affecting nonrelapse mortality in acute myelogenous leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100401
-
Haematopoeitic cell transplantation for Fanconi anaemia - when and how?
British journal of haematology 20100401
-
Reduced intensity conditioning regimen with fludarabine, busulfan, and low-dose TBI (Flu-BU2-TBI): clinical efficacy in high-risk patients.
American journal of hematology 20100401
-
Non-myeloablative conditioning and allogeneic transplantation for multiple myeloma.
American journal of hematology 20100401
-
Rituximab plus fludarabine and cyclophosphamide prolongs progression-free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100401
-
Ofatumumab as single-agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100401
-
Determinants of the optimal first-line therapy for follicular lymphoma: a decision analysis.
American journal of hematology 20100401
-
Graft manipulation and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation from mismatched unrelated and mismatched/haploidentical related donors in pediatric leukemia patients.
Journal of pediatric hematology/oncology 20100401
-
Effects of enzastaurin, alone or in combination, on signaling pathway controlling growth and survival of B-cell lymphoma cell lines.
Leukemia & lymphoma 20100401
-
Rituximab-associated infections.
Seminars in hematology 20100401
-
Cytomegalovirus ventriculoencephalitis after unrelated double cord blood stem cell transplantation with an alemtuzumab-containing preparative regimen for Philadelphia-positive acute lymphoblastic leukemia.
Journal of Korean medical science 20100401
-
Therapeutic strategy in p47-phox deficient chronic granulomatous disease presenting as inflammatory bowel disease.
The Journal of allergy and clinical immunology 20100401
-
Chronic lymphocytic leukemia: putting new treatment options into perspective.
Cancer control : journal of the Moffitt Cancer Center 20100401
-
Reduced-intensity conditioning followed by allogeneic hematopoietic stem cell transplantation in myelofibrosis.
Current hematologic malignancy reports 20100401
-
[Female case of successful engraftment after PBSCT from her HLA-haploidentical son for severe aplastic anemia during maintenance peritoneal dialysis].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20100401
-
[Fungal infections in oncohematology: the role of prophylaxis].
Drugs of today (Barcelona, Spain : 1998) 20100401
-
Rituximab. Chronic lymphoid leukaemia: no decisive advantage.
Prescrire international 20100401
-
Incidence and susceptibility to therapy-related myeloid neoplasms.
Chemico-biological interactions 20100319
-
HLA-matched allo-SCT after reduced intensity conditioning with fludarabine/CY in patients with metastatic breast cancer.
Bone marrow transplantation 20100301
-
Fludarabine, cyclophosphamide, mitoxantrone plus rituximab (FCM-R) in frontline CLL <70 Years.
Leukemia research 20100301
-
Cytomegalovirus infection and disease after reduced intensity conditioning allogeneic stem cell transplantation: single-centre experience.
Bone marrow transplantation 20100301
-
Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT.
Bone marrow transplantation 20100301
-
Rituximab retherapy in patients with relapsed aggressive B cell and mantle cell lymphoma.
Annals of hematology 20100301
-
Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100301
-
The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma.
European journal of haematology 20100301
-
Fludarabine, Bortezomib, Myocet and rituximab chemotherapy in relapsed and refractory mantle cell lymphoma.
British journal of haematology 20100301
-
R-DHAP is effective in fludarabine-refractory chronic lymphocytic leukemia.
Leukemia 20100301
-
The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research.
British journal of haematology 20100301
-
188Re anti-CD66 radioimmunotherapy combined with reduced-intensity conditioning and in-vivo T cell depletion in elderly patients undergoing allogeneic haematopoietic cell transplantation.
British journal of haematology 20100301
-
CD154 expression triggered by purine analogues in vitro: Correlation with treatment response and autoimmune events in chronic lymphocytic leukemia.
Experimental hematology 20100301
-
Changing paradigms in the treatment of chronic lymphocytic leukemia.
Leukemia 20100301
-
Selective elimination of a chemoresistant side population of B-CLL cells by cytotoxic T lymphocytes in subjects receiving an autologous hCD40L/IL-2 tumor vaccine.
Leukemia 20100301
-
Ofatumumab, a human anti-CD20 monoclonal antibody.
Expert opinion on biological therapy 20100301
-
Cytokine working group study of lymphodepleting chemotherapy, interleukin-2, and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma: clinical outcomes and peripheral-blood cell recovery.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100301
-
Natural pregnancy and delivery after unrelated bone marrow transplantation using fludarabine-based regimen in a Fanconi anemia patient.
International journal of hematology 20100301
-
A phase II study of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (Campath-FCD) in peripheral T-cell lymphomas.
Leukemia & lymphoma 20100301
-
Clinical and imaging features of fludarabine neurotoxicity.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 20100301
-
Severe pulmonary adverse effects in lymphoma patients treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus rituximab.
The Korean journal of internal medicine 20100301
-
Allogeneic hematopoietic stem cell transplantation is superior to immunosuppressive therapy in Indian children with aplastic anemia--a single-center analysis of 100 patients.
Pediatric hematology and oncology 20100301
-
[Early relapse of hemophagocytic syndrome after reduced-intensity cord blood transplantation for relapsed acute lymphoblastic leukemia].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20100301
-
Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma.
Collegium antropologicum 20100301
-
Therapy of chronic lymphocytic leukaemia.
Best practice & research. Clinical haematology 20100301
-
Monoclonal antibody therapy of chronic lymphocytic leukaemia.
Best practice & research. Clinical haematology 20100301
-
Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches.
Best practice & research. Clinical haematology 20100301
-
NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100220
-
Purified T-depleted, CD34+ peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia.
Blood 20100211
-
A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens.
Blood 20100204
-
Evidence of a clinical response at one yr after reduced-intensity allogeneic hematopoietic stem cell transplantation in heavily pretreated adolescents with aggressive refractory Hodgkin's lymphoma.
Pediatric transplantation 20100201
-
Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimen.
Bone marrow transplantation 20100201
-
Successful allo-SCT in a Fanconi anemia patient with renal impairment using reduced doses of CY and fludarabine.
Bone marrow transplantation 20100201
-
The frequency, manifestations, and duration of prolonged cytopenias after first-line fludarabine combination chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology 20100201
-
Delayed hemolytic transfusion reaction with hyperhemolysis after first red blood cell transfusion in child with beta-thalassemia: challenges in treatment.
Transfusion 20100201
-
Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR).
British journal of haematology 20100201
-
[Correlation of deoxycytidine kinase gene expression with fludarabine resistance in patients with chronic lymphocytic leukemia].
Zhongguo shi yan xue ye xue za zhi 20100201
-
Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia: a report of three cases and review of the literature.
Clinical lymphoma, myeloma & leukemia 20100201
-
Bone marrow transplantation for inherited bone marrow failure syndromes.
Pediatric clinics of North America 20100201
-
Drug-induced immune hemolytic anemia.
Clinical advances in hematology & oncology : H&O 20100201
-
Clofarabine in leukemia.
Expert review of hematology 20100201
-
Dural MALT lymphoma with disseminated disease.
Hematology reports 20100126
-
Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia.
Blood 20100121
-
Flavopiridol, fludarabine, and rituximab in mantle cell lymphoma and indolent B-cell lymphoproliferative disorders.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100120
-
Continuous non-invasive monitoring of the skin temperature of HSCT recipients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20100101
-
Cardiac complications in patients undergoing a reduced-intensity conditioning hematopoietic stem cell transplantation.
Bone marrow transplantation 20100101
-
Reduced-intensity conditioning using fludarabine with either antithymocyte globulin and BU, or low-dose TBI allowing allogeneic hematopoietic SCT.
Bone marrow transplantation 20100101
-
Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100101
-
Cord blood transplantation from unrelated donors in adults with high-risk acute myeloid leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100101
-
Renal dysfunction due to leukemic infiltration of kidneys in a case of chronic lymphocytic leukemia.
Hemodialysis international. International Symposium on Home Hemodialysis 20100101
-
Oral fludarabine in untreated patients with B-cell chronic lymphocytic leukemia.
Leukemia 20100101
-
Pharmacokinetics, bioavailability and effects on electrocardiographic parameters of oral fludarabine phosphate.
Biopharmaceutics & drug disposition 20100101
-
IFN-gamma triggered STAT1-PKB/AKT signalling pathway influences the function of alloantigen reactive regulatory T cells.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20100101
-
R-roscovitine (Seliciclib) affects CLL cells more strongly than combinations of fludarabine or cladribine with cyclophosphamide: Inhibition of CDK7 sensitizes leukemic cells to caspase-dependent apoptosis.
Journal of cellular biochemistry 20100101
-
Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation.
British journal of haematology 20100101
-
Low-dose fludarabine increases rituximab cytotoxicity in B-CLL cells by triggering caspases activation in vitro.
Leukemia & lymphoma 20100101
-
New agents for the treatment of genetically high-risk chronic lymphocytic leukemia.
Leukemia & lymphoma 20100101
-
Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology 20100101
-
Novel therapeutic approaches in systemic lupus erythematosus.
Frontiers in bioscience (Scholar edition) 20100101
-
A case of pathologic splenic rupture as the initial manifestation of acute myeloid leukemia M2.
Yonsei medical journal 20100101
-
T cell-prolymphocytic leukemia detected in a patient of breast cancer at the time of recurrence: a case report.
Cases journal 20100101
-
Successful autologous stem cell transplantation in two patients with juvenile dermatomyositis.
Scandinavian journal of rheumatology 20100101
-
Cutaneous Richter's syndrome, prognosis, and clinical, histological and immunohistological patterns: report of four cases and review of the literature.
Dermatology (Basel, Switzerland) 20100101
-
Nanoparticulate Quillaja saponin induces apoptosis in human leukemia cell lines with a high therapeutic index.
International journal of nanomedicine 20100101
-
An unusual cause of visual loss after Herpes zoster ophthalmicus: a case report.
Cases journal 20100101
-
Acquired haemophilia a in the elderly: case reports.
Current gerontology and geriatrics research 20100101
-
Decreased HIV diversity after allogeneic stem cell transplantation of an HIV-1 infected patient: a case report.
Virology journal 20100101
-
Successful treatment of cutaneous intravascular large B-cell lymphoma with fludarabine phosphate.
European journal of dermatology : EJD 20100101
-
Assessment of peripheral blood and bone marrow cells apoptosis caused by purine analogues in patients with chronic lymphocytic leukemia in correlation with parameters of disease progression.
Acta haematologica 20100101
-
Induction/engineering, detection, selection, and expansion of clinical-grade human antigen-specific CD8 cytotoxic T cell clones for adoptive immunotherapy.
Journal of biomedicine & biotechnology 20100101
-
Severe pulmonary toxicity associated with fludarabine and possible contribution of rituximab.
Chemotherapy 20100101
-
A rare occurrence of hairy cell leukemia in the Thai population: a case report.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20100101
-
[Evaluation of fludarabine-containing regimens versus immunochemotherapy for chronic lymphocytic leukemia].
Terapevticheskii arkhiv 20100101
-
Evolution of T-cell clonality in a patient with Ph-negative acute lymphocytic leukemia occurring after interferon and imatinib therapy for Ph-positive chronic myeloid leukemia.
Journal of hematology & oncology 20100101
-
MKEM: a Multi-level Knowledge Emergence Model for mining undiscovered public knowledge.
BMC bioinformatics 20100101
-
Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights.
Journal of hematology & oncology 20100101
-
Fludarabine-induced bradycardia in a patient with refractory leukemia.
Annals of Saudi medicine 20100101
-
Population preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility study.
Health and quality of life outcomes 20100101
-
Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia.
Molecular cancer 20100101
-
Improved survival for non-Hodgkin lymphoma patients in New South Wales, Australia.
BMC cancer 20100101
-
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia.
Molecular cancer 20100101
-
Vascular endothelial growth factor-related pathways in hemato-lymphoid malignancies.
Journal of oncology 20100101
-
Surveillance of active human cytomegalovirus infection in hematopoietic stem cell transplantation (HLA sibling identical donor): search for optimal cutoff value by real-time PCR.
BMC infectious diseases 20100101
-
Mutually positive regulatory feedback loop between interferons and estrogen receptor-alpha in mice: implications for sex bias in autoimmunity.
PloS one 20100101
-
The novel deacetylase inhibitor AR-42 demonstrates pre-clinical activity in B-cell malignancies in vitro and in vivo.
PloS one 20100101
-
Pharmacokinetics of rituximab in patients with CD20 positive B-cell malignancies.
Human antibodies 20100101
-
Choice of immunosuppression influences cytomegalovirus DNAemia in cynomolgus monkey (Macaca fascicularis) islet allograft recipients.
Cell transplantation 20100101
-
First-line treatment of chronic lymphocytic leukemia: role of alemtuzumab.
OncoTargets and therapy 20100101
-
Combination of intensive chemotherapy and anticancer vaccines in the treatment of human malignancies: the hematological experience.
Journal of biomedicine & biotechnology 20100101
-
Challenges in treating older patients with acute myeloid leukemia.
Journal of oncology 20100101
-
Use of clofarabine for acute childhood leukemia.
Biologics : targets & therapy 20100101
-
Eosinophilic panniculitis and insect bite-like eruption in a patient with chronic lymphocytic leukaemia: a spectrum of the same entity.
Dermatology research and practice 20100101
-
Ring chromosome 18 abnormality in acute myelogenous leukemia: the clinical dilemma.
Journal of hematology & oncology 20100101
-
Immune hemolytic anemia associated with drug therapy.
Blood reviews 20100101
-
Life-threatening adenovirus infections in the setting of the immunocompromised allogeneic stem cell transplant patients.
Advances in hematology 20100101
-
The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition.
Journal of molecular signaling 20100101
-
Recent advances in the treatment of acute myeloid leukemia.
F1000 medicine reports 20100101
-
Molecular and therapeutic potential and toxicity of valproic acid.
Journal of biomedicine & biotechnology 20100101
-
Recurrent myelitis after allogeneic stem cell transplantation. Report of two cases.
BMC neurology 20100101
-
Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma.
Journal of hematology & oncology 20100101
-
Prozone effect of serum IgE levels in a case of plasma cell leukemia.
Journal of hematology & oncology 20100101
-
Vitamin D in combination cancer treatment.
Journal of Cancer 20100101
-
[The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia].
Terapevticheskii arkhiv 20100101
-
Biclonal follicular lymphoma: histological, clinical and molecular characteristics.
Pathology 20100101
-
Temsirolimus in the treatment of relapsed or refractory mantle cell lymphoma.
OncoTargets and therapy 20100101
-
Flow cytometry and polymerase chain reaction-based analyses of minimal residual disease in chronic lymphocytic leukemia.
Advances in hematology 20100101
-
Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia.
Journal of hematology & oncology 20100101
-
Aminoglycoside-free interventional antibiotic management in patients undergoing haemopoietic stem cell transplantation.
GMS Krankenhaushygiene interdisziplinar 20100101
-
Decompressive abdominal laparotomy for abdominal compartment syndrome in an unengrafted bone marrow recipient with septic shock.
Critical care research and practice 20100101
-
Overview of cellular immunotherapy for patients with glioblastoma.
Clinical & developmental immunology 20100101
-
Human vocal cord infection with the Microsporidium Anncaliia algerae.
The Journal of eukaryotic microbiology 20100101
-
The spectrum of coincident entities with small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL) diagnosed by cytology.
CytoJournal 20100101
-
The effects of forodesine in murine and human multiple myeloma cells.
Advances in hematology 20100101
-
Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with dyskeratosis congenita.
Acta haematologica 20100101
-
Functional characterization of FLT3 receptor signaling deregulation in acute myeloid leukemia by single cell network profiling (SCNP).
PloS one 20100101
-
Concomitant heterochromatinisation and down-regulation of gene expression unveils epigenetic silencing of RELB in an aggressive subset of chronic lymphocytic leukemia in males.
BMC medical genomics 20100101
-
Flavopiridol pharmacogenetics: clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol disposition.
PloS one 20100101
-
Expansion and characterization of human melanoma tumor-infiltrating lymphocytes (TILs).
PloS one 20100101
-
Epstein-Barr virus infection and chronic lymphocytic leukemia: a possible progression factor?
Infectious agents and cancer 20100101
-
Therapeutic activity of two xanthones in a xenograft murine model of human chronic lymphocytic leukemia.
Journal of hematology & oncology 20100101
-
[Influence of hepatitis C virus replication on splenic lymphoma with villous lymphocytes].
Acta medica portuguesa 20100101
-
Nelarabine in the treatment of refractory T-cell malignancies.
Clinical Medicine Insights. Oncology 20100101
-
Role of comorbidities in optimizing decision-making for allogeneic hematopoietic cell transplantation.
Mediterranean journal of hematology and infectious diseases 20100101
-
Rituximab for the treatment of patients with chronic lymphocytic leukemia.
Cancer management and research 20100101
-
Temsirolimus in the treatment of relapsed and/or refractory mantle cell lymphoma.
Cancer management and research 20100101
-
Treatment of cutaneous melanoma: current approaches and future prospects.
Cancer management and research 20100101
-
Rituximab administration and reactivation of HBV.
Hepatitis research and treatment 20100101
-
Can engineered 'designer' T cells outsmart chronic hepatitis B?
Hepatitis research and treatment 20100101
-
Focus on adoptive T cell transfer trials in melanoma.
Clinical & developmental immunology 20100101
-
Impact of autologous and allogeneic stem cell transplantation in peripheral T-cell lymphomas.
Advances in hematology 20100101
-
The spectrum of use of rituximab in chronic lymphocytic leukemia.
OncoTargets and therapy 20100101
-
How I treat elderly or comorbid patients with chronic lymphocytic leukemia.
Acta medica (Hradec Kralove) 20100101
-
Outcome of allogeneic stem cell transplantation following reduced-intensity conditioninig regimen in patients with idiopathic myelofibrosis: the g.I.T.m.o. Experience.
Mediterranean journal of hematology and infectious diseases 20100101
-
Application of new drugs in chronic lymphocytic leukemia.
Mediterranean journal of hematology and infectious diseases 20100101
-
Role of allogeneic transplantation in multiple myeloma in the era of new drugs.
Mediterranean journal of hematology and infectious diseases 20100101
-
Allogeneic hematopoietic cell transplantation in the treatment of chronic lymphocytic leukemia: why and when?
Mediterranean journal of hematology and infectious diseases 20100101
-
Role and timing of hematopoietic cell transplantation for myelodysplastic syndrome.
Mediterranean journal of hematology and infectious diseases 20100101
-
Allogeneic transplantation for chronic lymphocytic leukemia.
Mediterranean journal of hematology and infectious diseases 20100101
-
Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives.
Clinical & developmental immunology 20100101
-
Rituximab in the treatment of B-cell non-Hodgkin lymphoma, focus on outcomes and comparative effectiveness.
ClinicoEconomics and outcomes research : CEOR 20100101
-
Cladribine and Fludarabine Nucleoside Change the Levels of CD Antigens on B-Lymphoproliferative Disorders.
International journal of proteomics 20100101
-
The role of ofatumumab in the treatment of chronic lymphocytic leukemia resistant to previous therapies.
Journal of blood medicine 20100101
-
Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL).
Journal of blood medicine 20100101
-
Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome.
Blood 20091224
-
Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Blood 20091217
-
Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage.
Blood 20091217
-
IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide.
Annals of hematology 20091201
-
Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemia.
Bone marrow transplantation 20091201
-
Fludarabine, Cyclophosphamide and Rituximab: an effective chemoimmunotherapy combination with high remission rates for chronic lymphocytic leukaemia.
Irish journal of medical science 20091201
-
Mechanisms of anti-cancer action and pharmacology of clofarabine.
Biochemical pharmacology 20091201
-
Antileukemic activity of valproic acid in chronic lymphocytic leukemia B cells defined by microarray analysis.
Leukemia 20091201
-
Impaired up-regulation of polo-like kinase 2 in B-cell chronic lymphocytic leukaemia lymphocytes resistant to fludarabine and 2-chlorodeoxyadenosine: a potential marker of defective damage response.
British journal of haematology 20091201
-
Successful use of entecavir for a severe case of reactivation of hepatitis B virus following polychemotherapy containing rituximab.
Journal of hepatology 20091201
-
Lysophosphatidic acid receptor expression in chronic lymphocytic leukemia leads to cell survival mediated though vascular endothelial growth factor expression.
Leukemia & lymphoma 20091201
-
Critical review of the determination process by the Japanese reviewing authority in approving the additional efficacy of fludarabine phosphate.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091201
-
Graft-versus-leukemia effect of nonmyeloablative stem cell transplantation.
The Korean journal of internal medicine 20091201
-
Optimising the conditioning regimen for acute myeloid leukaemia.
Best practice & research. Clinical haematology 20091201
-
[Changes of lymphocyte subsets in acute leukemia patients after HLA-mismatched nonmyeloablative hematopoietic stem cell transplantation].
Zhongguo shi yan xue ye xue za zhi 20091201
-
[FLAG regimen as consolidation therapy for patients with acute myeloid leukemia].
Zhongguo shi yan xue ye xue za zhi 20091201
-
The role of regulatory T cells in cancer.
Immune network 20091201
-
[The clinical features and risk factors for invasive fungal infection in multiple myeloma.].
Zhonghua nei ke za zhi 20091201
-
[A multicenter retrospective analysis of diagnosis and treatment of 72 hemophagocytic syndrome patients.].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20091201
-
In defence of the use of modern chemotherapy regimens for the treatment of patients with chronic lymphocytic leukaemia.
Internal medicine journal 20091201
-
Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type.
Cancer 20091115
-
Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units.
Blood 20091105
-
Antineoplastic activity of idazoxan hydrochloride.
Cancer chemotherapy and pharmacology 20091101
-
Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU/MEL conditioning regimen in context with BU/CY2.
Bone marrow transplantation 20091101
-
The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia.
Leukemia 20091101
-
Low-dose subcutaneous alemtuzumab in refractory chronic lymphocytic leukaemia (CLL): results of a prospective, single-arm multicentre study.
Leukemia 20091101
-
Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patients.
Experimental hematology 20091101
-
5-year survival in patients with relapsed or refractory chronic lymphocytic leukemia in a randomized, phase III trial of fludarabine plus cyclophosphamide with or without oblimersen.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091101
-
Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia.
British journal of haematology 20091101
-
Primary del 17 chronic lymphocytic leukaemia lymphocytes are hypersensitive to dasatinib in vitro.
British journal of haematology 20091101
-
Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSF.
American journal of hematology 20091101
-
Bendamustine-associated hemolytic anemia.
The Annals of pharmacotherapy 20091101
-
Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20091101
-
Reduced-intensity conditioning followed by peripheral blood stem cell transplantation for adult patients with high-risk acute lymphoblastic leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20091101
-
Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20091101
-
Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20091101
-
The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia.
Cancer research 20091101
-
Successful treatment with reduced-intensity stem cell transplantation for secondary myelofibrosis following polycythemia vera.
[Rinsho ketsueki] The Japanese journal of clinical hematology 20091101
-
Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France.
Journal of hematopathology 20091101
-
Tetraspanin-induced death of myeloma cell lines is autophagic and involves increased UPR signalling.
British journal of cancer 20091020
-
Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma.
British journal of cancer 20091020
-
First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia.
Blood 20091015
-
Chemo-sensitivity in a panel of B-cell precursor acute lymphoblastic leukemia cell lines, YCUB series, derived from children.
Leukemia research 20091001
-
Delivery of high levels of anti-proliferative nucleoside triphosphates to CYP3A-expressing cells as a potential treatment for hepatocellular carcinoma.
Cancer chemotherapy and pharmacology 20091001
-
Steroid effects on ZAP-70 and SYK in relation to apoptosis in poor prognosis chronic lymphocytic leukemia.
Leukemia research 20091001
-
Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia.
Leukemia 20091001
-
Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study.
Leukemia 20091001
-
Primary central nervous system post-transplant lymphoproliferative disorder presenting as cerebral hemorrhage after unrelated bone marrow transplantation.
Transplant infectious disease : an official journal of the Transplantation Society 20091001
-
Diagnosis by sheer coincidence.
The international journal of cardiovascular imaging 20091001
-
Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma.
Cancer science 20091001
-
Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphoma.
British journal of haematology 20091001
-
Nonmyeloablative allogeneic hematopoietic stem cell transplantation as immunotherapy for pancreatic cancer.
Pancreas 20091001
-
Second unrelated cord blood transplantation using a reduced-intensity conditioning regimen combined with gemtuzumab ozogamicin in patients with relapsed acute myelogenous leukemia.
International journal of hematology 20091001
-
Therapy with the FCR regimen does not overcome chronic lymphocytic leukemia biology: aberrant p53 expression predicts response and survival.
Leukemia & lymphoma 20091001
-
FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience.
American journal of hematology 20091001
-
Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20091001
-
Charting the path to the cure of chronic lymphocytic leukemia: consolidation strategies currently lead the way.
Leukemia & lymphoma 20091001
-
The Simplified Mantle-Cell Lymphoma International Prognostic Index predicts overall survival but not progression-free survival in patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide +/- rituximab: results of a randomized phase II trial.
Leukemia & lymphoma 20091001
-
Unrelated hematopoietic stem cell transplantation for children with acute leukemia: experience at a single institution.
Journal of Korean medical science 20091001
-
[Effect of FLAG consolidation therapy on mobilization of autologous peripheral blood stem cells in patients with acute myelogenous leukemia].
Zhongguo shi yan xue ye xue za zhi 20091001
-
[Clinical analysis of 14 patients with lymphoma associated hemophagocytic syndrome].
Zhongguo shi yan xue ye xue za zhi 20091001
-
Modern concepts in the treatment of chronic lymphocytic leukemia.
Hematology (Amsterdam, Netherlands) 20091001
-
Infectious complications in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approaches to prophylaxis.
Clinical lymphoma & myeloma 20091001
-
Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901.
Leukemia & lymphoma 20091001
-
p53 expression by immunohistochemistry is an important determinant of survival in patients with chronic lymphocytic leukemia receiving frontline chemo-immunotherapy.
Leukemia & lymphoma 20091001
-
Tumor lysis syndrome following chlorambucil therapy for chronic lymphocytic leukemia: case report and review of the literature.
Tennessee medicine : journal of the Tennessee Medical Association 20091001
-
Chemoimmunotherapy with modified dosing of fludarabine, cyclophosphamide, and rituximab shows significant clinical activity in patients with previously untreated chronic lymphocytic leukemia.
Current hematologic malignancy reports 20091001
-
Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial.
Blood 20090924
-
Rituximab, fludarabine, cyclophosphamide, and mitoxantrone: a new, highly active chemoimmunotherapy regimen for chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090920
-
Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 study.
Lancet (London, England) 20090912
-
Low toxicity of a conditioning with 8-Gy total body irradiation, fludarabine and cyclophosphamide as preparative regimen for allogeneic hematopoietic stem cell transplantation in pediatric hematological malignancies.
Pediatric transplantation 20090901
-
Chronic lymphocytic leukemia: treatment options for patients with refractory disease.
Cancer 20090901
-
Fludarabine combinations for patients with advanced marginal zone lymphomas--best treatment option or too toxic?
British journal of haematology 20090901
-
Myeloid/natural killer cell precursor acute leukemia with multiple subcutaneous nodules as the initial presentation: a case report and literature review.
International journal of hematology 20090901
-
High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090901
-
Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090901
-
Rituximab for polyneuropathy with IgM monoclonal gammopathy.
Journal of neurology, neurosurgery, and psychiatry 20090901
-
Lenalidomide-induced upregulation of CD80 on tumor cells correlates with T-cell activation, the rapid onset of a cytokine release syndrome and leukemic cell clearance in chronic lymphocytic leukemia.
Haematologica 20090901
-
Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen.
Haematologica 20090901
-
Enhancing the action of rituximab in chronic lymphocytic leukemia by adding fresh frozen plasma: complement/rituximab interactions & clinical results in refractory CLL.
Annals of the New York Academy of Sciences 20090901
-
Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma.
Health technology assessment (Winchester, England) 20090901
-
I-Tositumomab in lymphoma.
Current oncology (Toronto, Ont.) 20090901
-
Carcinoma and multiple lymphomas in one patient: establishing the diagnoses and analyzing risk factors.
Journal of hematopathology 20090901
-
Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantation.
Blood 20090820
-
Forodesine has high antitumor activity in chronic lymphocytic leukemia and activates p53-independent mitochondrial apoptosis by induction of p73 and BIM.
Blood 20090820
-
Subcutaneous alemtuzumab in fludarabine-refractory chronic lymphocytic leukemia: clinical results and prognostic marker analyses from the CLL2H study of the German Chronic Lymphocytic Leukemia Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090820
-
IL-27 abrogates receptor activator of NF-kappa B ligand-mediated osteoclastogenesis of human granulocyte-macrophage colony-forming unit cells through STAT1-dependent inhibition of c-Fos.
Journal of immunology (Baltimore, Md. : 1950) 20090815
-
A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic cell transplant patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 20090815
-
Calcineurin-inhibitor-induced pain syndrome after a second allogeneic bone marrow transplantation for a child with aplastic anemia.
Pediatric transplantation 20090801
-
Twice daily fludarabine/Ara-C associated to idarubicin, G-CSF and ATRA is an effective salvage regimen in non-promyelocytic acute myeloid leukemia.
Leukemia research 20090801
-
Long-term follow-up of metastatic renal cancer patients undergoing reduced-intensity allografting.
Bone marrow transplantation 20090801
-
Drug cross-resistance and therapy-induced resistance in chronic lymphocytic leukaemia by an enhanced method of individualised tumour response testing.
British journal of haematology 20090801
-
Influence of MBL-2 mutations in the infection risk of patients with follicular lymphoma treated with rituximab, fludarabine, and cyclophosphamide.
Leukemia & lymphoma 20090801
-
Graft-versus-host disease prophylaxis with tacrolimus and mycophenolate mofetil in HLA-matched nonmyeloablative transplant recipients is associated with very low incidence of GVHD and nonrelapse mortality.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090801
-
A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090801
-
Immunotherapy of distant metastatic disease.
Annals of oncology : official journal of the European Society for Medical Oncology 20090801
-
Influence of lactate dehydrogenase and cyclosporine A level on the incidence of acute graft-versus-host disease after allogeneic stem cell transplantation.
Journal of Korean medical science 20090801
-
Successful salvage unrelated umbilical cord blood transplantation with two units after engraftment failure with single unit in severe aplastic anemia.
Journal of Korean medical science 20090801
-
[High-dose methylprednisolone for the treatment of refractory chronic lymphocytic leukemia].
Zhongguo shi yan xue ye xue za zhi 20090801
-
Roscovitine triggers apoptosis in B-cell chronic lymphocytic leukemia cells with similar efficiency as combinations of conventional purine analogs with cyclophosphamide.
Annals of the New York Academy of Sciences 20090801
-
[Successful treatment of T-cell prolymphocytic leukemia (T-PLL) with fludarabine monophosphate].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20090801
-
[Successful induction of complete remission by gemtuzumab ozogamicin following chemotherapy in three patients with relapsed or refractory acute myeloid leukemia].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20090801
-
[Multicenter report of nonmyeloablative allogeneic stem cell transplantation for hematologic diseases].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20090801
-
[Conditioning regimen containing fludarabine instead of cyclophosphamide for haploidentical hematopoietic stem cell transplantation].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20090801
-
Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 20090715
-
Thalidomide induces phosphorylation of histone H2AX and increases rate of apoptosis caused by fludarabine in malignant lymphocytes of chronic lymphocytic leukemia in short-term cell cultures.
Leukemia research 20090701
-
Therapy-related myelodysplastic syndrome with der(17)t(12;17)(q13;p13) as a new recurrent cytogenetic abnormality after treatment for chronic lymphocytic leukemia.
Leukemia research 20090701
-
In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
European journal of haematology 20090701
-
Novel therapies for peripheral T-cell non-Hodgkin's lymphomas.
Current opinion in hematology 20090701
-
Treatment of fludarabine-refractory chronic lymphocytic leukemia.
Cancer 20090701
-
Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090701
-
Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia.
Cancer research 20090701
-
Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation.
Journal of pediatric hematology/oncology 20090701
-
[Haploidentical hematopoietic stem cell transplantation for beta-thalassemia major in children].
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20090701
-
T-regulatory cell modulation: the future of cancer immunotherapy?
British journal of cancer 20090602
-
Second myeloablative allogeneic stem cell transplantation (SCT) using cord blood for leukemia relapsed after initial allogeneic SCT.
Leukemia research 20090601
-
The combined use of Flu/ATG in nonmyeloablative SCT for severe aplastic anemia with multiple earlier transfusions.
Bone marrow transplantation 20090601
-
Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome.
Bone marrow transplantation 20090601
-
Transepithelial fluxes of adenosine and 2'-deoxyadenosine across human renal proximal tubule cells: roles of nucleoside transporters hENT1, hENT2, and hCNT3.
American journal of physiology. Renal physiology 20090601
-
A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas.
British journal of haematology 20090601
-
Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090601
-
Clofarabine: a new treatment option for patients with acute myeloid leukemia.
Expert opinion on pharmacotherapy 20090601
-
Genzyme takes Campath bet.
Nature biotechnology 20090601
-
Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity.
Mini reviews in medicinal chemistry 20090601
-
Acute fibrinous and organizing pneumonia following hematopoietic stem cell transplantation.
The Korean journal of internal medicine 20090601
-
The clinical outcome of FLAG chemotherapy without idarubicin in patients with relapsed or refractory acute myeloid leukemia.
Journal of Korean medical science 20090601
-
[Clinical study on fludarabine combined with cytarabine regimen in the treatment of patients with refractory and relapsed acute myeloid leukemia].
Zhongguo shi yan xue ye xue za zhi 20090601
-
Reduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemia.
Current opinion in oncology 20090601
-
Fludarabine phosphate for the first-line treatment of chronic lymphocytic leukaemia.
Health technology assessment (Winchester, England) 20090601
-
Fludarabine and melphalan conditioning with tacrolimus as GVHD prophylaxis for allogeneic stem cell transplant recipients is an effective reduced-intensity combination regimen compared to the conventional regimen.
International journal of clinical oncology 20090601
-
Pentostatin treatment combinations in chronic lymphocytic leukemia.
Clinical advances in hematology & oncology : H&O 20090601
-
[Toxoplasmosis after immunosuppressive therapy--our experience].
Klinicka mikrobiologie a infekcni lekarstvi 20090601
-
Lymphoplasmacytic lymphoma with IgA hypergammaglobulinemia and liver involvement.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20090601
-
Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach.
Blood 20090528
-
Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery.
Blood 20090507
-
Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML.
Bone marrow transplantation 20090501
-
Reduced-intensity conditioning for severe aplasia using fludarabine and CY followed by infusion of ex vivo T-cell-depleted grafts leads to excellent engraftment and absence of GVHD.
Bone marrow transplantation 20090501
-
Oxidative stress and delta-ALA-D activity in different conditioning regimens in allogeneic bone marrow transplantation patients.
Clinical biochemistry 20090501
-
Allogeneic hematopoietic stem cell transplantation of patients with FA and high risk features using fludarabine without radiation.
Pediatric blood & cancer 20090501
-
A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma.
Leukemia 20090501
-
Anthracycline-fludarabine-containing regimens with or without rituximab in the treatment of patients with advanced follicular lymphoma.
Cancer 20090501
-
Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity.
European journal of pharmacology 20090501
-
[Anti-CD20 in hematologic oncology].
Presse medicale (Paris, France : 1983) 20090501
-
Current treatments of chronic immune-mediated demyelinating polyneuropathies.
Muscle & nerve 20090501
-
Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients.
Journal of immunotherapy (Hagerstown, Md. : 1997) 20090501
-
Bone marrow CFU-GM and human tumor xenograft efficacy of three antitumor nucleoside analogs.
International journal of oncology 20090501
-
Busulfan in hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090501
-
Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090501
-
Autoimmune pancytopenia following combination chemotherapy for chronic lymphocytic leukaemia.
Journal of clinical pathology 20090501
-
Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanoma.
Ophthalmology 20090501
-
Allogeneic hematopoietic cell transplantation for refractory myasthenia gravis.
Archives of neurology 20090501
-
Radioresistance of Stat1 over-expressing tumour cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signalling.
International journal of radiation biology 20090501
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20090501
-
Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia.
Blood 20090416
-
Long-term persistence of nonpathogenic clonal chromosome abnormalities in donor hematopoietic cells after allogeneic stem cell transplantation.
Cancer genetics and cytogenetics 20090415
-
Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.
Blood 20090402
-
Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens.
Blood 20090402
-
Intracellular disposition of fludarabine triphosphate in human natural killer cells.
Cancer chemotherapy and pharmacology 20090401
-
Central and peripheral nervous system toxicity of common chemotherapeutic agents.
Cancer chemotherapy and pharmacology 20090401
-
Rituximab-associated acute thrombocytopenia: an under-diagnosed phenomenon.
American journal of hematology 20090401
-
Drug induction apoptosis assay as predictive value of chemotherapy response in patients with B-cell chronic lymphocytic leukemia.
Leukemia & lymphoma 20090401
-
[IDA-FLAG regimen in treatment of patients with refractory or relapsed acute leukemia].
Zhongguo shi yan xue ye xue za zhi 20090401
-
A kernel for open source drug discovery in tropical diseases.
PLoS neglected tropical diseases 20090401
-
A challenge to the claims that fludarabine and cyclophosphamide is the new standard treatment for chronic lymphocytic leukaemia.
Internal medicine journal 20090401
-
A single apheresis procedure in the donor may be enough to complete an allograft using the 'Mexican method' of non-ablative allografting.
Blood transfusion = Trasfusione del sangue 20090401
-
Alemtuzumab: new indication. First line treatment of chronic lymphocytic leukaemia: continue to use oral chlorambucil.
Prescrire international 20090401
-
Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation.
Blood 20090326
-
Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases.
Molecules (Basel, Switzerland) 20090323
-
Clinical response and pharmacokinetics from a phase 1 study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemia.
Blood 20090319
-
Follicular lymphoma in the United States: first report of the national LymphoCare study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090310
-
Chronic active Epstein-Barr virus infection with mosquito allergy successfully treated with reduced-intensity unrelated allogeneic bone marrow transplantation in a boy.
Pediatric transplantation 20090301
-
Feasibility of a dose-adjusted fludarabine-melphalan conditioning prior autologous stem cell transplantation in a dialysis-dependent patient with mantle cell lymphoma.
Annals of hematology 20090301
-
Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial.
Leukemia 20090301
-
Allogeneic blood SCT for children with Hurler's syndrome: results from the German multicenter approach MPS-HCT 2005.
Bone marrow transplantation 20090301
-
Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen.
Bone marrow transplantation 20090301
-
HIV-1 gp120 induces cytokine expression, leukocyte adhesion, and transmigration across the blood-brain barrier: modulatory effects of STAT1 signaling.
Microvascular research 20090301
-
Fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia: no country for old men?
Nature clinical practice. Oncology 20090301
-
Continuous infusion of intermediate-dose cytarabine and fludarabine with idarubicin for patients younger than 60 years with resistant acute myeloid leukemia: a prospective, multicenter phase II study.
American journal of hematology 20090301
-
Fludarabine, cyclophosphamide, anti-thymocyteglobulin, and low-dose total body irradiation conditioning enables 1-HLA-locus-mismatched hematopoietic stem cell transplantation for very severe aplastic anemia without affecting ovarian function.
American journal of hematology 20090301
-
Impairment of peripheral blood stem-cell mobilisation in patients with mantle-cell lymphoma following primary treatment with fludarabine and cyclophosphamide +/- rituximab.
Leukemia & lymphoma 20090301
-
Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysis.
Leukemia & lymphoma 20090301
-
Incorporating the use of GM-CSF in the treatment of chronic lymphocytic leukemia.
Leukemia & lymphoma 20090301
-
Assessment of bone marrow response in Waldenström's macroglobulinemia.
Clinical lymphoma & myeloma 20090301
-
Rituximab-based treatments in Waldenström's macroglobulinemia.
Clinical lymphoma & myeloma 20090301
-
Fludarabine-based combination therapies for Waldenström's macroglobulinemia.
Clinical lymphoma & myeloma 20090301
-
Cold agglutinin-mediated autoimmune hemolytic anemia in Waldenström's macroglobulinemia.
Clinical lymphoma & myeloma 20090301
-
Development of cell-cycle inhibitors for cancer therapy.
Current oncology (Toronto, Ont.) 20090301
-
Allogeneic hematopoietic cell transplantation for patients with myelofibrosis.
Current opinion in hematology 20090301
-
A novel phenotypic method to determine fludarabine triphosphate accumulation in T-lymphocytes from hematopoietic cell transplantation patients.
Cancer chemotherapy and pharmacology 20090201
-
Calorimetric study as a potential test for choosing treatment of B-cell chronic lymphocytic leukemia.
Leukemia research 20090201
-
Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients.
Annals of hematology 20090201
-
Bendamustine, but not fludarabine, exhibits a low stem cell toxicity in vitro.
Journal of cancer research and clinical oncology 20090201
-
Successful allogeneic unrelated bone marrow transplantation using reduced-intensity conditioning for the treatment of X-linked adrenoleukodystrophy in a one-yr-old boy.
Pediatric transplantation 20090201
-
Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3-6/6 HLA matched donors.
Bone marrow transplantation 20090201
-
Stem cell factor and high-dose twice daily filgrastim is an effective strategy for peripheral blood stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine: results of a Phase II study with an historical comparator.
Leukemia 20090201
-
Presence of heterozygous ATM deletion may not be critical in the primary response of chronic lymphocytic leukemia cells to fludarabine.
European journal of haematology 20090201
-
Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia.
British journal of haematology 20090201
-
Variations on the fludarabine, cyclophosphamide, and rituximab combination in chronic lymphocytic leukemia therapy: what have we learned?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090201
-
Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090201
-
Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responses.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090201
-
Allogeneic stem cell transplantation for severe aplastic anemia: graft rejection remains a problem.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 20090201
-
Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090201
-
Toxicity of fludarabine and cyclophosphamide with or without rituximab as initial therapy for patients with previously untreated mantle cell lymphoma: results of a randomised phase II study.
Leukemia & lymphoma 20090201
-
Reversible foetal cerebral ventriculomegaly and cardiomyopathy under chemotherapy for maternal AML.
Onkologie 20090201
-
Registry of Hospital das Clínicas of the University of São Paulo Medical School: first official solid organ and tissue transplantation report - 2008.
Clinics (Sao Paulo, Brazil) 20090201
-
Alkylating agents for Waldenstrom's macroglobulinaemia.
The Cochrane database of systematic reviews 20090121
-
Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090120
-
Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab.
Blood 20090115
-
Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090110
-
Dasatinib induces a response in chronic lymphocytic leukemia.
Blood 20090108
-
Human concentrative nucleoside transporter 3 is a determinant of fludarabine transportability and cytotoxicity in human renal proximal tubule cell cultures.
Cancer chemotherapy and pharmacology 20090101
-
A combination therapy with fludarabine, mitoxantrone and rituximab induces complete immunophenotypical remission in B-cell prolymphocytic leukaemia.
Annals of hematology 20090101
-
Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT.
Bone marrow transplantation 20090101
-
AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance.
Blood 20090101
-
Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease.
Immunologic research 20090101
-
Pharmacokinetics of alemtuzumab in combination with fludarabine in patients with relapsed or refractory B-cell chronic lymphocytic leukemia.
Haematologica 20090101
-
[First-line therapy of chronic lymphocytic leukemia in the elderly: be careful with overtreatment].
Presse medicale (Paris, France : 1983) 20090101
-
Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells.
British journal of haematology 20090101
-
Consolidation with alemtuzumab improves progression-free survival in patients with chronic lymphocytic leukaemia (CLL) in first remission: long-term follow-up of a randomized phase III trial of the German CLL Study Group (GCLLSG).
British journal of haematology 20090101
-
Central nervous system infections in immunocompromised patients: update on diagnostics and therapy.
Leukemia & lymphoma 20090101
-
Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols.
Haematologica 20090101
-
Radiosensitization by inhibiting STAT1 in renal cell carcinoma.
International journal of radiation oncology, biology, physics 20090101
-
Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090101
-
Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090101
-
A Phase II trial of autologous stem cell transplantation followed by mini-allogeneic stem cell transplantation for the treatment of multiple myeloma: an analysis of Eastern Cooperative Oncology Group ECOG E4A98 and E1A97.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090101
-
Enhancing the efficacy of cisplatin in ovarian cancer treatment - could arsenic have a role.
Journal of ovarian research 20090101
-
Reduced-intensity conditioning allogeneic hematopoietic cell transplantation using oral fludarabine as part of the conditioning regimen.
Cytotherapy 20090101
-
Brucella bacteremia in a recipient of an allogeneic hematopoietic stem cell transplant: a case report.
Cases journal 20090101
-
Influence of vector design and host cell on the mechanism of recombination and emergence of mutant subpopulations of replicating retroviral vectors.
BMC molecular biology 20090101
-
[Treatment of Waldenström macroglobulinaemia--the experience of one centre].
Vnitrni lekarstvi 20090101
-
ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC.
BMC cancer 20090101
-
Fludarabine modulates immune response and extends in vivo survival of adoptively transferred CD8 T cells in patients with metastatic melanoma.
PloS one 20090101
-
Studies on the binding affinity of anticancer drug mitoxantrone to chromatin, DNA and histone proteins.
Journal of biomedical science 20090101
-
Chronic lymphocytic leukaemia: current first-line therapy.
Internal medicine journal 20090101
-
R-CHOP versus R-CVP in the treatment of follicular lymphoma: a meta-analysis and critical appraisal of current literature.
Journal of hematology & oncology 20090101
-
Fludarabine-based reduced intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia and fungal infections.
Clinical transplantation 20090101
-
Type I interferons and interferon regulatory factors regulate TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected macrophages.
PloS one 20090101
-
Delta-ALA-D activity is a reliable marker for oxidative stress in bone marrow transplant patients.
BMC cancer 20090101
-
Fludarabine in the treatment of chronic lymphocytic leukemia: a review.
Therapeutics and clinical risk management 20090101
-
FOXP3 expression following bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning.
Immunologic research 20090101
-
Radiotherapy combined with intratumoral dendritic cell vaccination enhances the therapeutic efficacy of adoptive T-cell transfer.
Journal of immunotherapy (Hagerstown, Md. : 1997) 20090101
-
Targeted treatment of acute myeloid leukemia in older adults: role of gemtuzumab ozogamicin.
Clinical interventions in aging 20090101
-
STAT1 pathway mediates amplification of metastatic potential and resistance to therapy.
PloS one 20090101
-
Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?
Breast cancer research : BCR 20090101
-
A 15-year-old girl with pancytopenia and congenital defects.
Annals of Saudi medicine 20090101
-
Update in the management of chronic lymphocytic leukemia.
Journal of hematology & oncology 20090101
-
9-Aminoacridine inhibition of HIV-1 Tat dependent transcription.
Virology journal 20090101
-
Long-lasting response of chronic lymphocytic leukemia and multiple sclerosis in a patient treated with oral fludarabine alone.
Tumori 20090101
-
Economic burden of follicular non-Hodgkin's lymphoma.
PharmacoEconomics 20090101
-
Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance.
Journal of translational medicine 20090101
-
Generalized leukaemia cutis from a small cell variant of T-cell prolymphocytic leukaemia presenting with exfoliative dermatitis.
Acta dermato-venereologica 20090101
-
[Cost-reduction analysis for oral versus intravenous fludarabine (Beneflur) in Spain].
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20090101
-
Drugs associated with more suicidal ideations are also associated with more suicide attempts.
PloS one 20090101
-
Inflammation of actinic keratosis with combination of alkylating and taxane agents: a case report.
Cases journal 20090101
-
Successful treatment of severe sinusoidal obstruction syndrome despite multiple organ failure with defibrotide after allogeneic stem cell transplantation: a case report.
Journal of medical case reports 20090101
-
Oncogenic RAS enables DNA damage- and p53-dependent differentiation of acute myeloid leukemia cells in response to chemotherapy.
PloS one 20090101
-
Re-transplantation from the same unrelated donor in three adolescents with severe aplastic anemia after graft rejection.
Klinische Padiatrie 20090101
-
STAT1-dependent expression of energy metabolic pathways links tumour growth and radioresistance to the Warburg effect.
BMC medicine 20090101
-
Current and emerging treatments for chronic lymphocytic leukaemia.
Drugs 20090101
-
Full response of a localized renal tumour after reduced-intensity conditioned hematopoietic stem cell transplantation.
Case reports in medicine 20090101
-
An MDM2 antagonist (MI-319) restores p53 functions and increases the life span of orally treated follicular lymphoma bearing animals.
Molecular cancer 20090101
-
Characterization of an engineered human purine nucleoside phosphorylase fused to an anti-her2/neu single chain Fv for use in ADEPT.
Journal of experimental & clinical cancer research : CR 20090101
-
Outpatient-based therapy of oral fludarabine and subcutaneous alemtuzumab for asian patients with relapsed/refractory chronic lymphocytic leukemia.
Advances in hematology 20090101
-
Drug-induced hematologic syndromes.
Advances in hematology 20090101
-
Drug-induced immune hemolytic anemia.
Hematology. American Society of Hematology. Education Program 20090101
-
Immune hemolytic anemia--selected topics.
Hematology. American Society of Hematology. Education Program 20090101
-
State-of-the-art treatment of chronic lymphocytic leukemia.
Hematology. American Society of Hematology. Education Program 20090101
-
Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt/beta-catenin pathway.
PloS one 20090101
-
New targets for the treatment of follicular lymphoma.
Journal of hematology & oncology 20090101
-
Myelofibrosis-associated lymphoproliferative disease: retrospective study of 16 cases and literature review.
Advances in hematology 20090101
-
Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer.
Journal of oncology 20090101
-
Treatment options for ocular adnexal lymphoma (OAL).
Clinical ophthalmology (Auckland, N.Z.) 20090101
-
Development of fludarabine formulations in the treatment of chronic lymphocytic leukemia.
Drug design, development and therapy 20090101
-
An immunocompetent patient presenting with severe nasal herpes simplex: a case report.
Cases journal 20090101
-
Enhanced Expression of Radiation-induced Leukocyte CDKN1A mRNA in Multiple Primary Breast Cancer Patients: Potential New Marker of Cancer Susceptibility.
Biomarker insights 20090101
-
Non-Hodgkin's lymphoma associated membranoproliferative glomerulonephritis: rare case of long term remission with chemotherapy: a case report.
Cases journal 20090101
-
Rituximab for the treatment of refractory pediatric autoimmune diseases: a case series.
Cases journal 20090101
-
Specific factors influence the success of autologous and allogeneic hematopoietic stem cell transplantation.
Oxidative medicine and cellular longevity 20090101
-
Progressive multifocal leukoencephalopathy developing in a fludarabine naïve patient with chronic lymphocytic leukemia.
International journal of general medicine 20090101
-
Immunoregulation through IL-10 gene expression and the fate of cytotoxic T lymphocyte-mediated tumor immunotherapy.
Indian journal of human genetics 20090101
-
Role of bendamustine in the treatment of chronic lymphocytic leukemia.
OncoTargets and therapy 20090101
-
Expanded use of rituximab in the management of non-Hodgkin lymphoma.
OncoTargets and therapy 20090101
-
Update on the rational use of Y-ibritumomab tiuxetan in the treatment of follicular lymphoma.
OncoTargets and therapy 20090101
-
Profile of nelarabine: use in the treatment of T-cell acute lymphoblastic leukemia.
OncoTargets and therapy 20090101
-
Update on the rational use of tositumomab and iodine-131 tositumomab radioimmunotherapy for the treatment of non-Hodgkin's lymphoma.
OncoTargets and therapy 20090101
-
Bendamustine in the treatment of non-Hodgkin's lymphomas.
OncoTargets and therapy 20090101
-
Hematopoietic stem cell transplantation in patients with myelodysplastic syndrome.
F1000 medicine reports 20090101
-
The role of azacitidine in the management of myelodysplastic syndromes (MDS).
Cancer management and research 20090101
-
Review of Y-ibritumomab tiuxetan as first-line consolidation radio-immunotherapy for B-cell follicular non-Hodgkin's lymphoma.
Cancer management and research 20090101
-
The role of bendamustine in the treatment of indolent non-Hodgkin lymphoma.
Cancer management and research 20090101
-
Management of HBV infection during immunosuppressive treatment.
Mediterranean journal of hematology and infectious diseases 20090101
-
Aplastica anemia and viral hepatitis.
Mediterranean journal of hematology and infectious diseases 20090101
-
Hematopietic stem cell transplantation in thalassemia and related disorders.
Mediterranean journal of hematology and infectious diseases 20090101
-
Hematopoietic stem cell transplantation in thalassemia and sickle cell disease. Unicenter experience in a multi-ethnic population.
Mediterranean journal of hematology and infectious diseases 20090101
-
Epstein-barr virus related lymphoproliferations after stem cell transplantation.
Mediterranean journal of hematology and infectious diseases 20090101
-
c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches.
Blood 20081215
-
The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine.
Clinical cancer research : an official journal of the American Association for Cancer Research 20081215
-
Rates of inclusion of teenagers and young adults in England into National Cancer Research Network clinical trials: report from the National Cancer Research Institute (NCRI) Teenage and Young Adult Clinical Studies Development Group.
British journal of cancer 20081209
-
A conditioning regimen of busulfan, fludarabine, and melphalan for allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia.
Pediatric transplantation 20081201
-
Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years.
Leukemia research 20081201
-
Low-dose oral fludarabine plus cyclophosphamide in elderly patients with untreated and relapsed or refractory chronic lymphocytic Leukaemia.
Hematological oncology 20081201
-
Massive swelling of the cervical region: an uncommon manifestation of B cell chronic lymphocytic leukemia.
Oral and maxillofacial surgery 20081201
-
Using reduced intensity conditioning and HLA-identical sibling donors, antithymocyte globulin increases the risk of relapse, which can be overcome by a high stem cell dose.
Bone marrow transplantation 20081201
-
400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 20081201
-
Treatment of core-binding-factor in acute myelogenous leukemia with fludarabine, cytarabine, and granulocyte colony-stimulating factor results in improved event-free survival.
Cancer 20081201
-
Identification of TIGAR in the equilibrative nucleoside transporter 2-mediated response to fludarabine in chronic lymphocytic leukemia cells.
Haematologica 20081201
-
Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation.
British journal of haematology 20081201
-
Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabine in vitro.
British journal of haematology 20081201
-
Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target.
Molecular cancer research : MCR 20081201
-
Small-molecule Bcl-2 antagonists as targeted therapy in oncology.
Current oncology (Toronto, Ont.) 20081201
-
Rituximab in the treatment of non-Hodgkin's lymphoma.
Biologics : targets & therapy 20081201
-
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Journal of medicinal chemistry 20081113
-
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081110
-
Non-homologous end joining is the responsible pathway for the repair of fludarabine-induced DNA double strand breaks in mammalian cells.
Mutation research 20081110
-
Leptin inhibits rosiglitazone-induced adipogenesis in murine primary adipocytes.
Molecular and cellular endocrinology 20081106
-
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration.
Annals of hematology 20081101
-
Preferential sensitivity of hematopoietic (HPs) and mesenchymal (MPs) progenitors to fludarabine suggests impaired bone marrow niche and HP mobilization.
Leukemia 20081101
-
Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers.
Blood 20081101
-
Immunohistochemistry for human concentrative nucleoside transporter 3 protein predicts fludarabine sensitivity in chronic lymphocytic leukemia.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20081101
-
Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases.
European journal of haematology 20081101
-
p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism.
Blood 20081101
-
Images in haematology. Cerebral nocardiosis in a patient with lymphoplasmacytic lymphoma treated with fludarabine.
British journal of haematology 20081101
-
Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia.
Leukemia 20081101
-
Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies.
Journal of clinical pathology 20081101
-
Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience.
British journal of haematology 20081101
-
Monitoring for cytomegalovirus and Epstein-Barr virus infection in chronic lymphocytic leukemia patients receiving i.v. fludarabine-cyclophosphamide combination and alemtuzumab as consolidation therapy.
Haematologica 20081101
-
Epstein-Barr virus-associated B-cell lymphoma secondary to FCD-C therapy in patients with peripheral T-cell lymphoma.
International journal of hematology 20081101
-
Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20081101
-
Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20081101
-
The effect of in vivo T cell depletion with alemtuzumab on reduced-intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20081101
-
Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20081101
-
Successful outcome after nonmyeloablative allogeneic hematopoietic stem cell transplantation in patients with renal dysfunction.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20081101
-
Mycobacterium haemophilum infection after alemtuzumab treatment.
Emerging infectious diseases 20081101
-
Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major.
British journal of haematology 20081101
-
[Limited but potential efficacy by graft-versus-leukemia (GVL) for Pro T-ALL].
Gan to kagaku ryoho. Cancer & chemotherapy 20081101
-
Fatal acute liver failure due to reactivation of hepatitis B following treatment with fludarabine/cyclophosphamide/rituximab for low grade non-Hodgkin's lymphoma.
European journal of medical research 20081027
-
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081020
-
Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation.
Blood 20081015
-
Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease.
Transplantation 20081015
-
Synergy of Irofulven in combination with various anti-metabolites, enzyme inhibitors, and miscellaneous agents in MV522 lung carcinoma cells: marked interaction with gemcitabine and 5-fluorouracil.
Investigational new drugs 20081001
-
Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patients.
Cancer chemotherapy and pharmacology 20081001
-
Polyadenylation inhibition by the triphosphates of deoxyadenosine analogues.
Leukemia research 20081001
-
Simultaneous islet and kidney transplantation in seven patients with type 1 diabetes and end-stage renal disease using a glucocorticoid-free immunosuppressive regimen with alemtuzumab induction.
Diabetes 20081001
-
Fludarabine based treatment caused improvement of anemia in a patient with T-cell LGL leukemia despite evidence of the persistence of the abnormal T-cell clone.
Leukemia & lymphoma 20081001
-
Novel human antibody therapeutics: the age of the Umabs.
Biotechnology journal 20081001
-
High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemia.
British journal of haematology 20081001
-
Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies.
International journal of hematology 20081001
-
Impact of T cell chimerism on clinical outcome in 117 patients who underwent allogeneic stem cell transplantation with a busulfan-containing reduced-intensity conditioning regimen.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20081001
-
[Chronic lymphocytic leukemia and the related disorders].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20081001
-
Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions.
Molecular cancer therapeutics 20081001
-
HSCT for Fanconi anemia in children: factors that influence early and late results.
Bone marrow transplantation 20081001
-
Risk-adapted procedures for HSCT from alternative donor in children with severe aplastic anaemia.
Bone marrow transplantation 20081001
-
Treating recurrent cases of squamous cell carcinoma with radiotherapy.
Current oncology (Toronto, Ont.) 20081001
-
Survival from non-Hodgkin lymphoma in England and Wales up to 2001.
British journal of cancer 20080923
-
Survival from adult leukaemia in England and Wales up to 2001.
British journal of cancer 20080923
-
Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
Chinese medical journal 20080920
-
Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia.
Cancer 20080915
-
Imatinib inhibition of fludarabine uptake in T-lymphocytes.
Cancer chemotherapy and pharmacology 20080901
-
Fludarabine combination therapy for follicular lymphoma followed by acute myeloid leukemia: two further case records.
Leukemia 20080901
-
Long-term follow-up after nonmyeloablative allogeneic hematopoietic stem cell transplantation for systemic sclerosis.
Clinical rheumatology 20080901
-
The HMG-CoA inhibitor, simvastatin, triggers in vitro anti-tumour effect and decreases IgM secretion in Waldenstrom macroglobulinaemia.
British journal of haematology 20080901
-
Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism.
Blood 20080901
-
Treosulfan/fludarabine as an allogeneic hematopoietic stem cell transplant conditioning regimen for high-risk patients.
American journal of hematology 20080901
-
Epstein-Barr virus reactivation is a potentially severe complication in chronic lymphocytic leukemia patients with poor prognostic biological markers and fludarabine refractory disease.
Haematologica 20080901
-
Adding fresh frozen plasma to rituximab for the treatment of patients with refractory advanced CLL.
QJM : monthly journal of the Association of Physicians 20080901
-
Consolidation and maintenance rituximab therapy in chronic lymphocytic leukemia.
Current oncology reports 20080901
-
Pentostatin in chronic lymphocytic leukemia.
Expert opinion on drug metabolism & toxicology 20080901
-
Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080901
-
Unrelated cord blood transplantation for severe aplastic anemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080901
-
Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides.
Molecular cancer therapeutics 20080901
-
Umbilical cord-blood transplantations from unrelated donors in patients with inherited metabolic diseases: Single-institute experience.
Pediatric transplantation 20080901
-
Emerging hematological targets and therapy for cardiovascular disease: From bench to bedside.
Biologics : targets & therapy 20080901
-
Advances in the treatment of monoclonal gammopaties: The emerging role of targeted therapy in plasma cell dyscrasias.
Biologics : targets & therapy 20080901
-
Tipifarnib in the treatment of newly diagnosed acute myelogenous leukemia.
Biologics : targets & therapy 20080901
-
Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia.
Blood 20080815
-
The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgVH genes.
Blood 20080815
-
Impact of drug therapy, radiation dose, and dose rate on renal toxicity following bone marrow transplantation.
International journal of radiation oncology, biology, physics 20080801
-
Auto-immune neutropenia associated with metformin in a patient with splenic marginal zone lymphoma.
Pharmacy world & science : PWS 20080801
-
Characterization of acute graft-versus-host disease following reduced-intensity stem-cell transplantation from an HLA-identical related donor.
American journal of hematology 20080801
-
Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman-Diamond syndrome.
Bone marrow transplantation 20080801
-
Acquired pure red cell aplasia: updated review of treatment.
British journal of haematology 20080801
-
Transplantation from matched siblings using once-daily intravenous busulfan/fludarabine with thymoglobulin: a myeloablative regimen with low nonrelapse mortality in all but older patients with high-risk disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080801
-
Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080801
-
Sirolimus, tacrolimus, and low-dose methotrexate as graft-versus-host disease prophylaxis in related and unrelated donor reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080801
-
The combined effect of fludarabine monophosphate and radiation as well as gemcitabine and radiation on squamous carcinoma tumor cell lines in vitro.
International journal of radiation biology 20080801
-
[Treatment of chronic lymphocytic leukemia with regimen of fludarabine, cyclophosphamide and rituximab].
Zhongguo shi yan xue ye xue za zhi 20080801
-
Allogeneic transplantation following nonmyeloablative conditioning for aggressive lymphoma.
Bone marrow transplantation 20080801
-
Bone marrow and stem cell transplantation at King Hussein cancer center.
Bone marrow transplantation 20080801
-
Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia.
Leukemia & lymphoma 20080801
-
[Allogeneic hematopoietic stem cell transplantation following reduced intensity conditioning regimen for treatment of refractory leukemia].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20080801
-
Bendamustine HCL for the treatment of relapsed indolent non-Hodgkin's lymphoma.
Therapeutics and clinical risk management 20080801
-
Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignancies.
Blood 20080715
-
lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 20080715
-
CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers.
British journal of cancer 20080708
-
Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia.
Leukemia research 20080701
-
Infectious complications in chronic graft-versus-host disease: a retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced- and conventional-intensity conditioning regimens.
Transplant infectious disease : an official journal of the Transplantation Society 20080701
-
Successful bone marrow transplantation in a girl with Fanconi anemia and preterminal renal failure.
Bone marrow transplantation 20080701
-
Comparable engraftment and chimerism kinetics using oral and intravenous fludarabine as part of a reduced intensity conditioning regimen.
Bone marrow transplantation 20080701
-
Selective killing of Mycobacterium avium-infected macrophages by inhibition of phosphorylated signal transducer and activator of transcription type 1.
The Journal of infectious diseases 20080701
-
Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials - a systematic review to evaluate the added value in supporting clinical decision making.
European journal of cancer (Oxford, England : 1990) 20080701
-
Alemtuzumab for B-cell chronic lymphocytic leukemia.
Expert review of anticancer therapy 20080701
-
Comment to: Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study. Haematologica 2008; 93:398-403.
Haematologica 20080701
-
Frontline therapy for chronic lymphocytic leukemia: the dilemma continues.
Clinical cancer research : an official journal of the American Association for Cancer Research 20080701
-
[Prognostic significance of p53 and ATM gene deletion in patients with chronic lymphocytic leukemia].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20080701
-
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.
Blood 20080615
-
DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 20080615
-
[Novel medical treatment modalities in hematology].
Ugeskrift for laeger 20080609
-
Fludarabine/i.v. BU conditioning regimen: myeloablative, reduced intensity or both?
Bone marrow transplantation 20080601
-
Heterogeneity in the therapeutic approach to relapsed elderly patients with acute myeloid leukaemia: a survey from the Gruppo Italiano Malattie Ematologiche dell' Adulto (GIMEMA) Acute Leukaemia Working Party.
Hematological oncology 20080601
-
CsA can induce DNA double-strand breaks: implications for BMT regimens particularly for individuals with defective DNA repair.
Bone marrow transplantation 20080601
-
Lysophosphatidic acid (LPA) induces the expression of VEGF leading to protection against apoptosis in B-cell derived malignancies.
Cellular signalling 20080601
-
Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma.
Leukemia 20080601
-
Fludarabine, cyclophosphamide and rituximab (FCR) induced pulmonary hypertension in Waldenstrom macroglobulinemia.
Leukemia & lymphoma 20080601
-
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080601
-
Reduced-intensity conditioning allogeneic transplantation from unrelated donors: evaluation of mycophenolate mofetil plus cyclosporin A as graft-versus-host disease prophylaxis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080601
-
Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080601
-
Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia/lymphoma: impact of antithymocyte globulin on clinical outcome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080601
-
Treosulfan and fludarabine low-toxicity conditioning for allogeneic haematopoietic stem cell transplantation in chronic myeloid leukaemia.
British journal of haematology 20080601
-
Targeted therapies in Waldenström macroglobulinemia.
Current opinion in investigational drugs (London, England : 2000) 20080601
-
Non-MALT marginal zone lymphomas.
Annals of oncology : official journal of the European Society for Medical Oncology 20080601
-
Ofatumumab, a human monoclonal antibody for lymphoid malignancies and autoimmune disorders.
Current opinion in molecular therapeutics 20080601
-
Fludarabine induces differential expression of proteins in human leukemia and lymphoma cells.
Nucleosides, nucleotides & nucleic acids 20080601
-
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells.
Journal of cellular biochemistry 20080515
-
Cytotoxic activities of nucleoside and nucleobase analog drugs in malignant mesothelioma: characterization of a novel nucleobase transport activity.
Biochemical pharmacology 20080515
-
Adoptive transfer of T(reg) depleted autologous T cells in advanced renal cell carcinoma.
Cancer immunology, immunotherapy : CII 20080501
-
CD-34 selected hematopoetic stem cell transplantation from HLA identical family members for fanconi anemia.
Pediatric blood & cancer 20080501
-
Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome--Polish Adult Leukemia Group (PALG) pilot study.
Annals of hematology 20080501
-
IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitro.
Blood 20080501
-
A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantation.
Bone marrow transplantation 20080501
-
The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target.
Blood 20080501
-
Haematopoietic cell transplantation with non-myeloablative conditioning in Denmark: disease-specific outcome, complications and hospitalization requirements of the first 100 transplants.
Bone marrow transplantation 20080501
-
Arsenic trioxide induces apoptosis preferentially in B-CLL cells of patients with unfavourable prognostic factors including del17p13.
Journal of molecular medicine (Berlin, Germany) 20080501
-
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation.
Cancer 20080501
-
Mutated and non-mutated TP53 as targets in the treatment of leukaemia.
British journal of haematology 20080501
-
Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Experimental hematology 20080501
-
Nonmyeloablative chemotherapy followed by T-cell adoptive transfer and dendritic cell-based vaccination results in rejection of established melanoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 20080501
-
Myeloablative intravenous busulfan/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080501
-
Fludarabine/intermediate-dose cytarabine with or without allogeneic hematopoietic stem cell transplantation in poor-risk leukemia: a single center experience.
International journal of hematology 20080501
-
Profound hypogammaglobulinemia 7 years after treatment for indolent lymphoma.
Cancer investigation 20080501
-
Improved outcome of children with acute myeloid leukemia treated on 2 consecutive protocols.
Saudi medical journal 20080501
-
Long-term toxicity of allogeneic stem cell transplantation in fludarabine-refractory chronic lymphocytic leukemia.
Leukemia & lymphoma 20080501
-
The apoptosome: emerging insights and new potential targets for drug design.
Pharmaceutical research 20080401
-
Liposomal coencapsulated fludarabine and mitoxantrone for lymphoproliferative disorder treatment.
Journal of pharmaceutical sciences 20080401
-
Unrelated cord blood transplantation for severe combined immunodeficiency and other primary immunodeficiencies.
Bone marrow transplantation 20080401
-
Pilot experience with continuous infusion alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia.
European journal of haematology 20080401
-
High incidence of graft failure in unrelated cord blood transplantation using a reduced-intensity preparative regimen consisting of fludarabine and melphalan.
Bone marrow transplantation 20080401
-
Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 20080401
-
Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).
The Lancet. Oncology 20080401
-
Potential role of a mismatched HLA-specific CTL clone developed pre-transplant in graft rejection following cord blood transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080401
-
Chronic kidney disease after nonmyeloablative stem cell transplantation in adults.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080401
-
Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080401
-
Antibody therapy for chronic lymphocytic leukemia.
Seminars in hematology 20080401
-
Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells.
Leukemia & lymphoma 20080401
-
Use of TAGVHD warnings in patients receiving purine analogue chemotherapy.
Transfusion medicine (Oxford, England) 20080401
-
Acute tumor lysis syndrome during oral fludarabine treatment for CLL--a rare event that might be observed more frequently in the future.
Onkologie 20080401
-
Acute tumor lysis syndrome during oral fludarabine treatment for chronic lymphocytic leukemia. Role of treatment with rasburicase.
Onkologie 20080401
-
Alemtuzumab in the up-front setting.
Therapeutics and clinical risk management 20080401
-
Treating refractory leukemias in childhood, role of clofarabine.
Therapeutics and clinical risk management 20080401
-
Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase 2 trial of the Minnie Pearl Cancer Research Network.
Cancer 20080315
-
Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenström's macroglobulinemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 20080315
-
Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma.
Pediatric blood & cancer 20080301
-
Multiple forms of nuclear p53 formed in human Raji and MEC1 cells treated with fludarabine.
Leukemia 20080301
-
Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation.
Bone marrow transplantation 20080301
-
Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells.
Leukemia 20080301
-
Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Haematologica 20080301
-
Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080301
-
Chromosomal aberrations in 17p predict in vitro drug resistance and short overall survival in acute myeloid leukemia.
Leukemia & lymphoma 20080301
-
Chronic lymphocytic leukaemia cells are efficiently killed by an anti-CD20 monoclonal antibody selected for improved engagement of FcgammaRIIIA/CD16.
British journal of haematology 20080301
-
Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.
British journal of haematology 20080301
-
Phase I trial of nelarabine in indolent leukemias.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080301
-
Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma.
Haematologica 20080301
-
High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy.
Haematologica 20080301
-
Retreatment with fludarabine and cyclosporine for one case of refractory pure red cell aplasia.
Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih 20080301
-
[Treatment of refractory severe autoimmune disease by combined therapy with Chinese drug and autohemopoietic stem cell transplantation].
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20080301
-
Beta-thalassaemia major: bone marrow versus peripheral blood stem cell transplantation.
JPMA. The Journal of the Pakistan Medical Association 20080301
-
Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL).
Biologics : targets & therapy 20080301
-
Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase).
Biologics : targets & therapy 20080301
-
Adenosine kinase mediates high affinity adenosine salvage in Trypanosoma brucei.
The Journal of biological chemistry 20080227
-
Rituximab-CHOP induced interstitial pneumonitis in patients with disseminated extranodal marginal zone B cell lymphoma.
Yonsei medical journal 20080227
-
STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier.
Blood 20080215
-
Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapy.
Blood 20080215
-
The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia.
Blood 20080215
-
Modulation of the human equilibrative nucleoside transporter1 (hENT1) activity by IL-4 and PMA in B cells from chronic lymphocytic leukemia.
Biochemical pharmacology 20080215
-
A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma.
Cancer 20080215
-
Hodgkin lymphoma in a mutated ZAP-70 negative B-cell Chronic Lymphocytic Leukemia patient.
Leukemia research 20080201
-
Extramedullary, extranodal lymphoplasmacytic lymphoma with macroglobulinemia: long-term complete remission with fludarabine.
Annals of hematology 20080201
-
Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
International journal of radiation oncology, biology, physics 20080201
-
Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: a nationwide analysis.
Bone marrow transplantation 20080201
-
Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome.
Leukemia 20080201
-
Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents.
Cell death and differentiation 20080201
-
Fludarabine induces growth arrest and apoptosis of cytokine- or alloantigen-stimulated peripheral blood mononuclear cells, and decreases production of Th1 cytokines via inhibition of nuclear factor kappaB.
Bone marrow transplantation 20080201
-
Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group.
Blood 20080201
-
Scan of 977 nonsynonymous SNPs in CLL4 trial patients for the identification of genetic variants influencing prognosis.
Blood 20080201
-
Allogeneic hematopoietic cell transplantation (HCT) in Hurler's syndrome using a reduced intensity preparative regimen.
Bone marrow transplantation 20080201
-
Ibritumomab tiuxetan (Zevalin) combined with reduced-intensity conditioning and allogeneic stem-cell transplantation (SCT) in patients with chemorefractory non-Hodgkin's lymphoma.
Bone marrow transplantation 20080201
-
Mediation of apoptosis by and antitumor activity of lumiliximab in chronic lymphocytic leukemia cells and CD23+ lymphoma cell lines.
Blood 20080201
-
Intentional induction of mixed haematopoietic chimerism as platform for cellular therapy after HLA-matched allogeneic stem cell transplantation in childhood leukaemia patients.
British journal of haematology 20080201
-
Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group.
European journal of haematology 20080201
-
Fludarabine based reduced intensity conditioning regimens in children undergoing allogeneic stem cell transplantation for severe aplastic anemia.
Pediatric transplantation 20080201
-
Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080201
-
Invasive fungal sinusitis in patients treated with fludarabine.
The Journal of infection 20080201
-
Hematopoietic stem cell transplantation after reduced intensity conditioning in acute myelogenous leukemia patients older than 40 years.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080201
-
High busulfan exposure is associated with worse outcomes in a daily i.v. busulfan and fludarabine allogeneic transplant regimen.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080201
-
Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080201
-
Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience.
Haematologica 20080201
-
Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning.
Haematologica 20080201
-
High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphoma.
Haematologica 20080201
-
Economic evaluation of rituximab plus cyclophosphamide, vincristine and prednisolone for advanced follicular lymphoma.
Leukemia & lymphoma 20080201
-
Allogeneic peripheral blood stem cell transplantation from related donors mismatched at 2 HLA loci in the host-versus-graft direction.
The Tohoku journal of experimental medicine 20080201
-
Unrelated bone marrow transplantation with a reduced toxicity myeloablative conditioning regimen in Wiskott-Aldrich syndrome.
Journal of Korean medical science 20080201
-
Infratentorial progressive multifocal leukoencephalopathy in a patient treated with fludarabine and rituximab.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20080201
-
Pharmacovigilance: Safety matters….
Indian journal of pharmacology 20080201
-
BCL2 expression in chronic lymphocytic leukemia: lack of association with the BCL2 938A>C promoter single nucleotide polymorphism.
Blood 20080115
-
Long-term donor-specific tolerance in rat cardiac allografts by intrabone marrow injection of donor bone marrow cells.
Transplantation 20080115
-
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080110
-
Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080110
-
A phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disorders.
Leukemia research 20080101
-
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
Blood cells, molecules & diseases 20080101
-
Treatment-related acute myeloid leukemia with 11q23 translocation following treatment with fludarabine, cyclophosphamide and rituximab.
Leukemia research 20080101
-
Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients.
Blood cells, molecules & diseases 20080101
-
Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis.
Experimental hematology 20080101
-
Comparable non-relapse mortality and survival after HLA-identical sibling blood stem cell transplantation with reduced or conventional-intensity preparative regimens for high-risk myelodysplasia or acute myeloid leukemia in first remission.
Bone marrow transplantation 20080101
-
Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia.
Cancer 20080101
-
Hydrogen peroxide stimulates tetrahydrobiopterin synthesis through activation of the Jak2 tyrosine kinase pathway in vascular endothelial cells.
The international journal of biochemistry & cell biology 20080101
-
The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype.
Haematologica 20080101
-
Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: high response rate and disease eradication.
Clinical cancer research : an official journal of the American Association for Cancer Research 20080101
-
Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia.
Medical oncology (Northwood, London, England) 20080101
-
Phase II study of low-grade non-Hodgkin lymphomas with fludarabine and mitoxantrone followed by rituximab consolidation: promising results in marginal zone lymphoma.
Leukemia & lymphoma 20080101
-
Quantitative image analysis of intra-tumoral bFGF level as a molecular marker of paclitaxel resistance.
Journal of translational medicine 20080101
-
Waldenström macroglobulinemia of the orbit.
Ophthalmic plastic and reconstructive surgery 20080101
-
Successful treatment of chronic granulomatous disease with fludarabine-based reduced-intensity conditioning and unrelated bone marrow transplantation.
International journal of hematology 20080101
-
Allogeneic hematopoietic stem cell transplantation using a reduced-intensity conditioning regimen in infants: experience at a single institution in Mexico.
Pediatric hematology and oncology 20080101
-
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy.
Clinical transplantation 20080101
-
The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of bias.
BMC medical research methodology 20080101
-
[The treatment of Waldenström macroglobulinemia and the therapy of diseases caused by monoclonal IgM gammaglobulin].
Vnitrni lekarstvi 20080101
-
Prodrug converting enzyme gene delivery by L. monocytogenes.
BMC cancer 20080101
-
Paradoxical exacerbation of psoriasis during therapy with fludarabine.
European journal of dermatology : EJD 20080101
-
Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma.
Molecular cancer 20080101
-
Adenosine transporter ENT4 is a direct target of EWS/WT1 translocation product and is highly expressed in desmoplastic small round cell tumor.
PloS one 20080101
-
Presence of low dose of fludarabine in cultures blocks regulatory T cell expansion and maintains tumor-specific cytotoxic T lymphocyte activity generated with peripheral blood lymphocytes.
Pathobiology : journal of immunopathology, molecular and cellular biology 20080101
-
Severe prolonged immunosuppression following fludarabine and rituximab combination therapy.
Chemotherapy 20080101
-
HDAC inhibitors act with 5-aza-2'-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells.
PloS one 20080101
-
Prognostic impact of combined fludarabine, treosulfan and mitoxantrone resistance profile in childhood acute myeloid leukemia.
Anticancer research 20080101
-
Successful long-term monotherapy with rituximab in a patient with chronic lymphocytic leukemia of the B-cell-lineage: a case report.
Journal of medical case reports 20080101
-
Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model.
BMC cancer 20080101
-
Successful outcome of Langerhans cell histiocytosis complicated by therapy-related myelodysplasia and acute myeloid leukemia: a case report.
Cases journal 20080101
-
High-dose chemotherapy without stem cell transplantation for refractory childhood systemic lupus erythematosus.
Chemotherapy 20080101
-
Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression.
Immunology and cell biology 20080101
-
Klebsiella oxytoca bacteremia causing septic shock in recipients of hematopoietic stem cell transplant: Two case reports.
Cases journal 20080101
-
Use of fludarabine-containing chemotherapeutic regimen results in durable complete remission of subcutaneous panniculitis-like T-cell lymphoma.
American journal of clinical dermatology 20080101
-
Paraneoplastic pemphigus despite treatment with rituximab, fludarabine and cyclophosphamide in chronic lymphocytic leukemia.
European journal of dermatology : EJD 20080101
-
Disease-specific complications of chronic lymphocytic leukemia.
Hematology. American Society of Hematology. Education Program 20080101
-
Current status of haploidentical stem cell transplantation for leukemia.
Journal of hematology & oncology 20080101
-
Fludarabine in lymphoproliferative malignancies: a single-centre experience.
The National medical journal of India 20080101
-
Extravasational side effects of cytotoxic drugs: A preventable catastrophe.
Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India 20080101
-
Magnetic resonance imaging may simulate progressive multifocal leucoencephalopathy in a patient with chronic lymphocytic leukemia after fludarabine therapy.
Annals of Indian Academy of Neurology 20080101
-
Modulation of IL-4 level by fludarabine and its relation to apoptosis in chronic B-cell lymphocytic leukemia.
The Egyptian journal of immunology 20080101
-
Acute thrombosis in superior mesenteric artery as first symptom in a AML patient.
International journal of general medicine 20080101
-
Experimental antioxidant therapy in ataxia telangiectasia.
Clinical medicine. Oncology 20080101
-
T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin.
Blood 20071215
-
Have we forgotten the purpose of phase III studies?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071210
-
Characterization of graft-versus-leukemia responses in patients treated for advanced chronic lymphocytic leukemia with donor lymphocyte infusions after in vitro T-cell depleted allogeneic stem cell transplantation following reduced-intensity conditioning.
Leukemia 20071201
-
Reduced intensity stem cell transplantation for treatment of class 3 Lucarelli severe thalassemia patients.
American journal of hematology 20071201
-
Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation.
Bone marrow transplantation 20071201
-
Recent progress in the management of chronic lymphocytic leukemia.
Cancer treatment reviews 20071201
-
Fludarabine reduces survivability of HepG2 cells through VEGF under hypoxia.
Archives of biochemistry and biophysics 20071201
-
Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071201
-
Antitumor activity of fludarabine against human multiple myeloma in vitro and in vivo.
European journal of haematology 20071201
-
Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20071201
-
Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20071201
-
Gemtuzumab ozogamicin (mylotarg) for the treatment of acute myeloid leukemia--ongoing trials.
Onkologie 20071201
-
Fludarabine and treosulfan: a novel modified myeloablative regimen for allogeneic hematopoietic stem-cell transplantation with effective antileukemia activity in patients with acute myeloid leukemia and myelodysplastic syndromes.
Leukemia & lymphoma 20071201
-
Umbilical-cord blood cell transplantation conditioned with a reduced intensity-regimen is a practical salvage therapy for severe aplastic anemia refractory to immunosuppressive therapy with antithymocyte globulin/ciclosporin.
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 20071201
-
[Effects of FLAG protocol in treatment of the first time induced non-remission acute myeloid leukemia].
Zhongguo shi yan xue ye xue za zhi 20071201
-
Clofarabine: new drug. Children with acute lymphoblastic leukaemia: a last resort.
Prescrire international 20071201
-
Therapeutic experience of Bing-Neel Syndrome associated with Waldenstrom's macroglobulinemia.
Journal of Korean medical science 20071201
-
Switching of donor cells after urgent second cord blood transplantation for suspected graft failure.
International journal of hematology 20071201
-
Graft-versus-myeloma effects in reduced-intensity cord blood transplantation.
International journal of hematology 20071201
-
What is the optimal initial treatment for chronic lymphocytic leukemia?
Oncology (Williston Park, N.Y.) 20071201
-
Role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
Therapeutics and clinical risk management 20071201
-
Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can synergize with fludarabine.
Cancer research 20071115
-
Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia.
Blood 20071101
-
Late death after unrelated-BMT for dyskeratosis congenita following conditioning with alemtuzumab, fludarabine and melphalan.
Bone marrow transplantation 20071101
-
Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome.
Bone marrow transplantation 20071101
-
Cerebral toxoplasmosis in a patient with chronic lymphocytic leukaemia treated with fludarabine.
British journal of haematology 20071101
-
Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen.
Bone marrow transplantation 20071101
-
Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia.
British journal of haematology 20071101
-
Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20071101
-
Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosis.
Experimental hematology 20071101
-
Direct antiglobulin test negative autoimmune haemolytic anaemia associated with fludarabine/cyclophosphamide/rituximab therapy.
British journal of haematology 20071101
-
[MALT (mucosa-associated lymphoid tissue) lymphoma of the lacrimal gland].
Journal francais d'ophtalmologie 20071101
-
Phase I trial of FLAGM with high doses of cytosine arabinoside for relapsed, refractory acute myeloid leukemia: study of the Japan Adult Leukemia Study Group (JALSG).
International journal of hematology 20071101
-
[Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
Vnitrni lekarstvi 20071101
-
Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.
Blood 20071015
-
Hematopoietic stem-cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens.
Blood 20071015
-
Fludarabine, mitoxantrone and dexamethasone as first-line treatment for T-cell large granular lymphocyte leukemia.
Leukemia 20071001
-
Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan.
American journal of hematology 20071001
-
Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone.
Blood 20071001
-
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Blood 20071001
-
Nonmyeloablative allogeneic stem cell transplantation in elderly patients with hematological malignancies: results from the GITMO (Gruppo Italiano Trapianto Midollo Osseo) multicenter prospective clinical trial.
American journal of hematology 20071001
-
Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine/busulfan.
Leukemia 20071001
-
Parotid gland involvement, the presenting sign of high grade non-Hodgkin lymphoma in two patients with Gaucher disease and sicca syndrome.
Journal of inherited metabolic disease 20071001
-
Transplantation tolerance: lessons from experimental rodent models.
Transplant international : official journal of the European Society for Organ Transplantation 20071001
-
Intense reversal of bone marrow angiogenesis after sequential fludarabine-induction and alemtuzumab-consolidation therapy in advanced chronic lymphocytic leukemia.
Haematologica 20071001
-
Clofarabine: past, present, and future.
Leukemia & lymphoma 20071001
-
Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.
British journal of haematology 20071001
-
Low-dose oral fludarabine plus cyclophosphamide as first-line treatment in elderly patients with indolent non-Hodgkin lymphoma.
British journal of haematology 20071001
-
A novel regimen incorporating the concomitant administration of fludarabine and alemtuzumab for the treatment of refractory adult acute lymphoblastic leukaemia: a report of three cases.
British journal of haematology 20071001
-
High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20071001
-
Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy.
Hematology (Amsterdam, Netherlands) 20071001
-
Chronic lymphocytic leukaemia resistant to both fludarabine and alemtuzumab--double jeopardy.
Leukemia & lymphoma 20071001
-
The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy.
Leukemia & lymphoma 20071001
-
Antiangiogenic activity of thalidomide in combination with fludarabine, carboplatin, and topotecan for high-risk acute myelogenous leukemia.
Leukemia & lymphoma 20071001
-
Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands.
The Netherlands journal of medicine 20071001
-
[Curative efficacy of fludarabine combined with rituximab and amifostine on aged patient with B-chronic lymphocytic leukemia].
Zhongguo shi yan xue ye xue za zhi 20071001
-
[Application of low dose of fludarabine and cyclophosphamide combined with donor NK Cells as a non-myeloablative conditioning regimen for the haploidentical hematopoietic stem cell transplantation in mice].
Zhongguo shi yan xue ye xue za zhi 20071001
-
Comparison of myeloablative and nonmyeloablative hematopoietic stem cell transplantation for treatment of chronic myeloid leukemia.
International journal of hematology 20071001
-
The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group.
Haematologica 20071001
-
Oblimersen for the treatment of patients with chronic lymphocytic leukemia.
Therapeutics and clinical risk management 20071001
-
Irreversible visual loss and optic nerve dysfunction associated with central retinal vein occlusion in Waldenstrom Macroglobulinemia.
The Medical journal of Malaysia 20071001
-
Nonmyeloablative stem cell transplantation in follicular B-cell lymphoma.
Current hematologic malignancy reports 20071001
-
Graft versus host disease after stem cell allotransplantation with low-dose total body irradiation, fludarabine, and antithymocyte globulin.
Transplantation 20070915
-
Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia.
British journal of cancer 20070911
-
R-etodolac (SDX-101) and the related indole-pyran analogues SDX-308 and SDX-309 potentiate the antileukemic activity of standard cytotoxic agents in primary chronic lymphocytic leukaemia cells.
Cancer chemotherapy and pharmacology 20070901
-
Drosophila deoxyribonucleoside kinase mutants with enhanced ability to phosphorylate purine analogs.
Gene therapy 20070901
-
Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation.
Bone marrow transplantation 20070901
-
Non-myeloablative stem cell transplantation in patients with relapsed acute lymphoblastic leukemia: results of a multicenter study.
Bone marrow transplantation 20070901
-
New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2.
Bone marrow transplantation 20070901
-
Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070901
-
Chemoimmunotherapy of chronic lymphocytic leukemia.
Best practice & research. Clinical haematology 20070901
-
Minimal residual disease assessment in chronic lymphocytic leukaemia.
Best practice & research. Clinical haematology 20070901
-
Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
Pediatric hematology and oncology 20070901
-
CD154 induces a switch in pro-survival Bcl-2 family members in chronic lymphocytic leukaemia.
British journal of haematology 20070901
-
Fatal Epstein-Barr virus-associated lymphoproliferative disorder following treatment with a novel mTOR inhibitor for relapsed chronic lymphocytic leukemia leukemia cells.
Haematologica 20070901
-
Transformation of cytogenetically normal chronic myelomonocytic leukaemia to an acute myeloid leukaemia and the emergence of a novel +13, +15 double trisomy resulting in an adverse outcome.
The Ulster medical journal 20070901
-
Translocation (4;11)(p12;q23) with rearrangement of FRYL and MLL in therapy-related acute myeloid leukemia.
Cancer genetics and cytogenetics 20070901
-
B-lymphocytes as targets for therapy in chronic cold agglutinin disease.
Cardiovascular & hematological disorders drug targets 20070901
-
Monoclonal antibodies as targeted therapy in hematologic malignancies in older adults.
The American journal of geriatric pharmacotherapy 20070901
-
Cannabinoid receptors expression in bone marrow trephine biopsy of chronic lymphocytic leukaemia patients treated with purine analogues.
Experimental oncology 20070901
-
[A clinical observation of fludarabine-containing regimens in the treatment of low grade non-Hodgkin's lymphoma].
Zhonghua zhong liu za zhi [Chinese journal of oncology] 20070901
-
Yttrium ibritumomab tiuxetan in the treatment of non-Hodgkin's lymphoma: current status and future prospects.
Biologics : targets & therapy 20070901
-
Downregulation of Bfl-1 protein expression sensitizes malignant B cells to apoptosis.
Oncogene 20070823
-
Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders.
Blood 20070815
-
Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases.
Transplantation 20070815
-
Development of a Richter syndrome with a monoclonal component from a true B-cell chronic lymphocytic leukemia (B-CLL) treated with fludarabine.
Annals of hematology 20070801
-
Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation.
Annals of hematology 20070801
-
Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood.
Bone marrow transplantation 20070801
-
Delayed attainment of full donor chimaerism following alemtuzumab-based reduced-intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes is associated with improved outcomes.
British journal of haematology 20070801
-
Alkylator-free conditioning regimen for patients with acquired aplastic anemia, transplanted from genetically identical twins.
Pediatric transplantation 20070801
-
The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease.
Transfusion 20070801
-
Regurgitation of esophageal mucosa.
Mayo Clinic proceedings 20070801
-
Diffuse large B-cell lymphoma developing following treatment of Waldenstrom's macroglobulinaemia: spontaneous resolution upon cessation of fludarabine.
Leukemia & lymphoma 20070801
-
Combination therapies for previously untreated CLL.
Lancet (London, England) 20070721
-
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial.
Lancet (London, England) 20070721
-
Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chronic lymphocytic leukaemia cells.
British journal of cancer 20070716
-
Fludarabine allows dose reduction for total body irradiation in pediatric hematopoietic stem cell transplantation.
International journal of radiation oncology, biology, physics 20070715
-
T-cell large granular lymphocytic (T-LGL) leukemia: experience in a single institution over 8 years.
Leukemia research 20070701
-
Successful second cord blood transplantation using fludarabine and cyclophosphamide as a preparative regimen for graft rejection following reduced-intensity cord blood transplantation.
Bone marrow transplantation 20070701
-
Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia.
Bone marrow transplantation 20070701
-
Parvovirus B19 pneumonia in a child undergoing allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 20070701
-
Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients.
Bone marrow transplantation 20070701
-
A CD19-specific single-chain immunotoxin mediates potent apoptosis of B-lineage leukemic cells.
Leukemia 20070701
-
Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphoma.
Cancer 20070701
-
Comparable incidence and severity of cytomegalovirus infections following T cell-depleted allogeneic stem cell transplantation preceded by reduced intensity or myeloablative conditioning.
Bone marrow transplantation 20070701
-
Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070701
-
Allogeneic transplantation for adult acute leukemia in first and second remission with a novel regimen incorporating daily intravenous busulfan, fludarabine, 400 CGY total-body irradiation, and thymoglobulin.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070701
-
Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine.
Experimental hematology 20070701
-
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patients.
British journal of haematology 20070701
-
Successful nonmyeloablative bone marrow transplantation for leukocyte adhesion deficiency type I from an unrelated donor.
International journal of hematology 20070701
-
[Bone marrow-restricted involvement of T-cell granular lymphocyte leukemia].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20070701
-
Chemotherapy for myeloid malignancy in children with Fanconi anemia.
Pediatric blood & cancer 20070615
-
Dictyostelium discoideum salvages purine deoxyribonucleosides by highly specific bacterial-like deoxyribonucleoside kinases.
Journal of molecular biology 20070608
-
A phase I study of bendamustine hydrochloride administered day 1+2 every 3 weeks in patients with solid tumours.
British journal of cancer 20070604
-
Inhibition of interleukin 1-induced matrix metalloproteinase 13 expression in human chondrocytes by interferon gamma.
Annals of the rheumatic diseases 20070601
-
Mixed chimerism and graft failure following conditioning with the fludarabine and cyclophosphamide nonablative regimen; conversion to full donor chimerism.
American journal of hematology 20070601
-
Anti-tumor efficacy of Cloretazine (VNP40101M) alone and in combination with fludarabine in murine tumor and human xenograft tumor models.
Cancer chemotherapy and pharmacology 20070601
-
Protein kinase C inhibitor enzastaurin induces in vitro and in vivo antitumor activity in Waldenstrom macroglobulinemia.
Blood 20070601
-
Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation.
American journal of physiology. Heart and circulatory physiology 20070601
-
Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis.
Rheumatology (Oxford, England) 20070601
-
Efficient electrogene therapy for pancreatic adenocarcinoma treatment using the bacterial purine nucleoside phosphorylase suicide gene with fludarabine.
International journal of oncology 20070601
-
Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 20070601
-
Non-myeloablative hematopoietic stem cell transplantation is of limited value in advanced or refractory acute myeloblastic leukemia. The Mexican experience.
Hematology (Amsterdam, Netherlands) 20070601
-
The beneficial effect of chronic graft-versus-host disease on the clinical outcome of transplantation with fludarabine/busulfan-based reduced-intensity conditioning for patients with de novo myelodysplastic syndrome.
International journal of hematology 20070601
-
Chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
Leukemia & lymphoma 20070601
-
Alemtuzumab in chronic lymphocytic leukemia.
Current oncology (Toronto, Ont.) 20070601
-
[Reactivation of familial hemophagocytic lymphohistiocytosis after non-myeloablative cord blood stem cell transplantation resulted in the early graft failure].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20070601
-
[Chronic lymphoid leukemia and intravenous immunoglobulins].
La Revue de medecine interne 20070601
-
Radioimmunotherapy with tositumomab and iodine-131 tositumomab for non-Hodgkin's lymphoma.
Biologics : targets & therapy 20070601
-
Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia.
Oncogene 20070528
-
Management of symptomatic, untreated chronic lymphocytic leukemia.
Blood reviews 20070501
-
Drug resistance in B-cell chronic lymphocytic leukemia: predictable by in vitro evaluation with a multiparameter flow cytometric cytotoxicity assay.
Cytometry. Part B, Clinical cytometry 20070501
-
Imexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell lines.
Cancer chemotherapy and pharmacology 20070501
-
Allogeneic bone marrow transplantation for Pearson's syndrome.
Bone marrow transplantation 20070501
-
Fludarabine induces apoptosis of human T-cell leukemia virus type 1-infected T cells via inhibition of the nuclear factor-kappaB signal pathway.
Leukemia 20070501
-
Health-related quality of life in younger patients with chronic lymphocytic leukemia treated with fludarabine plus cyclophosphamide or fludarabine alone for first-line therapy: a study by the German CLL Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070501
-
Antitumor activity of a monoclonal antibody against CD47 in xenograft models of human leukemia.
Oncology reports 20070501
-
A novel case of IgA paraneoplastic pemphigus associated with chronic lymphocytic leukemia.
Journal of the American Academy of Dermatology 20070501
-
A prospective multicenter trial of peripheral blood stem cell sibling allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclophosphamide reduced intensity conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070501
-
Immunodeficiency-related Hodgkin lymphoma and its mimics.
Advances in anatomic pathology 20070501
-
Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia.
British journal of haematology 20070501
-
In vitro effect of fludarabine, cyclophosphamide, and cytosine arabinoside on chromosome breakage in Fanconi anemia patients: relevance to stem cell transplantation.
International journal of hematology 20070501
-
Immunomodulatory drugs in chronic lymphocytic leukemia: a new treatment paradigm.
Leukemia & lymphoma 20070501
-
Acquired hemophilia in chronic lymphocytic leukemia.
Leukemia & lymphoma 20070501
-
Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.
Haematologica 20070501
-
Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC).
Haematologica 20070501
-
[Ulcers in a patient with chronic lymphocytic leukemia].
Actas dermo-sifiliograficas 20070501
-
Single-centre experience with nonmyeloablative allogeneic stem cell transplantation in patients with multiple myeloma: prolonged remissions induced.
The Netherlands journal of medicine 20070501
-
Dihydrodiol dehydrogenase in drug resistance and sensitivity of human carcinomas.
Cancer chemotherapy and pharmacology 20070401
-
Correlation of ZAP-70 expression in B cell leukemias to the ex vivo response to a combination of fludarabine/genistein.
Cancer immunology, immunotherapy : CII 20070401
-
Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070401
-
Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma.
Bone marrow transplantation 20070401
-
Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases.
Bone marrow transplantation 20070401
-
Unrelated donor haematopoietic cell transplantation after non-myeloablative conditioning for patients with high-risk multiple myeloma.
European journal of haematology 20070401
-
Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070401
-
Current treatment options in prolymphocytic leukemia.
Medical science monitor : international medical journal of experimental and clinical research 20070401
-
Seronegative Lyme neuroborreliosis in a patient on treatment for chronic lymphatic leukemia.
Infection 20070401
-
Gene expression signatures that predict radiation exposure in mice and humans.
PLoS medicine 20070401
-
Allogeneic stem cell transplantation for patients with advanced hematological malignancies: comparison of fludarabine-based reduced intensity conditioning versus myeloablative conditioning.
Journal of Korean medical science 20070401
-
Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Hematology (Amsterdam, Netherlands) 20070401
-
Reduced intensity conditioning with thiotepa, fludarabine, and melphalan is effective in advanced multiple myeloma.
Leukemia & lymphoma 20070401
-
Unrelated-donor bone marrow transplantation with a conditioning regimen including fludarabine, busulfan, and 4 Gy total body irradiation.
International journal of hematology 20070401
-
Current status of reduced-intensity-conditioning allogeneic stem cell transplantation for acute myeloid leukemia.
Haematologica 20070401
-
Multifocal extranodal mucosa-associated lymphoid tissue lymphoma affecting the larynx.
The Annals of otology, rhinology, and laryngology 20070401
-
Outline for writing an article for current treatment options in oncology: splenic lymphoma with villous lymphocytes.
Current treatment options in oncology 20070401
-
Splenic marginal zone lymphoma with and without villous lymphocytes.
Current treatment options in oncology 20070401
-
Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070320
-
Adaptive dosing and platinum-DNA adduct formation in children receiving high-dose carboplatin for the treatment of solid tumours.
British journal of cancer 20070312
-
Low-dose thalidomide in combination with oral fludarabine and cyclophosphamide is ineffective in heavily pretreated patients with chronic lymphocytic leukemia.
Leukemia research 20070301
-
Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells.
Blood 20070301
-
Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).
Leukemia 20070301
-
Levels of soluble HLA-I and beta2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapy.
Leukemia 20070301
-
Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts.
Cancer gene therapy 20070301
-
Oral fludarabine treatment of cutaneous infiltration in a patient with B-cell chronic lymphocytic leukaemia.
Clinical and experimental dermatology 20070301
-
Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070301
-
Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070301
-
Non-bacterial infections in allogeneic non-myeloablative stem cell transplant recipients.
Transplant infectious disease : an official journal of the Transplantation Society 20070301
-
Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070301
-
Safe and efficacious allogeneic bone marrow transplantation for nonmalignant disorders using partial T cell depletion and no posttransplantation graft-versus-host-disease prophylaxis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070301
-
Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070301
-
Fludarabine, cyclophosphamide, and antithymocyte globulin for a patient with dyskeratosis congenita and severe bone marrow failure.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070301
-
Reduced intensity stem cell transplantation for advanced soft tissue sarcomas in adults: a retrospective analysis of the European Group for Blood and Marrow Transplantation.
Haematologica 20070301
-
Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors.
British journal of haematology 20070301
-
Mucosa associated lymphoid tissue lymphoma of the lung: the Royal Marsden Hospital experience.
Leukemia & lymphoma 20070301
-
Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: rituximab as the treatment of choice?
Leukemia research 20070201
-
Low-dose thalidomide in combination with oral fludarabine and cyclophosphamide is ineffective in heavily pre-treated patients with chronic lymphocytic leukemia.
Leukemia research 20070201
-
F-ara-A pharmacokinetics during reduced-intensity conditioning therapy with fludarabine and busulfan.
Bone marrow transplantation 20070201
-
Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman-Diamond syndrome.
Bone marrow transplantation 20070201
-
Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trial.
Bone marrow transplantation 20070201
-
Fatal leukoencephalopathy after reduced-intensity allogeneic stem cell transplantation.
Onkologie 20070201
-
Alemtuzumab in chronic lymphocytic leukemia.
Future oncology (London, England) 20070201
-
Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
European journal of haematology 20070201
-
Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
European journal of haematology 20070201
-
Fludarabine-mediated circumvention of cytarabine resistance is associated with fludarabine triphosphate accumulation in cytarabine-resistant leukemic cells.
International journal of hematology 20070201
-
17p Deletion is associated with resistance of B-cell chronic lymphocytic leukemia cells to in vitro fludarabine-induced apoptosis.
Leukemia & lymphoma 20070201
-
Allogeneic stem-cell transplantation with fludarabine and 2-Gy TBI-based conditioning regimen for chronic hematological malignancy: a study of 25 consecutive patients and a literature review.
Leukemia & lymphoma 20070201
-
Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery.
Haematologica 20070201
-
Cryptococcus lung infection complicating fludarabine treatment in a chronic lymphocytic leukemia patient.
Leukemia research 20070101
-
Preclinical assessment of curcumin as a potential therapy for B-CLL.
American journal of hematology 20070101
-
Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning.
Blood 20070101
-
Successful engraftment of mismatched unrelated cord blood transplantation following reduced intensity preparative regimen using fludarabine and busulfan.
Annals of hematology 20070101
-
STAT1 signaling is associated with acquired crossresistance to doxorubicin and radiation in myeloma cell lines.
International journal of cancer 20070101
-
Due to low infection rates no routine anti-infective prophylaxis is required in younger patients with chronic lymphocytic leukaemia during fludarabine-based first line therapy.
British journal of haematology 20070101
-
Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies.
Journal of the American Academy of Dermatology 20070101
-
Conditioning with fludarabine alone and allogeneic transplantation as a successful rescue therapy for persistent, severe iatrogenic aplasia after relapse of acute myeloid leukemia.
Bone marrow transplantation 20070101
-
Role of Janus kinase/signal transducer and activator of transcription pathway in regulation of expression and inflammation-promoting activity of high mobility group box protein 1 in rat peritoneal macrophages.
Shock (Augusta, Ga.) 20070101
-
Highly variable mycophenolate mofetil bioavailability following nonmyeloablative hematopoietic cell transplantation.
Journal of clinical pharmacology 20070101
-
Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients.
British journal of haematology 20070101
-
Double unrelated reduced-intensity umbilical cord blood transplantation in adults.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070101
-
Successful bone marrow transplantation in a patient with DNA ligase IV deficiency and bone marrow failure.
Orphanet journal of rare diseases 20070101
-
Cord blood in regenerative medicine: do we need immune suppression?
Journal of translational medicine 20070101
-
Improved outcome after relapse in children with acute myeloid leukaemia.
British journal of haematology 20070101
-
Atypical cutaneous herpes virus infection associated with fludarabine chemotherapy of lymphoma.
European journal of dermatology : EJD 20070101
-
Advances in CLL.
Clinical advances in hematology & oncology : H&O 20070101
-
Ligand bound beta1 integrins inhibit procaspase-8 for mediating cell adhesion-mediated drug and radiation resistance in human leukemia cells.
PloS one 20070101
-
Pilot study of gemtuzumab ozogamicin (GO), fludarabine, cytarabine and idarubicin combined regimen (GO-FLAI) as first-line induction therapy plus GO alone as consolidation therapy for elderly acute myeloid leukemia patients.
Acta haematologica 20070101
-
Importance of allogeneic T-cells for disease control after stem cell transplantation for high-risk Langerhans cell histiocytosis.
Haematologica 20070101
-
Cutaneous Mycobacterium chelonae infection in chronic lymphocytic leukaemia.
Haematologica 20070101
-
A novel small molecule that selectively inhibits glioblastoma cells expressing EGFRvIII.
Molecular cancer 20070101
-
Combination of transient lymphodepletion with busulfan and fludarabine and peptide vaccination in a phase I clinical trial for patients with advanced melanoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 20070101
-
Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis.
Journal of nanobiotechnology 20070101
-
Fibrillary glomerulonephritis with small fibrils in a patient with the antiphospholipid antibody syndrome successfully treated with immunosuppressive therapy.
BMC nephrology 20070101
-
[Anemia in chronic lymphatic leukemia: is erythropoietin the solution?].
Revista de medicina de la Universidad de Navarra 20070101
-
Validated assay for the simultaneous determination of the anti-cancer agent gemcitabine and its metabolite 2',2'-difluorodeoxyuridine in human plasma by high-performance liquid chromatography with tandem mass spectrometry.
Rapid communications in mass spectrometry : RCM 20070101
-
Reduced intensity transplantation for metastatic renal cell cancer with 2-year follow-up.
Journal of immunotherapy (Hagerstown, Md. : 1997) 20070101
-
Fludarabine, treosulfan and etoposide sensitivity and the outcome of hematopoietic stem cell transplantation in childhood acute myeloid leukemia.
Anticancer research 20070101
-
Hepatotoxicity induced by horse ATG and reversed by rabbit ATG: a case report.
Journal of medical case reports 20070101
-
Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer.
Genome biology 20070101
-
Fludarabine: a review of its use in non-Hodgkin's lymphoma.
Drugs 20070101
-
Paraneoplastic pemphigus associated with fludarabine use.
Medical oncology (Northwood, London, England) 20070101
-
[Visual cortes--is it a concern?].
Bulletin de la Societe belge d'ophtalmologie 20070101
-
Oblimersen: Augmerosen, BCL-2 antisense oligonucleotide - Genta, G 3139, GC 3139, oblimersen sodium.
Drugs in R&D 20070101
-
[Allogenic transplantation of hemopoietic stem cells in low-intensity regimes in patients with hematological malignancies].
Terapevticheskii arkhiv 20070101
-
[Prognostic significance of immunoglobulin variable region gene mutations in B-CLL patients treated with combination therapy fludarabine plus cyclophosphamide].
Terapevticheskii arkhiv 20070101
-
Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune response.
Journal of translational medicine 20070101
-
Economic evaluation of third-line treatment with alemtuzumab for chronic lymphocytic leukaemia.
Clinical drug investigation 20070101
-
Chronic lymphocytic leukemia masquerading as uveitis.
Retina (Philadelphia, Pa.) 20070101
-
The effects of nucleoside analogues on promoter methylation of selected tumor suppressor genes in MCF-7 and MDA-MB-231 breast cancer cell lines.
Nucleosides, nucleotides & nucleic acids 20070101
-
Chronic lymphocytic leukemia in the recent 10 years and treatment effects of Fludarabin.
Asian Pacific journal of cancer prevention : APJCP 20070101
-
IPEX as a result of mutations in FOXP3.
Clinical & developmental immunology 20070101
-
Rituximab maintenance in relapsed or refractory follicular non-Hodgkin's lymphoma: the evidence of its therapeutic value.
Core evidence 20070101
-
Pneumonia caused by Moraxella catarrhalis in haematopoietic stem cell transplant patients. Report of two cases and review of the literature.
The Libyan journal of medicine 20070101
-
Targeting receptors, transporters and site of absorption to improve oral drug delivery.
Drug target insights 20070101
-
Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: Results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG).
Blood 20061215
-
Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removal.
Blood 20061215
-
Neurologic and hematologic response to fludarabine treatment in IgM MGUS polyneuropathy.
Neurology 20061212
-
Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
Leukemia research 20061201
-
Chronic lymphocytic leukaemia Is terminal del(14)(q24) a new marker for prognostic stratification?
Leukemia research 20061201
-
Characterization of the rat Na+/nucleoside cotransporter 2 and transport of nucleoside-derived drugs using electrophysiological methods.
American journal of physiology. Cell physiology 20061201
-
High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine + cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patients.
American journal of hematology 20061201
-
Engraftment and survival following hematopoietic stem cell transplantation for osteopetrosis using a reduced intensity conditioning regimen.
Bone marrow transplantation 20061201
-
Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061201
-
Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?
Nature clinical practice. Oncology 20061201
-
Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Haematologica 20061201
-
Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells.
Experimental hematology 20061201
-
Hepatic injury following reduced intensity unrelated cord blood transplantation for adult patients with hematological diseases.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061201
-
Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061201
-
Cytotoxic effect of R-etodolac (SDX-101) in combination with purine analogs or monoclonal antibodies on ex vivo B-cell chronic lymphocytic leukemia cells.
Leukemia & lymphoma 20061201
-
Progressive bicytopenia due to persistent parvovirus B19 infection after immunochemotherapy with fludarabine/cyclophosphamide and rituximab for relapsed B cell lymphoma.
Haematologica 20061201
-
Efficacy of low dose clofarabine in refractory precursor T- acute lymphoblastic leukemia.
The Yale journal of biology and medicine 20061201
-
Azacytidine (Vidaza(R)) in the treatment of myelodysplastic syndromes.
Therapeutics and clinical risk management 20061201
-
Fludarabine delivery by autologous red blood cells induces macrophage depletion in chronically SIV-infected Sooty Mangabeys.
Journal of controlled release : official journal of the Controlled Release Society 20061128
-
CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53.
Blood 20061115
-
Simultaneous sustained release of fludarabine monophosphate and Gd-DTPA from an interstitial liposome depot in rats: potential for indirect monitoring of drug release by magnetic resonance imaging.
Cancer chemotherapy and pharmacology 20061101
-
Different outcome of allogeneic transplantation in myelofibrosis using conventional or reduced-intensity conditioning regimens.
British journal of haematology 20061101
-
Rapid progression of metastatic osteosarcoma after initiation of a reduced-intensity conditioning regimen with immunosuppressive fludarabine.
Pediatric transplantation 20061101
-
Herpes simplex and Epstein-Barr virus lymphadenitis in a patient with chronic lymphocytic leukemia treated with fludarabine.
European journal of haematology 20061101
-
Treatment-related myelodysplasia following fludarabine combination chemotherapy.
Haematologica 20061101
-
Allogeneic hematopoietic cell transplantation following reduced intensity conditioning for treatment of myelofibrosis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061101
-
Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061101
-
Incidence of second neoplasia in patients with B-cell chronic lymphocytic leukemia treated with chlorambucil maintenance chemotherapy.
Leukemia & lymphoma 20061101
-
Chronic lymphocytic leukemia: current and emerging treatment approaches.
Clinical advances in hematology & oncology : H&O 20061101
-
Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning.
Transplantation 20061015
-
Fludarabine, cytarabine, and mitoxantrone (FLAM) for the treatment of relapsed and refractory adult acute lymphoblastic leukemia. A phase study by the Polish Adult Leukemia Group (PALG).
Annals of hematology 20061001
-
Successful father-to-son stem cell transplantation in a child with hemophagocytic lymphohistiocytosis using a reduced-intensity conditioning regimen.
European journal of haematology 20061001
-
The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations.
British journal of haematology 20061001
-
Outcomes of alemtuzumab-based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromes.
British journal of haematology 20061001
-
Comparable kinetics of myeloablation between fludarabine/full-dose busulfan and fludarabine/melphalan conditioning regimens in allogeneic peripheral blood stem cell transplantation.
Bone marrow transplantation 20061001
-
Clinical outcomes and direct hospital costs of reduced-intensity allogeneic transplantation in chronic myeloid leukemia.
Bone marrow transplantation 20061001
-
Enhanced killing of melanoma cells by simultaneously targeting Mcl-1 and NOXA.
Cancer research 20061001
-
Phase I study of bryostatin 1 and fludarabine in patients with chronic lymphocytic leukemia and indolent (non-Hodgkin's) lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 20061001
-
Allogeneic hematopoietic stem cell transplantation from an alternative stem cell source in Fanconi anemia patients: analysis of 47 patients from a single institution.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20061001
-
Flow cytometric evaluation of red blood cell chimerism after bone marrow transplantation in Iranian patients: a preliminary study.
Archives of Iranian medicine 20061001
-
Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061001
-
Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061001
-
Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061001
-
New directions in the treatment of mantle cell lymphoma: an overview.
Clinical lymphoma & myeloma 20061001
-
[T-large granular lymphocyte leukaemia. An important differential diagnosis to Felty's syndrome].
Zeitschrift fur Rheumatologie 20060901
-
Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia.
Cancer 20060901
-
Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies.
Bone marrow transplantation 20060901
-
Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
Journal of viral hepatitis 20060901
-
Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060901
-
High incidence of non-neutropenic infections induced by rituximab plus fludarabine and associated with hypogammaglobulinemia: a frequently unrecognized and easily treatable complication.
Annals of oncology : official journal of the European Society for Medical Oncology 20060901
-
Role of fludarabine in hematological malignancies.
Expert review of anticancer therapy 20060901
-
Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 20060901
-
Prognostic factors for non-Hodgkin's lymphoma patients treated with chemotherapy may not predict outcome in patients treated with rituximab.
Leukemia & lymphoma 20060901
-
Rituximab therapy of severe aplastic anemia induced by fludarabine and cyclophosphamide in a patient affected by B-cell chronic lymphocytic leukemia.
Leukemia & lymphoma 20060901
-
Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia.
International journal of nanomedicine 20060901
-
Nelarabine: a new purine analog in the treatment of hematologic malignancies.
Reviews on recent clinical trials 20060901
-
Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia.
Blood 20060815
-
The influence of increasing age on the deliverability and toxicity of fludarabine-based combination chemotherapy regimens in patients with indolent lymphoproliferative disorders.
Cancer 20060815
-
A phase I dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemia.
British journal of cancer 20060807
-
Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia.
Blood 20060801
-
Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation.
Blood 20060801
-
Hemophagocytosis during fludarabine-based SCT for systemic juvenile idiopathic arthritis.
Bone marrow transplantation 20060801
-
Detection of a hepatitis B surface antigen variant emerging in a patient with chronic lymphocytic leukaemia treated with fludarabine.
Journal of medical virology 20060801
-
Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: a systematic review and meta-analysis.
Cancer treatment reviews 20060801
-
Graft failure and severe autoimmune haemolysis following fludarabine-based reduced-intensity matched unrelated donor bone marrow transplantation for severe aplastic anaemia: salvage by second transplant with conventional dose conditioning.
Bone marrow transplantation 20060801
-
Central line-related bacteraemia due to Roseomonas mucosa in a neutropenic patient with acute myeloid leukaemia in Piraeus, Greece.
Journal of medical microbiology 20060801
-
A study of a reduced-intensity conditioning regimen followed by allogeneic stem cell transplantation for patients with hematologic malignancies using Campath-1H as part of a graft-versus-host disease strategy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060801
-
Allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia following nonmyeloablative conditioning using 200-cGy total body irradiation and fludarabine.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060801
-
Fludarabine in chronic lymphocytic leukaemia.
Expert opinion on pharmacotherapy 20060801
-
Concomitant Epstein-Barr virus-negative large B-cell lymphoma (Richter syndrome) and Epstein-Barr virus- positive B-cell lymphoproliferation after treatment with fludarabine and cyclophosphamide in a patient with B-cell chronic lymphocytic leukemia.
Archives of pathology & laboratory medicine 20060801
-
In vitro screening for synergism of high-linear energy transfer 213Bi-radiotherapy with other therapeutic agents for the treatment of B-cell chronic lymphocytic leukemia.
Cancer biotherapy & radiopharmaceuticals 20060801
-
MicroRNAs in leukemia.
Clinical advances in hematology & oncology : H&O 20060801
-
Purine antagonists for chronic lymphocytic leukaemia.
The Cochrane database of systematic reviews 20060719
-
Cord blood transplantation for acute myelogenous leukemia using a conditioning regimen consisting of granulocyte colony-stimulating factor-combined high-dose cytarabine, fludarabine, and total body irradiation.
European journal of haematology 20060701
-
An antecedent diagnosis of refractory anemia with excess blasts has no prognostic relevance in acute myeloid leukemia of older adult patients.
Annals of oncology : official journal of the European Society for Medical Oncology 20060701
-
Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060701
-
Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: a CALGB intergroup phase II study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060701
-
Graft engineering using ex vivo methods to limit GVHD: fludarabine treatment generates superior GVL effects in allogeneic BMT.
Experimental hematology 20060701
-
Clinical and pharmacokinetic study of clofarabine in chronic lymphocytic leukemia: strategy for treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research 20060701
-
Subcutaneous Taenia crassiceps infection in a patient with non-Hodgkin's lymphoma.
The American journal of tropical medicine and hygiene 20060701
-
Allogeneic haematopoietic cell transplantation from alternative donors with a conditioning regimen of low-dose irradiation, fludarabine and cyclophosphamide in Fanconi anaemia.
British journal of haematology 20060701
-
High incidence of therapy-related myelodysplasia and acute leukaemia in general haematology clinic patients treated with fludarabine and cyclophosphamide for indolent lymphoproliferative disorders.
British journal of haematology 20060701
-
[Reduced-intensity stem cell transplantation using allogeneic peripheral blood stem cells from the same donor for relapsed leukemia after bone marrow transplantation].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20060701
-
Reduced-intensity transplantation for lymphoma.
Current treatment options in oncology 20060701
-
Signaling molecules and cytokine production in T cells of patients with B-cell chronic lymphocytic leukemia: long-term effects of fludarabine and alemtuzumab treatment.
Leukemia & lymphoma 20060701
-
Long-term complete responses after 131I-tositumomab therapy for relapsed or refractory indolent non-Hodgkin's lymphoma.
British journal of cancer 20060619
-
Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial.
Blood 20060615
-
A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab.
European journal of haematology 20060601
-
Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphoma.
Cancer 20060601
-
Myelodysplastic syndrome and acute myeloid leukemia after treatment with fludarabine, mitoxantrone, and dexamethasone.
American journal of hematology 20060601
-
Another case of myelodysplasia with monosomy 7 following fludarabine-based chemotherapy.
American journal of hematology 20060601
-
Activation of tubular epithelial cells in diabetic nephropathy and the role of the peroxisome proliferator-activated receptor-gamma agonist.
Journal of the American Society of Nephrology : JASN 20060601
-
Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodgkin lymphoma.
British journal of haematology 20060601
-
Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine-based preparative regimen.
British journal of haematology 20060601
-
Peritransplant use of ultraviolet-B irradiation (UV-B) therapy is detrimental to allogeneic stem cell transplantation outcome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060601
-
A non-myeloablative conditioning regimen in allogeneic stem cell transplantation from related and unrelated donors in elderly patients.
Haematologica 20060601
-
Sensitivity analysis of cost factors for various therapy options in the treatment of follicular lymphoma.
Onkologie 20060601
-
Successful treatment of refractory peripheral T-cell lymphoma with a combination of fludarabine and cyclophosphamide.
International journal of hematology 20060601
-
Diagnosis of a primary testicular lymphoma by echography and magnetic resonance imaging.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060601
-
[Waldemström s macroglobulinemia].
Anales de medicina interna (Madrid, Spain : 1984) 20060601
-
Nonmyeloablative allogeneic blood stem cell transplantation in patients with metastatic solid tumors.
Hematology (Amsterdam, Netherlands) 20060601
-
Successful reduced-intensity stem cell transplantation in a patient with myelodysplastic syndrome combined with Sweet's syndrome.
Hematology (Amsterdam, Netherlands) 20060601
-
Administration of anti-HER2 antibody after nonmyeloablative allogeneic stem cell transplantation in metastatic breast cancer.
British journal of cancer 20060522
-
Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060520
-
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL).
Blood 20060515
-
MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells.
Blood 20060515
-
Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.
Pediatric blood & cancer 20060501
-
DHMEQ, a new NF-kappaB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukemia cells.
Leukemia 20060501
-
Fludarabine induces pro-inflammatory activation of human monocytic cells through a MAPK/ERK pathway.
International immunopharmacology 20060501
-
Reduced-intensity allogeneic haemopoietic stem cell transplantation induces durable responses in patients with chronic B-lymphoproliferative disorders.
Bone marrow transplantation 20060501
-
New agents in chronic lymphocytic leukemia.
Current treatment options in oncology 20060501
-
Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation.
British journal of haematology 20060501
-
Stable engraftment after a conditioning regimen with fludarabine and melphalan for bone marrow transplantation from an unrelated donor.
International journal of hematology 20060501
-
Successful autologous hematopoietic stem cell transplantations for severe multiple sclerosis with fludarabine and cyclophosphamide conditioning.
International journal of hematology 20060501
-
Unusual cutaneous manifestation of angiocentric T-cell lymphoma: a case report.
Cutis 20060501
-
t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
Cancer 20060415
-
The mitochondrial effects of small organic ligands of BCL-2: sensitization of BCL-2-overexpressing cells to apoptosis by a pyrimidine-2,4,6-trione derivative.
The Journal of biological chemistry 20060414
-
Functional characterization of human osteoclast inhibitory peptide-1 (OIP-1/hSca) gene promoter.
Gene 20060412
-
Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells.
Journal of cellular physiology 20060401
-
Non-anthracycline based remission induction therapy for newly diagnosed patients with acute myeloid leukemia aged 60 or older.
Leukemia research 20060401
-
Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia.
Bone marrow transplantation 20060401
-
Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060401
-
The effect of fludarabine on interferon-gamma production by lymphoid cells from healthy donors and patients with B-cell chronic lymphocytic leukemia.
Haematologica 20060401
-
Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060401
-
Pharmacokinetics of a test dose of intravenous busulfan guide dose modifications to achieve an optimal area under the curve of a single daily dose of intravenous busulfan in children undergoing a reduced-intensity conditioning regimen with hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060401
-
The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation.
Seminars in hematology 20060401
-
Purine analogue-based chemotherapy regimens for second-line therapy in patients with chronic lymphocytic leukemia.
Seminars in hematology 20060401
-
Purine analogue-based chemotherapy regimens for patients with previously untreated B-chronic lymphocytic leukemia.
Seminars in hematology 20060401
-
Successful reduced intensity allogeneic stem cell transplantation for systemic AL amyloidosis.
American journal of hematology 20060401
-
The infectious consequences of rituximab addition to fludarabine-containing regimens.
Blood 20060401
-
Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060401
-
Phase III intergroup study of fludarabine phosphate compared with cyclophosphamide, vincristine, and prednisone chemotherapy in newly diagnosed patients with stage III and IV low-grade malignant Non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060401
-
High incidence of myelodysplasia and secondary leukaemia in the UK Medical Research Council Pilot of autografting in chronic lymphocytic leukaemia.
British journal of haematology 20060401
-
Current trends of infectious complications following hematopoietic stem cell transplantation in a single center.
Journal of Korean medical science 20060401
-
Clinical characteristics and outcomes of posttransplant lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation in Korea.
Journal of Korean medical science 20060401
-
Richter's transformation in chronic lymphocytic leukemia.
Seminars in oncology 20060401
-
Brief oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20060401
-
Successful report of reduced-intensity stem cell transplantation from unrelated umbilical cord blood in a girl with chronic active Epstein-Barr virus infection.
Journal of pediatric hematology/oncology 20060401
-
[State of the art in the treatment of chronic leukemias].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20060401
-
Beyond detectable minimal residual disease in chronic lymphocytic leukemia.
Seminars in oncology 20060401
-
Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation.
Transplantation 20060327
-
PS exposure increases the susceptibility of cells to fusion with DOTAP liposomes.
Chemico-biological interactions 20060325
-
Chronic lymphocytic leukaemia, synchronous small cell carcinoma and squamous neoplasia of the urinary bladder in a paraplegic man following long-term phenoxybenzamine therapy.
Spinal cord 20060301
-
Total body irradiation, fludarabine, melphalan, and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematologic malignancies.
Bone marrow transplantation 20060301
-
Fludarabine phosphate and melphalan: a reduced intensity conditioning regimen suitable for allogeneic transplantation that maintains the graft versus malignancy effect.
Bone marrow transplantation 20060301
-
Long-term follow-up results of the combination of topotecan and cytarabine and other intensive chemotherapy regimens in myelodysplastic syndrome.
Cancer 20060301
-
Transplant strategies for patients with myelodysplastic syndromes.
Current opinion in hematology 20060301
-
Positron emission tomography--positive distal femur following fludarabine, dexamethasone and mitoxantrone chemotherapy.
British journal of haematology 20060301
-
Guidelines on the management of Waldenström macroglobulinaemia.
British journal of haematology 20060301
-
Exacerbation of chronic epidural abscess following a fludarabine-based preparative regimen.
American journal of hematology 20060301
-
Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: the Mexican experience.
American journal of hematology 20060301
-
Fludarabine induces apoptosis in chronic lymphocytic leukemia--the role of P53, Bcl-2, Bax, Mcl-1, and Bag-1 proteins.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20060301
-
Inflammatory cytokines predominate in cases of tumor regression after hematopoietic stem cell transplantation for solid cancer.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060301
-
Emerging drugs for chronic lymphocytic leukaemia.
Expert opinion on emerging drugs 20060301
-
Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies.
Clinical and experimental medicine 20060301
-
[Inhibition effect of fludarabine on the growth of myelodysplastic syndrome cell line MUTZ-1 and its mechanism].
Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20060301
-
F-ara-AMP is a substrate of cytoplasmic 5'-nucleotidase II (cN-II): HPLC and NMR studies of enzymatic dephosphorylation.
Nucleosides, nucleotides & nucleic acids 20060301
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20060301
-
Advances in the treatment of chronic lymphocytic leukemia.
Current hematologic malignancy reports 20060301
-
Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study.
Blood 20060215
-
Monoclonal antibody therapy of chronic lymphocytic leukemia.
Cancer immunology, immunotherapy : CII 20060201
-
Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia.
Blood 20060201
-
Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis.
Blood 20060201
-
Phase I and pharmacokinetic study of oral fludarabine phosphate in relapsed indolent B-cell non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology 20060201
-
Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity.
Leukemia 20060201
-
Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML.
Bone marrow transplantation 20060201
-
Subsequent therapy can be administered after tositumomab and iodine I-131 tositumomab for non-Hodgkin lymphoma.
Cancer 20060201
-
Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning.
Bone marrow transplantation 20060201
-
Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancer.
Bone marrow transplantation 20060201
-
Resistant pure red cell aplasia after allogeneic bone marrow transplantation with major ABO mismatch treated by purified CD34+ cell infusion.
European journal of haematology 20060201
-
Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS).
Bone marrow transplantation 20060201
-
Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen.
Bone marrow transplantation 20060201
-
The structure of human deoxycytidine kinase in complex with clofarabine reveals key interactions for prodrug activation.
Acta crystallographica. Section D, Biological crystallography 20060201
-
Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-CD20 monoclonal antibody rituximab.
Clinical and laboratory haematology 20060201
-
Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed hodgkin lymphoma: results of a spanish prospective cooperative protocol.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060201
-
Tacrolimus and mycophenolate mofetil after nonmyeloablative matched-sibling donor allogeneic stem-cell transplantations conditioned with fludarabine and low-dose total body irradiation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060201
-
Clinical significance of platelet count at day +60 after allogeneic peripheral blood stem cell transplantation.
Journal of Korean medical science 20060201
-
Apoptotic effect of fludarabine is independent of expression of IAPs in B-cell chronic lymphocytic leukemia.
Apoptosis : an international journal on programmed cell death 20060201
-
Successful reduced-intensity hematopoietic stem cell transplantation in myelodysplastic syndrome with severe coronary artery disease.
International journal of hematology 20060201
-
Phase I and pharmacokinetic study of once-daily dosing of intravenously administered busulfan in the setting of a reduced-intensity preparative regimen and allogeneic hematopoietic stem cell transplantation as immunotherapy for renal cell carcinoma.
Military medicine 20060201
-
[The outcomes of the thirty patients with refractory leukemia treated with related HLA haploidentical stem cells transplantation].
Zhonghua nei ke za zhi 20060201
-
[Effect of inhibitors of signal transducer and activator of transcription-1/3 on expression of tumor necrosis factor-alpha induced by high mobility group box-1 protein inflammatory response in rat peritoneal macrophages].
Zhonghua wai ke za zhi [Chinese journal of surgery] 20060201
-
Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060120
-
Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060120
-
A retrospective comparison of three sequential groups of patients with Recurrent/Refractory chronic lymphocytic leukemia treated with fludarabine-based regimens.
Cancer 20060115
-
Targeting endoplasmic reticulum protein transport: a novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL.
Blood 20060101
-
Functional characterization and haplotype analysis of polymorphisms in the human equilibrative nucleoside transporter, ENT2.
Drug metabolism and disposition: the biological fate of chemicals 20060101
-
A comparison of the transportability, and its role in cytotoxicity, of clofarabine, cladribine, and fludarabine by recombinant human nucleoside transporters produced in three model expression systems.
Molecular pharmacology 20060101
-
Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis.
Leukemia 20060101
-
Allogeneic hematopoietic cell transplantation following conditioning with 90Y-ibritumomab-tiuxetan.
Leukemia & lymphoma 20060101
-
Phase II study of oral fludarabine phosphate in relapsed indolent B-Cell non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060101
-
Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study.
European journal of haematology 20060101
-
PRIMA-1 induces apoptosis in acute myeloid leukaemia cells with p53 gene deletion.
British journal of haematology 20060101
-
Early-onset autoimmune hemolytic anemia after cladribine therapy for Waldenström's macroglobulinemia.
Transfusion 20060101
-
The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060101
-
Alemtuzumab, fludarabine and melphalan as a conditioning therapy in severe aplastic anemia and hypoplastic myelodysplastic syndrome--single center experience.
Japanese journal of clinical oncology 20060101
-
Costs of chemotherapy for indolent follicular non-Hodgkin's lymphoma in the UK: an observational study.
Acta haematologica 20060101
-
Chronic kidney disease following non-myeloablative hematopoietic cell transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20060101
-
In vitro sensitivity and cross-resistance to deoxynucleoside analogs in childhood acute leukemia.
Haematologica 20060101
-
Reduced-intensity conditioning followed by unrelated umbilical cord blood transplantation for advanced hematologic malignancies: rapid engraftment in bone marrow.
International journal of hematology 20060101
-
Fludarabine induced autoimmune haemolytic anaemia in a patient with chronic lymphocytic leukaemia.
JPMA. The Journal of the Pakistan Medical Association 20060101
-
[Allogeneic stem cell transplantation with fludarabine/melphalan (non-TBI and non-BU/CY) for patients aged 50 or more].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20060101
-
Invasive fungal infections in neutropenic enterocolitis: a systematic analysis of pathogens, incidence, treatment and mortality in adult patients.
BMC infectious diseases 20060101
-
Secondary leukemia after treatment with paclitaxel and carboplatin in a patient with recurrent ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101
-
[Fever and dyspnea in a patient with chronic lymphatic leukemia under treatment with fludarabine].
Enfermedades infecciosas y microbiologia clinica 20060101
-
[Allogeneic transplantation of peripheral blood hematopoietic stem-cells with low intensity conditioning for the treatment of a metastatic clear cell carcinoma. Preliminary results after two years of follow-up].
Archivos espanoles de urologia 20060101
-
Alemtuzumab therapy for severe autoimmune hemolysis in a patient with B-cell chronic lymphocytic leukemia.
Medical oncology (Northwood, London, England) 20060101
-
Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg) in children with relapsed/refractory myeloid leukemia.
BMC cancer 20060101
-
[Microcellular lung carcinoma in patient with hepatosplenic T-cell lymphoma: a case report].
Lijecnicki vjesnik 20060101
-
Histone deacetylase enzymes as potential drug targets in cancer and parasitic diseases.
Journal of biomedicine & biotechnology 20060101
-
JAK inhibitors AG-490 and WHI-P154 decrease IFN-gamma-induced iNOS expression and NO production in macrophages.
Mediators of inflammation 20060101
-
Preparation of a fludarabine intermediate via selective alkylation of 2-fluoroadenine.
Nucleosides, nucleotides & nucleic acids 20060101
-
[Remission in T-cell prolymphocytic leukemia during the FMC treatment course].
Terapevticheskii arkhiv 20060101
-
IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience.
American journal of therapeutics 20060101
-
High-risk fludarabine-pretreated B-cell chronic lymphocytic leukemia's high response rate following sequential DHAP and alemtuzumab administration though in absence of molecular remission.
Medical oncology (Northwood, London, England) 20060101
-
Alteration of DNA methylation status in K562 and MCF-7 cancer cell lines by nucleoside analogues.
Nucleosides, nucleotides & nucleic acids 20060101
-
A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantation.
BMC infectious diseases 20060101
-
Combination phenylbutyrate/gemcitabine therapy effectively inhibits in vitro and in vivo growth of NSCLC by intrinsic apoptotic pathways.
Journal of carcinogenesis 20060101
-
Current and investigational therapies for patients with CLL.
Hematology. American Society of Hematology. Education Program 20060101
-
Reduced-intensity regimens in allogeneic hematopoietic stem cell transplantation for hemoglobinopathies.
Hematology. American Society of Hematology. Education Program 20060101
-
Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity.
Current medicinal chemistry 20060101
-
Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor-prognosis solid tumors - Bulgarian experience.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20060101
-
Radioimmunotherapy: a brief overview.
Biomedical imaging and intervention journal 20060101
-
Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051220
-
Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation.
Blood 20051215
-
The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia.
Cancer 20051215
-
The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia.
British journal of cancer 20051212
-
OSW-1: a natural compound with potent anticancer activity and a novel mechanism of action.
Journal of the National Cancer Institute 20051207
-
Sustained engraftment post bone marrow transplant despite anti-platelet antibodies in Glanzmann thrombasthenia.
Pediatric blood & cancer 20051201
-
Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma.
Bone marrow transplantation 20051201
-
Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party.
Bone marrow transplantation 20051201
-
Efficacy and safety of oral fludarabine/cyclophosphamide regimen in previously treated indolent lymphomas.
Leukemia & lymphoma 20051201
-
Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase.
European journal of haematology 20051201
-
Treatment of X-linked childhood cerebral adrenoleukodystrophy by the use of an allogeneic stem cell transplantation with reduced intensity conditioning regimen.
Clinical transplantation 20051201
-
Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: a review.
Expert opinion on pharmacotherapy 20051201
-
Phase I study of low-dose interleukin-2, fludarabine, and cyclophosphamide for previously untreated indolent lymphoma and chronic lymphocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 20051201
-
Cytomegalovirus DNAemia and disease: incidence, natural history and management in settings other than allogeneic stem cell transplantation.
Haematologica 20051201
-
[Preliminary report of fludarabine, mitoxantrone and dexamethasone in treating refractory or relapsed multiple myeloma].
Ai zheng = Aizheng = Chinese journal of cancer 20051201
-
Contrast-enhanced MR imaging in the indirect monitoring of drug release from an interstitial depot.
International journal of clinical pharmacology and therapeutics 20051201
-
Significance of VH genes mutation status for prognosis of CLL patients.
Experimental oncology 20051201
-
[Second transplant from the same donor without conditioning for bone marrow aplasia after non-myeloablative hematopoietic stem cell transplantation for chronic myeloid leukemia].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20051201
-
[The role of Janus kinase-signal transducer and transcription activator pathway in the regulation of synthesis and release of lipopolysaccharide-induced high mobility group box-1 protein].
Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns 20051201
-
Microbiologic consequences of new approaches to managing hematologic malignancies.
Reviews in clinical and experimental hematology 20051201
-
Characterisation and internalisation of recombinant humanised HMFG-1 antibodies against MUC1.
British journal of cancer 20051128
-
Results of a phase 1 clinical trial of thalidomide in combination with fludarabine as initial therapy for patients with treatment-requiring chronic lymphocytic leukemia (CLL).
Blood 20051115
-
An irradiation-free nonmyeloablative bone marrow transplantation model: importance of the balance between donor T-cell number and the intensity of conditioning.
Transplantation 20051115
-
Engineering T cells for cancer therapy.
British journal of cancer 20051114
-
Flavopiridol administered as a 24-hour continuous infusion in chronic lymphocytic leukemia lacks clinical activity.
Leukemia research 20051101
-
Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT.
Blood 20051101
-
Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
Blood 20051101
-
FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia.
Annals of hematology 20051101
-
Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantation.
Bone marrow transplantation 20051101
-
Reduced intensity conditioning prior to allogeneic stem cell transplantation for patients with acute myeloblastic leukemia as a first-line treatment.
Cancer 20051101
-
Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706.
Leukemia 20051101
-
Fludarabine may induce durable remission in patients with leptomeningeal involvement of chronic lymphocytic leukemia.
Leukemia & lymphoma 20051101
-
Fludarabine phosphate-CVP in patients over 60 years of age with advanced, low-grade and follicular lymphoma: a dose-finding study.
European journal of cancer (Oxford, England : 1990) 20051101
-
The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donors.
Haematologica 20051101
-
Case of a patient with progressive adult T-cell leukemia/lymphoma treated successfully by reduced-intensity conditioning stem cell transplantation from an HLA-incompatible related donor.
International journal of hematology 20051101
-
Fatal West Nile Virus infection after rituximab/fludarabine--induced remission for non-Hodgkin's lymphoma.
Clinical lymphoma & myeloma 20051101
-
[A case of therapy-related leukemia/myelodysplastic syndrome following treatment of refractory testicular germ cell tumor].
Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20051101
-
[Chronic GVHD with polymyositis after non-myeloablative stem cell transplantation].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20051101
-
[Second nonmyeloablative allogeneic peripheral blood stem cell transplantation with more immunosuppressive conditioning regimen for the late graft failure of the patient with acute myeloid leukemia].
Fukuoka igaku zasshi = Hukuoka acta medica 20051101
-
Phase I to II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in patients with advanced chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051020
-
Richter's syndrome--the downside of fludarabine?
Leukemia research 20051001
-
Alemtuzumab induced complete remission of therapy-resistant pure red cell aplasia.
Leukemia research 20051001
-
Fludarabine plus cyclophosphamide in Waldenström's macroglobulinemia: results in 49 patients.
Leukemia 20051001
-
Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review).
International journal of oncology 20051001
-
Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: results of a phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051001
-
Myelodysplastic syndrome with complex karyotypic abnormality in a patient with Waldenström's macroglobulinemia after sequential treatment with chlorambucil and fludarabine.
Japanese journal of clinical oncology 20051001
-
Nephrotic syndrome: an under-recognised immune-mediated complication of non-myeloablative allogeneic haematopoietic cell transplantation.
British journal of haematology 20051001
-
High activity and incomplete cross resistance of nucleoside analogues cladribine and fludarabine versus Ara-C on leukemic cells from patients with AML.
Therapeutic drug monitoring 20051001
-
Nonmyeloablative stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia in patients 60 years or older.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20051001
-
Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients.
British journal of haematology 20051001
-
Haematopoietic stem cell transplantation for Shwachman-Diamond disease: a study from the European Group for blood and marrow transplantation.
British journal of haematology 20051001
-
Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 20051001
-
Cost analysis of common treatment options for indolent follicular non-Hodgkin's lymphoma.
Haematologica 20051001
-
Alemtuzumab (Campath 1-H).
Clinical journal of oncology nursing 20051001
-
Excellent response of chemotherapy-resistant B-cell-type chronic lymphocytic leukemia with meningeal involvement to rituximab.
International journal of clinical oncology 20051001
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20051001
-
[Allogeneic blood stem cell transplantation in high-risk patients after conditioning with treosulfan and fludarabine].
Deutsche medizinische Wochenschrift (1946) 20050923
-
Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050920
-
Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine.
Blood 20050915
-
A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group.
Annals of hematology 20050901
-
Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells.
Blood 20050901
-
Complete substitution of cyclophosphamide by fludarabine and ATG in a busulfan-based preparative regimen for children and adolescents with beta-thalassemia.
Bone marrow transplantation 20050901
-
Successful HSCT using nonradiotherapy-based conditioning regimens and alternative donors in patients with Fanconi anaemia--experience in a single UK centre.
Bone marrow transplantation 20050901
-
Advances in the treatment of chronic lymphocytic leukemia.
Current oncology reports 20050901
-
Graft-vs-host disease after non-myeloablative hematopoietic cell transplantation.
Leukemia & lymphoma 20050901
-
'Specific' cutaneous infiltrate of B-cell chronic lymphocytic leukemia at the site of a florid herpes simplex infection.
Journal of cutaneous pathology 20050901
-
Lineage-specific engraftment and outcomes after T-cell-depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioning.
British journal of haematology 20050901
-
Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050901
-
Purine nucleoside analogues for the treatment of hematological malignancies: pharmacology and clinical applications.
Current cancer drug targets 20050901
-
Successful nonmyeloablative cord blood transplantation for an infant with malignant infantile osteopetrosis.
Journal of pediatric hematology/oncology 20050901
-
Fludarabine combination therapy is highly effective in first-line and salvage treatment of patients with Waldenström's macroglobulinemia.
Clinical lymphoma & myeloma 20050901
-
[Pulmonary tuberculosis and adenovirus-hemorrhagic cystitis after autologous peripheral blood stem cell transplantation for follicular lymphoma].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20050901
-
P2X(7) receptor: Death or life?
Purinergic signalling 20050901
-
Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles.
British journal of cancer 20050822
-
[Successful combined treatment with rituximab and high dose immunoglobulin in a patient with chronic lymphocytic leukemia with fludarabine-induced severe immune thrombocytopenia].
Orvosi hetilap 20050821
-
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820
-
Unrelated donor marrow transplantation for B-cell chronic lymphocytic leukemia after using myeloablative conditioning: results from the Center for International Blood and Marrow Transplant research.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820
-
Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820
-
Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820
-
Unusual leukemia presentations. Case 3. Type I IgGlambda cryoglobulinemia associated with chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820
-
[Treatment of refractory and relapsed acute lymphocytic leukemia in adults].
Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 20050818
-
Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation.
Blood 20050801
-
Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning.
Bone marrow transplantation 20050801
-
Efficacy of reduced-intensity allogeneic stem cell transplantation in chemotherapy-refractory non-hodgkin lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20050801
-
Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia.
American journal of hematology 20050801
-
Risk factors for and attributable mortality from tuberculosis in patients with hematologic malignances.
Haematologica 20050801
-
188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study.
British journal of haematology 20050801
-
[Establishment of rhesus model for haploidentical hematopoietic stem cell transplantation with nonmyeloablative conditioning].
Zhongguo shi yan xue ye xue za zhi 20050801
-
[Treatment of thalassemia major with unrelated donor bone marrow transplantation].
Zhonghua er ke za zhi = Chinese journal of pediatrics 20050801
-
The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells.
Blood 20050715
-
Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen.
Cancer 20050715
-
Early immune reaction after reduced-intensity cord-blood transplantation for adult patients.
Transplantation 20050715
-
Mobilization of peripheral blood stem cells in CLL patients after front-line fludarabine treatment.
Annals of hematology 20050701
-
An evaluation of busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation.
Japanese journal of clinical oncology 20050701
-
Extrapulmonary tuberculous abscess in chronic lymphocytic leukaemia (CLL) treated with fludarabine: case report and review of literature.
American journal of hematology 20050701
-
Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: incidence and effects on survival.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20050701
-
Mycosis fungoides and Sezary syndrome: therapeutic approach and outcome in 113 patients.
International journal of dermatology 20050701
-
[Auto-immune manifestations in Non-Hodgkin's lymphoma].
La Revue de medecine interne 20050701
-
Hydatid disease in acute leukemia: effect of anticancer treatment on echinococcosis.
Microbes and infection 20050701
-
Accelerated growth of skin carcinoma following fludarabine therapy for chronic lymphocytic leukemia.
Leukemia & lymphoma 20050701
-
Idiopathic thrombocytopenic purpura and myasthenia gravis after fludarabine treatment for chronic lymphocytic leukemia.
Leukemia & lymphoma 20050701
-
Control of advanced and refractory acute myelogenous leukaemia with sirolimus-based non-myeloablative allogeneic stem cell transplantation.
British journal of haematology 20050701
-
Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage.
PLoS genetics 20050701
-
Pulmonary non-caseating granuloma in Waldenström macroglobulinemia.
The Tokai journal of experimental and clinical medicine 20050701
-
[Establishment of a rhesus haploidentical hematopoietic stem cell and mesenchymal stem cell transplantation model by nonmyeloablative conditioning].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20050701
-
A highly sensitive high-performance liquid chromatography-mass spectrometry method for quantification of fludarabine triphosphate in leukemic cells.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050625
-
Changing the way we think about chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050620
-
Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050620
-
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050620
-
Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha.
Blood 20050615
-
Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients.
Transplantation 20050615
-
Inhibition of the PI3K pathway sensitizes fludarabine-induced apoptosis in human leukemic cells through an inactivation of MAPK-dependent pathway.
Biochemical and biophysical research communications 20050603
-
A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival.
Blood 20050601
-
Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT.
Blood 20050601
-
Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML.
Leukemia 20050601
-
Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050601
-
CD52 and CD45 monoclonal antibodies for reduced intensity hemopoietic stem cell transplantation from HLA matched and one antigen mismatched unrelated donors.
Bone marrow transplantation 20050601
-
Successful non-T-cell-depleted HLA-haploidentical 3-loci mismatched bone marrow transplantation.
European journal of haematology 20050601
-
Dialysate concentration and pharmacokinetics of 2F-Ara-A in a patient with acute renal failure.
European journal of haematology 20050601
-
Fludarabine increases complete response but not survival compared with conventional alkylator-based regimens for previously untreated chronic lymphocytic leukaemia.
Cancer treatment reviews 20050601
-
Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma.
British journal of haematology 20050601
-
Treatment of relapsed chronic lymphocytic leukemia by 72-hour continuous infusion or 1-hour bolus infusion of flavopiridol: results from Cancer and Leukemia Group B study 19805.
Clinical cancer research : an official journal of the American Association for Cancer Research 20050601
-
Preclinical evaluation of gemcitabine combination regimens for application in acute myeloid leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 20050601
-
Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20050601
-
Reduced-intensity conditioning allogeneic blood stem cell transplantation with fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20050601
-
An unusual reoccurrence of Waldenstrom's macroglobulinemia as pleural effusions that had a discordant response with treatment.
Clinical and laboratory haematology 20050601
-
Pulmonary lymphoma of the mucosa-associated lymphoid tissue type: Report of a case with cytological, histological, immunophenotypical correlation, and review of the literature.
Annals of diagnostic pathology 20050601
-
Fludarabine and cytarabine as continuous sequential infusion for elderly patients with acute myeloid leukemia.
Haematologica 20050601
-
Economic assessment on the management of chronic lymphocytic leukaemia.
Expert opinion on pharmacotherapy 20050601
-
The combination of fludarabine, cyclophosphamide, and granulocyte-macrophage colony-stimulating factor in the treatment of patients with relapsed chronic lymphocytic leukemia and low-grade Non-Hodgkin's lymphoma.
Clinical lymphoma 20050601
-
FLAG-IDA in the treatment of refractory/relapsed acute leukaemias: single centre study.
JPMA. The Journal of the Pakistan Medical Association 20050601
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20050601
-
Apoptosis of peripheral human blood lymphocytes induced by physical-chemical influences and generation of reactive oxygen species.
Annals of the New York Academy of Sciences 20050601
-
Resistance to 9-beta-D-arabinofuranosyl-2-fluoroadenine due to reduced incorporation into DNA from competition by excess deoxyadenosine triphosphate: implications for different sensitivities to nucleoside analogues.
International journal of hematology 20050601
-
Blastic transformation after splenectomy in a patient with nonvillous splenic marginal zone lymphoma with p53 overexpression: a case report.
International journal of hematology 20050601
-
Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050520
-
Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma.
Blood 20050515
-
The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analog.
Cancer 20050515
-
Alemtuzumab induces enhanced apoptosis in vitro in B-cells from patients with chronic lymphocytic leukemia by antibody-dependent cellular cytotoxicity.
European journal of pharmacology 20050509
-
Reduced-intensity conditioning followed by allografting of CD34-selected stem cells and < or =10(6)/kg T cells may have an adverse effect on transplant-related mortality.
Annals of hematology 20050501
-
Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation.
Bone marrow transplantation 20050501
-
High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation.
Leukemia 20050501
-
Oligotide, a defibrotide derivative, protects human microvascular endothelial cells against fludarabine-induced activation, damage and allogenicity.
Bone marrow transplantation 20050501
-
Haplotype mismatched transplantation using high doses of peripheral blood CD34+ cells together with stratified conditioning regimens for high-risk adult acute myeloid leukemia patients: a pilot study in a single Korean institution.
Bone marrow transplantation 20050501
-
In vitro cytotoxic effect of proteasome inhibitor bortezomib in combination with purine nucleoside analogues on chronic lymphocytic leukaemia cells.
European journal of haematology 20050501
-
Symmetric bony involvement of the lower extremities with lymphoma demonstrated on gallium scintigraphy.
Clinical nuclear medicine 20050501
-
Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation.
British journal of haematology 20050501
-
Prolymphocytic leukemia.
Current treatment options in oncology 20050501
-
Reversal of bone marrow angiogenesis in chronic lymphocytic leukemia following fludarabine therapy.
Haematologica 20050501
-
Early and late infectious consequences of adding rituximab to fludarabine and cyclophosphamide in patients with indolent lymphoid malignancies.
Haematologica 20050501
-
Haematopoietic stem cell transplantation to treat aplastic anaemia.
Expert opinion on biological therapy 20050501
-
Successful reduced-intensity stem cell transplantation (RIST) for a patient with malignant lymphoma and an ileostomy.
Internal medicine (Tokyo, Japan) 20050501
-
[Nonmyleoablative allogeneic stem cell transplantation combined with imatinib in treatment of chronic myeloid leukemia: a clinical study].
Zhonghua yi xue za zhi 20050427
-
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.
Blood 20050415
-
Graft-versus-tumor effect against advanced pancreatic cancer after allogeneic reduced-intensity stem cell transplantation.
Transplantation 20050415
-
Analysis of human equilibrative nucleoside transporter 1 (hENT1) protein in non-Hodgkin's lymphoma by immunohistochemistry.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20050401
-
Successful treatment of lymphoma with fludarabine combined with rituximab after immune thrombocytopenia induced by fludarabine.
Annals of hematology 20050401
-
Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20050401
-
Richter's transformation of chronic lymphocytic leukemia. The possible role of fludarabine and the Epstein-Barr virus in its pathogenesis.
Leukemia research 20050401
-
Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia.
Bone marrow transplantation 20050401
-
AT514, a cyclic depsipeptide from Serratia marcescens, induces apoptosis of B-chronic lymphocytic leukemia cells: interference with the Akt/NF-kappaB survival pathway.
Leukemia 20050401
-
Mini-ICE effectively mobilises peripheral blood stem cells after fludarabine-based regimens in acute myeloid leukaemia.
European journal of haematology 20050401
-
HLA-haploidentical nonmyeloablative stem cell transplantation: induction to tolerance without passing through mixed chimaerism.
Clinical and laboratory haematology 20050401
-
Inefficiency of high-dose G-CSF alone as second mobilization regimen in fludarabin-cyclophosphamide-treated CLL patients who failed to mobilize after chemotherapy and G-CSF.
Bone marrow transplantation 20050401
-
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050401
-
p53 Aberrations do not predict individual response to fludarabine in patients with B-cell chronic lymphocytic leukaemia in advanced stages Rai III/IV.
British journal of haematology 20050401
-
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20050401
-
Reduced-intensity unrelated cord blood transplantation for patients with advanced malignant lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20050401
-
Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine.
British journal of haematology 20050401
-
Five-month marrow aplasia in a child with refractory acute myeloid leukemia: successful management with continuous granulocyte support and reduced-intensity conditioning followed by matched unrelated bone marrow transplantation.
Journal of pediatric hematology/oncology 20050401
-
[Clinical study on transplantation of G-CSF-mobilized allo-PBSC and allo-bone marrow for leukemia patients].
Zhongguo shi yan xue ye xue za zhi 20050401
-
Reduced intensity conditioning compared to standard conditioning preserves the in vitro growth capacity of bone marrow stroma, which remains of host origin.
Stem cells and development 20050401
-
Superior quality and duration of responses among patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide with or without rituximab compared with prior responses to CHOP.
Leukemia & lymphoma 20050401
-
Treatment of streptozotocin-induced diabetes mellitus in rats by transplantation of islet cells from two major histocompatibility complex disparate rats in combination with intra bone marrow injection of allogeneic bone marrow cells.
Transplantation 20050327
-
Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050320
-
Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell dose.
Blood 20050315
-
An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital.
British journal of cancer 20050314
-
Lysophosphatidic acid (LPA) protects primary chronic lymphocytic leukemia cells from apoptosis through LPA receptor activation of the anti-apoptotic protein AKT/PKB.
The Journal of biological chemistry 20050311
-
Adaphostin-induced apoptosis in CLL B cells is associated with induction of oxidative stress and exhibits synergy with fludarabine.
Blood 20050301
-
Role of the STAT1 pathway in apoptosis induced by fludarabine and JAK kinase inhibitors in B-cell chronic lymphocytic leukemia.
Leukemia & lymphoma 20050301
-
Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning.
Bone marrow transplantation 20050301
-
Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia.
Bone marrow transplantation 20050301
-
Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation.
Leukemia 20050301
-
Fludarabine: risk factor for aggressive behaviour of squamous cell carcinoma of the skin?
Annals of oncology : official journal of the European Society for Medical Oncology 20050301
-
Long-term follow-up of a randomized trial of fludarabine-mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the era of monoclonal antibodies.
Annals of oncology : official journal of the European Society for Medical Oncology 20050301
-
In vitro drug resistance in B cell chronic lymphocytic leukemia: a comparison with acute myelocytic and acute lymphocytic leukemia.
Anti-cancer drugs 20050301
-
Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning.
British journal of haematology 20050301
-
Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosis.
British journal of haematology 20050301
-
Innovations in antineoplastic therapy.
The Nursing clinics of North America 20050301
-
Diagnosis and management of Waldenstrom's macroglobulinemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050301
-
Hairy cell leukemia variant with features of intrasinusoidal bone marrow involvement.
Archives of pathology & laboratory medicine 20050301
-
Complete remission following clofarabine treatment in refractory juvenile myelomonocytic leukemia.
Journal of pediatric hematology/oncology 20050301
-
Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 20050301
-
Targeting once-daily intravenous busulfan in combination with fludarabine before allogeneic hematopoietic cell transplantation.
Bone marrow transplantation 20050301
-
[Current and new therapeutic strategies in acute myeloid leukemia].
Gan to kagaku ryoho. Cancer & chemotherapy 20050301
-
CHOP plus rituximab therapy in Waldenstrom's macroglobulinemia.
Clinical lymphoma 20050301
-
Early results of a phase I trial of oblimersen sodium for relapsed or refractory Waldenstrom's macroglobulinemia.
Clinical lymphoma 20050301
-
Phase III study of chlorambucil versus fludarabine as initial therapy for Waldenstrom's macroglobulinemia and related disorders.
Clinical lymphoma 20050301
-
Hematopoietic transplantation for bone marrow failure syndromes and thalassemia.
Bone marrow transplantation 20050301
-
[Metabolism, mechanism of action and resistance to cytotoxic nucleoside analogues].
Bulletin du cancer 20050301
-
[News in therapeutic management of chronic lymphoid leukemia].
Bulletin du cancer 20050301
-
[Umbilical cord blood transplantation for patients with beta-thalassemia major].
Zhonghua er ke za zhi = Chinese journal of pediatrics 20050301
-
High expression of bfl-1 contributes to the apoptosis resistant phenotype in B-cell chronic lymphocytic leukemia.
International journal of cancer 20050220
-
Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.
Blood 20050215
-
Cardiac toxicity of high-dose chemotherapy.
Bone marrow transplantation 20050201
-
Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago Experience.
Bone marrow transplantation 20050201
-
The place of cladribine in the treatment of chronic lymphocytic leukemia: a 10-year experience in Poland.
Annals of hematology 20050201
-
Transplantation of allogeneic CD34-selected stem cells after fludarabine-based conditioning regimen for children with mucopolysaccharidosis 1H (M. Hurler).
Bone marrow transplantation 20050201
-
A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders.
Bone marrow transplantation 20050201
-
Fludarabine-based conditioning for allogeneic stem cell transplantation for multiply transfused patients with Fanconi's anemia.
Bone marrow transplantation 20050201
-
Successful bone marrow transplantation in a patient with c-mpl-mutated congenital amegakaryocytic thrombocytopenia from a carrier donor.
Pediatric transplantation 20050201
-
Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050201
-
The role of mitoxantrone in the treatment of indolent lymphomas.
The oncologist 20050201
-
Delayed response to fludarabine in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia.
Haematologica 20050201
-
Advanced Waldenström's macroglobulinemia: usefulness of Morel's scoring system in establishing prognosis.
Haematologica 20050201
-
Peripheral blood stem cell mobilization and harvesting after fludarabine therapy for low-grade lymphoma and chronic lymphocytic leukemia.
Stem cells and development 20050201
-
Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 20050201
-
Outcome following alemtuzumab (CAMPATH-1H)-containing reduced intensity allogeneic transplant regimen for relapsed and refractory non-Hodgkin's lymphoma (NHL).
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 20050201
-
Fludarabine: new indication. First-line treatment of CLL: unconvincing evidence.
Prescrire international 20050201
-
Successful salvage with high-dose sequential chemotherapy coupled with in vivo purging and autologous stem cell transplantation in 2 patients with primary refractory mantle cell lymphoma presenting in the leukemic phase.
International journal of hematology 20050201
-
Lymphoma: diagnosis, staging, natural history, and treatment strategies.
Seminars in oncology 20050201
-
Future trends in radioimmunotherapy.
Seminars in oncology 20050201
-
Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations.
Blood 20050115
-
Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011.
Blood 20050101
-
Equilibrative nucleoside transporter-2 (hENT2) protein expression correlates with ex vivo sensitivity to fludarabine in chronic lymphocytic leukemia (CLL) cells.
Leukemia 20050101
-
Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning.
Leukemia 20050101
-
Impact of early NK cell recovery on development of GvHD and CMV reactivation in dose-reduced regimen prior to allogeneic PBSCT.
Bone marrow transplantation 20050101
-
Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin.
Bone marrow transplantation 20050101
-
Proapoptotic activity of alemtuzumab alone and in combination with rituximab or purine nucleoside analogues in chronic lymphocytic leukemia cells.
Leukemia & lymphoma 20050101
-
Myocardial kinetics of reporter probe 124I-FIAU in isolated perfused rat hearts after in vivo adenoviral transfer of herpes simplex virus type 1 thymidine kinase reporter gene.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20050101
-
How we treat Waldenström's macroglobulinemia.
Haematologica 20050101
-
Acute renal failure and disseminated intravascular coagulation following an idiosyncratic reaction to Alemtuzumab (Campath 1H) or fludarabine.
Haematologica 20050101
-
Gene expression profiling revealed novel mechanism of action of Taxotere and Furtulon in prostate cancer cells.
BMC cancer 20050101
-
PNP with Waldenström's macroglobulinaemia.
Clinical and experimental dermatology 20050101
-
Alemtuzumab in the treatment of chronic lymphocytic leukemia.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20050101
-
Fludarabine-based conditioning used in successful bone marrow transplantation from an unrelated donor in a heavily transfused patient with severe aplastic anemia.
International journal of hematology 20050101
-
Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3).
The pharmacogenomics journal 20050101
-
In vitro sensitivity of leukemic cells to nucleoside derivatives in childhood acute leukemias: good activity in leukemic relapses.
Neoplasma 20050101
-
Analysis of 1H NMR-detectable mobile lipid domains for assessment of apoptosis induced by inhibitors of DNA synthesis and replication.
Cell biology international 20050101
-
Development of malignant mesothelioma during treatment for prolymphocytic leukemia: is asbestos or simian virus 40 a link?
Anticancer research 20050101
-
Fludarabine phosphate may be useful in the treatment of graft-versus-host disease.
Medical hypotheses 20050101
-
Lipid nucleoside conjugates for the treatment of cancer.
Current pharmaceutical design 20050101
-
Allogeneic non-myeloablative hematopoietic stem cell transplantation for treatment of metastatic renal cell carcinoma -- single center experience.
Neoplasma 20050101
-
Determination of caspase-3 activation fails to predict chemosensitivity in primary acute myeloid leukemia blasts.
BMC cancer 20050101
-
Waldenström's macroglobulinemia.
Best practice & research. Clinical haematology 20050101
-
Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scid mice.
BMC cancer 20050101
-
In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis.
BMC cancer 20050101
-
Eradication of minimal residual disease with alemtuzumab in B-cell chronic lymphocytic leukemia (B-CLL) patients: the need for a standard method of detection and the potential impact of bone marrow clearance on disease outcome.
Cancer investigation 20050101
-
Primary and secondary autoimmune neutropenia.
Arthritis research & therapy 20050101
-
Simultaneous quantification of fludarabine and cyclophosphamide in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
Rapid communications in mass spectrometry : RCM 20050101
-
Genotypic prognostic markers.
Current topics in microbiology and immunology 20050101
-
Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
Annals of the New York Academy of Sciences 20050101
-
Soluble form of TRAIL, Fas and FasL in the serum of patients with B-CLL.
Roczniki Akademii Medycznej w Bialymstoku (1995) 20050101
-
Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues: facts and controversies.
Drugs & aging 20050101
-
[Progress and perspectives in the treatment of systemic lupus erythematosus].
Przeglad lekarski 20050101
-
First two successful unrelated donor bone marrow transplantations for paroxysmal nocturnal hemoglobinuria in Poland.
Annals of transplantation 20050101
-
[Mantle cell lymphoma mimicking chronic lymphocytic leukemia].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20050101
-
Reduced-intensity allogeneic hematopoietic stem-cell transplantation as an immunotherapy for metastatic colorectal cancer.
Transplantation 20041227
-
Adenine deoxynucleotides fludarabine and cladribine induce apoptosis in a CD95/Fas receptor, FADD and caspase-8-independent manner by activation of the mitochondrial cell death pathway.
Oncogene 20041216
-
Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma.
Blood 20041215
-
Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma.
Blood 20041201
-
Increased mitochondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to fludarabine.
Leukemia 20041201
-
Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia.
Bone marrow transplantation 20041201
-
Reduced-intensity conditioning using TBI (8 Gy), fludarabine, cyclophosphamide and ATG in elderly CML patients provides excellent results especially when performed in the early course of the disease.
Bone marrow transplantation 20041201
-
Purine nucleoside phosphorylase and fludarabine phosphate gene-directed enzyme prodrug therapy suppresses primary tumour growth and pseudo-metastases in a mouse model of prostate cancer.
The journal of gene medicine 20041201
-
Immunobiologic therapies for myelodysplastic syndrome.
Best practice & research. Clinical haematology 20041201
-
Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignancies.
Bone marrow transplantation 20041201
-
VH gene mutation status and cellular drug resistance in chronic lymphocytic leukaemia.
European journal of haematology 20041201
-
The influence of farnesyl protein transferase inhibitor R115777 (Zarnestra) alone and in combination with purine nucleoside analogs on acute myeloid leukemia progenitors in vitro.
European journal of haematology 20041201
-
The effect of G-CSF on the in vitro cytotoxicity of cytarabine and fludarabine in the FLAG combination in pediatric acute myeloid leukemia.
International journal of oncology 20041201
-
Nonmyeloablative allogeneic bone marrow transplantation for treatment of myelodysplastic syndrome complicated by recent intracerebral hemorrhage.
American journal of hematology 20041201
-
Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens.
Clinical cancer research : an official journal of the American Association for Cancer Research 20041201
-
Phase II study of fludarabine and alpha-interferon in patients with low-grade non-Hodgkin's lymphoma.
Haematologica 20041201
-
A reduced intensity conditioning regimen for allografting following autografting is feasible and has strong anti-myeloma activity.
Haematologica 20041201
-
Effect of fludarabine on leukocyte functions.
Chemotherapy 20041201
-
Genistein induces G2 arrest in malignant B cells by decreasing IL-10 secretion.
Cell cycle (Georgetown, Tex.) 20041201
-
Remission induction using alemtuzumab can permit chemotherapy-refractory chronic lymphocytic leukemia (CLL) patients to undergo allogeneic stem cell transplantation.
Leukemia & lymphoma 20041201
-
Role of liposomal daunorubicin, fludarabine and cytarabine (FLAD) in the salvage therapy of adult acute lymphoblastic leukemia.
Leukemia & lymphoma 20041201
-
Treatment options in Waldenstrom's macroglobulinemia.
Clinical lymphoma 20041201
-
Unmanipulated reduced-intensity stem cell transplantation from a haploidentical donor mismatched at 3 HLA antigens to a patient with leukemic transformation of myelodysplastic syndrome: successful second transplantation after graft rejection.
International journal of hematology 20041201
-
Megadose CD34+ hemopoietic stem cell transplantation for patients with high risk acute myeloid leukemia who have no HLA matched donor--a pilot study of a full haplotype mismatch transplantation.
The Korean journal of internal medicine 20041201
-
Fludarabine as a second-line treatment of advanced stage chronic lymphocytic leukemia.
Saudi medical journal 20041201
-
The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group.
Blood 20041115
-
Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia.
Annals of hematology 20041101
-
Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus.
Gene therapy 20041101
-
A new model for predicting infectious complications during fludarabine-based combination chemotherapy among patients with indolent lymphoid malignancies.
Cancer 20041101
-
Fludarabine therapy in patients with splenic lymphoma with villous lymphocytes: an update.
Leukemia 20041101
-
Inhibition of repair of carboplatin-induced DNA damage by 9-beta-D-arabinofuranosyl-2-fluoroadenine in quiescent human lymphocytes.
Biochemical pharmacology 20041101
-
Effects of PRIMA-1 on chronic lymphocytic leukaemia cells with and without hemizygous p53 deletion.
British journal of haematology 20041101
-
Unrelated donor hematopoietic stem cell transplantation for patients with hematologic malignancies using a nonmyeloablative conditioning regimen of fludarabine, low-dose total body irradiation, and rabbit antithymocyte globulin.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20041101
-
Fludarabine in comparison to alkylator-based regimen as induction therapy for chronic lymphocytic leukemia: a systematic review and meta-analysis.
Leukemia & lymphoma 20041101
-
Fludarabine-induced apoptosis in CD19+/CD5+B-CLL cells is a direct and nurse-like-cell independent effect.
Leukemia & lymphoma 20041101
-
Importance of receptor density in alpha radioimmunotherapy in B cell malignancies: an in-vitro study.
Nuclear medicine communications 20041101
-
Conditioning regimen of melphalan, fludarabine and total body irradiation in unmanipulated HLA haploidentical stem cell transplantation based on feto-maternal tolerance.
Internal medicine (Tokyo, Japan) 20041101
-
Unrelated cord blood transplantation with a reduced-intensity conditioning regimen following autologous transplantation for multiple myeloma.
International journal of hematology 20041101
-
Potential therapeutic applications of oblimersen in CLL.
Oncology (Williston Park, N.Y.) 20041101
-
The influence of chemotherapy on bone marrow in patients with chronic lymphocytic leukaemia.
Folia morphologica 20041101
-
Differential roles of STAT1alpha and STAT1beta in fludarabine-induced cell cycle arrest and apoptosis in human B cells.
Blood 20041015
-
Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Blood 20041015
-
A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation.
Transplantation 20041015
-
A phase I and pharmacodynamic study of fludarabine, carboplatin, and topotecan in patients with relapsed, refractory, or high-risk acute leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 20041015
-
How to improve the design of trials of antifungal prophylaxis among neutropenic adults with acute leukemia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20041015
-
Establishment and characterisation of a human carcinoma cell line with acquired resistance to Aplidin.
British journal of cancer 20041004
-
Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20041001
-
Significant thrombocytopenia associated with the addition of rituximab to a combination of fludarabine and cyclophosphamide in the treatment of relapsed follicular lymphoma.
European journal of haematology 20041001
-
Farnesyltransferase inhibitor BMS-214662 induces apoptosis in B-cell chronic lymphocytic leukemia cells.
Leukemia 20041001
-
Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia.
Leukemia & lymphoma 20041001
-
Chlorambucil plus theophylline vs chlorambucil alone as a front line therapy for B-cell chronic lymphatic leukemia.
Leukemia & lymphoma 20041001
-
Blastic natural killer (NK)-cell lymphoma: report of an unusual CD4 negative case and review of the CD4 negative neoplasms with blastic features in the literature.
Leukemia & lymphoma 20041001
-
Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20041001
-
Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes.
British journal of haematology 20041001
-
Early-onset Guillain-Barré syndrome associated with reactivation of Epstein-Barr virus infection after nonmyeloablative stem cell transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20041001
-
[Establishment of nonmyeloablative allogeneic stem cell transplantation model in H-2 haploidentical mice and its related study].
Zhongguo shi yan xue ye xue za zhi 20041001
-
Successful unrelated cord blood transplantation using a reduced-intensity conditioning regimen in a 6-month-old infant with congenital neutropenia complicated by severe pneumonia.
International journal of hematology 20041001
-
Allogeneic bone marrow transplantation in beta-thalassaemia--single centre study.
JPMA. The Journal of the Pakistan Medical Association 20041001
-
Clofarabine in adult acute leukemias: clinical success and pharmacokinetics.
Nucleosides, nucleotides & nucleic acids 20041001
-
Modulation of cytarabine induced cytotoxicity using novel deoxynucleoside analogs in the HL60 cell line.
Nucleosides, nucleotides & nucleic acids 20041001
-
Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning.
Blood 20040915
-
Excellent in vivo bystander activity of fludarabine phosphate against human glioma xenografts that express the escherichia coli purine nucleoside phosphorylase gene.
Cancer research 20040915
-
The novel sequence-specific DNA cross-linking agent SJG-136 (NSC 694501) has potent and selective in vitro cytotoxicity in human B-cell chronic lymphocytic leukemia cells with evidence of a p53-independent mechanism of cell kill.
Cancer research 20040915
-
Effects of gemcitabine on APE/ref-1 endonuclease activity in pancreatic cancer cells, and the therapeutic potential of antisense oligonucleotides.
British journal of cancer 20040913
-
Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response.
Blood 20040901
-
Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors.
Blood 20040901
-
Effectiveness of fludarabine, idarubicin and cyclophosphamide (FLUIC) combination regimen for young patients with untreated non-follicular low-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 20040901
-
Fludarabine and bendamustine in refractory and relapsed indolent lymphoma--a multicenter phase I/II Trial of the east german society of hematology and oncology (OSHO).
Leukemia & lymphoma 20040901
-
BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning.
Leukemia 20040901
-
Severe acquired hemophilia with factor VIII inhibition associated with acetaminophen and chlorpheniramine.
The Annals of pharmacotherapy 20040901
-
Reduced-intensity conditioning prior to allogeneic transplantation of hematopoietic stem cells: the need for T cells early after transplantation to induce a graft-versus-lymphoma effect.
Bone marrow transplantation 20040901
-
The role of fludarabine in the treatment of follicular and mantle cell lymphoma.
Cancer 20040901
-
[New perspectives in the evolution of prognosis and treatment of chronic lymphocytic leukaemia].
Orvosi hetilap 20040829
-
Fludarabine, adriamycin and dexamethasone (FAD) in newly diagnosed advanced follicular lymphoma: a phase II study by the British National Lymphoma Investigation (BNLI).
British journal of cancer 20040816
-
New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years.
Blood 20040815
-
Characterization of a gemcitabine-resistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug.
Clinical cancer research : an official journal of the American Association for Cancer Research 20040815
-
Reversible paraneoplastic neuropathy associated with T-cell large granular lymphocyte leukemia.
Neurology 20040810
-
Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.
Blood 20040801
-
In vitro assessment of nucleoside analogs in multiple myeloma.
Cancer chemotherapy and pharmacology 20040801
-
Fludarabine, low-dose busulfan and antithymocyte globulin as conditioning for Fanconi anemia patients receiving bone marrow transplantation from HLA-compatible related donors.
Bone marrow transplantation 20040801
-
Nonmyeloablative stem cell transplantation in metastatic renal cell carcinoma: delayed graft-versus-tumor effect is associated with chimerism conversion but transplantation has high toxicity.
Bone marrow transplantation 20040801
-
Favourable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodies.
European journal of haematology 20040801
-
Histone deacetylase inhibitor enhances the anti-leukemic activity of an established nucleoside analogue.
Cancer biology & therapy 20040801
-
Fatal peripheral neuropathy following FLA chemotherapy.
Clinical and laboratory haematology 20040801
-
Successful reduced-intensity allogeneic transplantation utilizing a fludarabine-based preparative regimen in a patient with chronic lymphocytic leukaemia and a history of fludarabine-associated autoimmune haemolytic anaemia.
British journal of haematology 20040801
-
Cytopenia and hematopoietic recovery after low intensity conditioning transplants.
Croatian medical journal 20040801
-
Molecular genetics and its clinical relevance.
Hematology/oncology clinics of North America 20040801
-
Antibody therapy for chronic lymphocytic leukemia: a promising new modality.
Hematology/oncology clinics of North America 20040801
-
Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism.
Arthritis and rheumatism 20040801
-
The conjugate Rituximab/saporin-S6 completely inhibits clonogenic growth of CD20-expressing cells and produces a synergistic toxic effect with Fludarabine.
Leukemia 20040701
-
Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation.
Bone marrow transplantation 20040701
-
Patient perceptions about chemotherapy-induced oral mucositis: implications for primary/secondary prophylaxis strategies.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20040701
-
Ajoene (natural garlic compound): a new anti-leukaemia agent for AML therapy.
Leukemia research 20040701
-
Metabolic response patterns of nucleotides in B-cell chronic lymphocytic leukaemias to cladribine, fludarabine and deoxycoformycin.
Leukemia research 20040701
-
Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040701
-
The clinical and epidemiological burden of chronic lymphocytic leukaemia.
European journal of cancer care 20040701
-
Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20040701
-
An update on the management of chronic lymphocytic leukaemia.
Expert opinion on pharmacotherapy 20040701
-
Acute renal failure after nonmyeloablative hematopoietic cell transplantation.
Journal of the American Society of Nephrology : JASN 20040701
-
9-beta-D-arabinofuranosyl-2-fluoroadenine inhibits expression of vascular endothelial growth factor through hypoxia-inducible factor-1 in human ovarian cancer cells.
Molecular pharmacology 20040701
-
Neurological complications following alemtuzumab-based reduced-intensity allogeneic transplantation.
Bone marrow transplantation 20040701
-
Low transplant-related mortality with allogeneic stem cell transplantation in elderly patients.
Bone marrow transplantation 20040701
-
Allogeneic hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen for treatment of metastatic renal cell carcinoma: single institution experience with a minimum 1-year follow-up.
Experimental hematology 20040701
-
Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children.
Lancet (London, England) 20040701
-
Advances in chemotherapy for chronic lymphocytic leukemia.
Seminars in hematology 20040701
-
The role of stem cell transplantation in chronic lymphocytic leukemia.
Seminars in hematology 20040701
-
Clinical trials for malignant lymphoma in Japan.
Japanese journal of clinical oncology 20040701
-
Upon drug-induced apoptosis in lymphoma cells X-linked inhibitor of apoptosis (XIAP) translocates from the cytosol to the nucleus.
Leukemia & lymphoma 20040701
-
Guillain-Barré syndrome complicating mobilization therapy in a case of B-cell chronic lymphocytic leukemia.
Leukemia & lymphoma 20040701
-
Ex vivo therapeutic index by drug sensitivity assay using fresh human normal and tumor cells.
Journal of experimental therapeutics & oncology 20040701
-
Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
Clinical advances in hematology & oncology : H&O 20040701
-
Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040615
-
Fludarabine and mitoxantrone for patients with chronic lymphocytic leukemia.
Cancer 20040615
-
Allogeneic hematopoietic stem cell transplantation in a patient affected by large granular lymphocyte leukemia and multiple sclerosis.
Annals of hematology 20040601
-
Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies.
Bone marrow transplantation 20040601
-
Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG).
Leukemia 20040601
-
Irreversible myelosuppression after fludarabine-melphalan conditioning: observations in patients with graft rejection.
Blood 20040601
-
Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040601
-
Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases.
Clinical cancer research : an official journal of the American Association for Cancer Research 20040601
-
Treatment of inflammatory and paraproteinemic neuropathies.
Current drug targets. Immune, endocrine and metabolic disorders 20040601
-
Severe T-mediated bone marrow aplasia in a patient with splenic lymphoma with villous lymphocytes (SLVL) previously treated with fludarabine regimen.
Haematologica 20040601
-
Purine nucleoside antimetabolites in development for the treatment of cancer.
Current opinion in investigational drugs (London, England : 2000) 20040601
-
Fludarabine, cyclophosphamide and mitoxantrone for untreated follicular lymphoma: a report from the non-Hodgkin's lymphoma co-operative study group.
Leukemia & lymphoma 20040601
-
Efficacy and safety of fludarabine and cyclophosphamide combined therapy in patients with refractory/recurrent B-cell chronic lymphocytic leukaemia (B-CLL)-Polish multicentre study.
Leukemia & lymphoma 20040601
-
High dose chemotherapy and autologous stem cell transplantation for poor risk and recurrent non-Hodgkin's lymphoma: a single-center experience of 50 patients.
The Korean journal of internal medicine 20040601
-
Hypoxia/re-oxygenation-induced, redox-dependent activation of STAT1 (signal transducer and activator of transcription 1) confers resistance to apoptotic cell death via hsp70 induction.
The Biochemical journal 20040515
-
Fludarabine and cyclophosphamide using an attenuated dose schedule is a highly effective regimen for patients with indolent lymphoid malignancies.
Cancer 20040515
-
Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.
Cancer 20040515
-
Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions.
Blood 20040501
-
Predictive factors for successful stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine.
Leukemia 20040501
-
Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies.
Bone marrow transplantation 20040501
-
Economic burden of acute myeloid leukemia: a literature review.
Cancer treatment reviews 20040501
-
High-dose chemotherapy using BEAM for tumor debulking without stem cell support followed by early allogeneic reduced intensity conditioning transplantation to induce a graft-versus-lymphoma effect in patients with high risk or refractory lymphoma.
Bone marrow transplantation 20040501
-
Unusual case of subcutaneous panniculitis-like T-cell lymphoma.
The Australasian journal of dermatology 20040501
-
Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era.
Leukemia research 20040501
-
Alemtuzumab (CAMPATH 1H) does not kill chronic lymphocytic leukemia cells in serum free medium.
Leukemia research 20040501
-
Paraneoplastic pemphigus secondary to fludarabine evolving into unusual oral pemphigus vegetans.
Journal of the European Academy of Dermatology and Venereology : JEADV 20040501
-
Distinct clonal origin in two cases of Hodgkin's lymphoma variant of Richter's syndrome associated With EBV infection.
The American journal of surgical pathology 20040501
-
Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation point to the donor CD8(+) T-cell count on day + 14 as a predictor of acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20040501
-
Adoptive immunotherapy with allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes for recurrent, EBV-positive Hodgkin disease.
Cancer 20040501
-
Fatal immune-mediated pancytopenia and a TRALI-like syndrome associated with high titers of recipient-type antibodies against donor-derived peripheral blood cells after allogeneic bone marrow transplantation following dose reduced conditioning.
Haematologica 20040501
-
[Chronic active Epstein-Barr virus infection treated with reduced intensity stem cell transplantation].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20040501
-
Fludarabine, cyclophosphamide and mitoxantrone in relapsed or refractory chronic lymphocytic leukemia and low grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 20040501
-
Bryostatin induces protein kinase C modulation, Mcl-1 up-regulation and phosphorylation of Bcl-2 resulting in cellular differentiation and resistance to drug-induced apoptosis in B-cell chronic lymphocytic leukemia cells.
Leukemia & lymphoma 20040501
-
The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients.
Blood 20040415
-
Allogeneic peripheral blood stem cell transplantation following fludarabine-based conditioning in six children with advanced Hodgkin's disease.
Annals of hematology 20040401
-
Autologous hematopoietic stem cell transplantation for refractory antiphospholipid syndrome causing myocardial necrosis.
Bone marrow transplantation 20040401
-
Feasibility of reduced intensity hematopoietic stem cell transplantation from an HLA-matched unrelated donor.
Bone marrow transplantation 20040401
-
Donor lymphocyte infusions for refractory pure red cell aplasia relapsing after both autologous and nonmyeloablative allogeneic peripheral stem cell transplantation.
Bone marrow transplantation 20040401
-
Third EBMT/AMGEN Workshop on reduced-intensity conditioning allogeneic haemopoietic stem cell transplants (RIC-HSCT), and panel consensus.
Bone marrow transplantation 20040401
-
Cytomegalovirus-specific immune recovery following allogeneic HLA-identical sibling transplantation with reduced-intensity preparative regimen.
Bone marrow transplantation 20040401
-
Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040401
-
The Mexican schedule to conduct allogeneic stem cell transplantation is related to a low risk of cytomegalovirus reactivation and disease.
American journal of hematology 20040401
-
Haematopoietic stem cell transplantation with non-myeloablative conditioning in the outpatient setting: results, complications and admission requirements in a single institution.
British journal of haematology 20040401
-
The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells.
Cancer research 20040401
-
Aspergillus fumigatus: a rare cause of vertebral osteomyelitis.
Haematologica 20040401
-
Addition of treosulfan to a nonmyeloablative conditioning regimen results in enhanced chimerism and immunologic tolerance in an experimental allogeneic bone marrow transplant model.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20040401
-
The risk of cytomegalovirus infection in non-myeloablative peripheral stem cell transplantation compared with conventional bone marrow transplantation.
Journal of Korean medical science 20040401
-
Nonmyeloablative allogeneic stem cell transplantation for patients with unresectable pancreatic cancer.
Pancreas 20040401
-
[Treatment of lymphoma patients with fludarabine-based regimens: a report of 29 cases].
Ai zheng = Aizheng = Chinese journal of cancer 20040401
-
Transient absence of hepatic uptake on gallium-67 scintigraphy following fludarabine therapy.
Clinical nuclear medicine 20040401
-
Sensitivity of B-cell chronic lymphocytic leukemia to Rituximab and Campath-1H and correlation with the expression of cell cycle regulatory proteins.
Croatian medical journal 20040401
-
A fludarabine, topotecan, and cytarabine regimen is active in patients with refractory acute myelogenous leukemia.
Leukemia research 20040401
-
Treatment of chronic lymphocytic leukemia.
Seminars in oncology 20040401
-
[Non-myeloablative stem cell transplantation from an HLA identical sibling donor in a case of treatment-related acute myelogenous leukemia].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20040401
-
Fludarabine- and cyclophosphamide-based nonmyeloablative conditioning regimen for transplantation of chronic granulomatous disease: possible correlation with prolonged pure red cell aplasia.
International journal of hematology 20040401
-
[Immunosuppression with cyclophosphamide and fudarabine, with support of autologous CD-34+ stem cells, in the treatment of severe scleroderma].
Revista brasileira de reumatologia 20040401
-
[Waldenstrom macroglobulinemia].
Praxis 20040331
-
Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs.
Blood 20040301
-
Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation--a retrospective analysis.
Bone marrow transplantation 20040301
-
A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients.
Bone marrow transplantation 20040301
-
Reversible acute renal failure following single administration of fludarabine.
Bone marrow transplantation 20040301
-
Nucleoside transporters in chronic lymphocytic leukaemia.
Leukemia 20040301
-
Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.
The Journal of rheumatology 20040301
-
Fludarabine, mitoxantrone and dexamethasone in the treatment of indolent B- and T-cell lymphoid malignancies in Chinese patients.
British journal of haematology 20040301
-
MEK/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M-stimulated CCL2 expression in human osteoblasts through a common transcription factor.
Arthritis and rheumatism 20040301
-
[Reduced intensity stem cell transplantation for metastatic renal cell carcinoma].
Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20040301
-
In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation.
Blood 20040215
-
Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning.
Blood 20040201
-
Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivo.
Leukemia research 20040201
-
Nonmyeloablative hematopoietic stem cell transplant for X-linked hyper-immunoglobulin m syndrome with cholangiopathy.
Pediatrics 20040201
-
Simultaneous manifestation of chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL).
American journal of hematology 20040201
-
Antitumor activity of sugar-modified cytosine nucleosides.
Cancer science 20040201
-
Nonmyeloablative stem cell transplantation for lymphoma.
Seminars in oncology 20040201
-
Adoptive immunotherapy with antigen-specific T cells in myeloma: a model of tumor-specific donor lymphocyte infusion.
Seminars in oncology 20040201
-
[Non-myeloablative allogeneic stem cell transplantation in patients with hematologic malignancies].
Zhongguo shi yan xue ye xue za zhi 20040201
-
[Decrease of chronic graft-versus-host disease by adding anti-human thymocyte globulin to the conditioning regimen].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20040201
-
Treatment of advanced mycosis fungoides/Sézary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy.
The British journal of dermatology 20040201
-
[Drug-resistant B cell chronic lymphocytic leukemia safely treated with rituximab to control leukemic cell increment and platelet transfusion dependence].
Gan to kagaku ryoho. Cancer & chemotherapy 20040201
-
Successful treatment of mu-heavy chain disease with fludarabine monophosphate: a case report.
International journal of hematology 20040201
-
Advancing therapy for chronic lymphocytic leukemia--the role of rituximab.
Seminars in oncology 20040201
-
[Nonmyeloablative allogeneic stem cell transplantation for a 70-year-old woman with relapsed acute myelogenous leukemia].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20040201
-
Monoclonal antibodies in the treatment of chronic lymphoid leukemias.
Leukemia & lymphoma 20040201
-
High dose chlorambucil in the treatment of lymphoid malignancies.
Leukemia & lymphoma 20040201
-
An evaluation of gemcitabines differential radiosensitising effect in related bladder cancer cell lines.
British journal of cancer 20040126
-
Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors.
Blood 20040115
-
Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation.
Blood 20040115
-
Simple and sensitive method for quantification of fludarabine triphosphate intracellular concentration in leukemic cells using isocratic liquid chromatography.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040105
-
Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients.
Blood 20040101
-
Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia.
Blood 20040101
-
Post-transcriptional regulation of inducible nitric oxide synthase in chronic lymphocytic leukemia B cells in pro- and antiapoptotic culture conditions.
Leukemia 20040101
-
Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1H.
Leukemia 20040101
-
Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes.
British journal of haematology 20040101
-
Long-acting beta2-adrenergic formoterol and salmeterol induce the apoptosis of B-chronic lymphocytic leukaemia cells.
British journal of haematology 20040101
-
Treatment options for newly diagnosed patients with chronic lymphocytic leukemia.
Current hematology reports 20040101
-
Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease.
The journal of gene medicine 20040101
-
Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival.
Experimental hematology 20040101
-
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation.
The hematology journal : the official journal of the European Haematology Association 20040101
-
Fludarabine-induced hemolytic anemia: successful treatment by rituximab.
The hematology journal : the official journal of the European Haematology Association 20040101
-
Matched unrelated donor bone marrow transplantation for the treatment of platinum refractory ovarian carcinoma: a case report.
Gynecologic oncology 20040101
-
Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20040101
-
Salvage therapy with an outpatient DHAP schedule followed by PBSC transplantation in 79 lymphoma patients: an intention to mobilize and transplant analysis.
European journal of haematology 20040101
-
Successful treatment with nonmyeloablative allogeneic hematopoietic stem cell transplantation in a patient with acute myeloid leukemia complicated with pulmonary infection.
International journal of hematology 20040101
-
Repeated rituximab maintenance courses in fludarabine-failed young patients with chronic lymphocytic leukaemia responding to FAND chemotherapy.
The hematology journal : the official journal of the European Haematology Association 20040101
-
Fludarabine, mitoxantrone and dexamethasone as front-line therapy in elderly patients affected by newly-diagnosed, low-grade non-Hodgkin's lymphomas with unfavorable prognostic factors: results of a phase II study.
Leukemia & lymphoma 20040101
-
Fludarabine in chronic lymphocytic leukemia and other hematological malignancies: progress in treatment. Fludarabine supplement.
The hematology journal : the official journal of the European Haematology Association 20040101
-
Treatment options in chronic lymphocytic leukemia.
The hematology journal : the official journal of the European Haematology Association 20040101
-
Role of fludarabine as monotherapy in the treatment of chronic lymphocytic leukemia.
The hematology journal : the official journal of the European Haematology Association 20040101
-
Chemotherapy combination treatment regimens with fludarabine in chronic lymphocytic leukemia.
The hematology journal : the official journal of the European Haematology Association 20040101
-
Oral fludarabine therapy in chronic lymphocytic leukemia--increased convenience.
The hematology journal : the official journal of the European Haematology Association 20040101
-
Clinical experience with fludarabine in indolent non-Hodgkin's lymphoma.
The hematology journal : the official journal of the European Haematology Association 20040101
-
Use of fludarabine in the treatment of mantle cell lymphoma, Waldenström's macroglobulinemia and other uncommon B- and T-cell lymphoid malignancies.
The hematology journal : the official journal of the European Haematology Association 20040101
-
Use of fludarabine in the treatment of acute myeloid leukemia.
The hematology journal : the official journal of the European Haematology Association 20040101
-
Treatment of hematological malignancies with allogeneic nonmyeloablative stem cell transplantation: conditioning regimens with fludarabine.
The hematology journal : the official journal of the European Haematology Association 20040101
-
Future prospects for fludarabine-containing regimens in the treatment of hematological cancers.
The hematology journal : the official journal of the European Haematology Association 20040101
-
[Autologous peripheral stem cell transplantation in a patient with diffuse systemic sclerosis: our experience].
Reumatismo 20040101
-
Treosulfan/fludarabine: a new conditioning regimen in allogeneic transplantation.
Annals of hematology 20040101
-
Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia.
The Annals of pharmacotherapy 20040101
-
Treatment of resistant/relapsing chronic lymphocytic leukemia with a combination regimen containing deoxycoformycin and rituximab.
Acta haematologica 20040101
-
Fludarabine combination regimen severely affected peripheral blood stem cell mobilization.
Acta haematologica 20040101
-
A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes.
The hematology journal : the official journal of the European Haematology Association 20040101
-
Fludarabine as the possible cause of acute myelofibrosis.
The hematology journal : the official journal of the European Haematology Association 20040101
-
Quantitative molecular evaluation of minimal residual disease in patients with chronic lymphocytic leukemia: efficacy of in vivo purging by alemtuzumab (Campath-1H).
Journal of immunotherapy (Hagerstown, Md. : 1997) 20040101
-
Nonmyeloablative stem cell transplantation in patients with ALL and AML results in low nonrelapse mortality despite high rate of infections and GVHD.
The hematology journal : the official journal of the European Haematology Association 20040101
-
Purine analogs in leukemia.
Advances in pharmacology (San Diego, Calif.) 20040101
-
Canadian multicenter pilot trial of haploidentical donor transplantation.
Blood cells, molecules & diseases 20040101
-
Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.
Blood cells, molecules & diseases 20040101
-
Chronic lymphocytic leukemia.
Hematology. American Society of Hematology. Education Program 20040101
-
Low-dose oral fludarabine plus cyclophosphamide in elderly patients with chronic lymphoproliferative disorders.
The hematology journal : the official journal of the European Haematology Association 20040101
-
Acute tumour lysis syndrome after oral fludarabine in a patient with chronic lymphocytic leukaemia.
The hematology journal : the official journal of the European Haematology Association 20040101
-
[Evaluation of the clinical effectivity and toxicity of the FDN regimen (fludarabin, mitoxantron, dexamethason) in patients with follicular lymphoma].
Casopis lekaru ceskych 20040101
-
Effects of fludarabine treatment on murine lupus nephritis.
Lupus 20040101
-
[Use of fludarabin in conjunction with other cytostatics in the treatment of non-Hodgkin lymphoma resistant to standard chemotherapy].
Voprosy onkologii 20040101
-
T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation.
Transplantation 20031227
-
Successful allogeneic leg transplantation in rats in conjunction with intra-bone marrow injection of donor bone marrow cells.
Transplantation 20031215
-
Mylotarg, fludarabine, cytarabine (ara-C), and cyclosporine (MFAC) regimen as post-remission therapy in acute myelogenous leukemia.
Cancer chemotherapy and pharmacology 20031201
-
High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities.
Annals of hematology 20031201
-
In vitro susceptibility of CD4+ and CD8+ T cell subsets to fludarabine.
Biochemical pharmacology 20031201
-
Nonmyeloablative stem cell transplantation with fludarabine and cyclophosphamide for patients with hematologic malignancies.
Clinical and laboratory haematology 20031201
-
Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus.
Transfusion 20031201
-
Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031201
-
Allogeneic bone marrow transplantation in a patient with T-prolymphocytic leukemia with small-intestinal involvement.
International journal of clinical oncology 20031201
-
Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study.
Haematologica 20031201
-
[Effect of modified FLAG regimen therapy on 33 patients with relapsed/refractory leukemia].
Ai zheng = Aizheng = Chinese journal of cancer 20031201
-
B-cell lymphoproliferative syndrome and peripheral blood CD20+ cells expansion after hematopoietic stem cell transplantation: association with fludarabine and anti-thymocyte globulin containing conditioning regimen.
Transplantation proceedings 20031201
-
[Hairy cell leukemia: report on one case with survival for 10 years].
Zhongguo shi yan xue ye xue za zhi 20031201
-
Successful treatment of primary refractory acute myeloid leukemia with megadose stem cell transplantation, bone marrow boost and reduced intensity conditioning avoiding chronic graft vs. host disease and severe late toxicity.
Pediatric transplantation 20031201
-
Variant Richter's syndrome: a rare case of classical Hodgkin's lymphoma developing in a patient with chronic lymphocytic leukemia treated with fludarabine.
Leukemia & lymphoma 20031201
-
[Allogeneic stem cell transplantation following non-myeloablative conditioning: favorable results in 21 high risk patients with hematological malignancies treated in the Utrecht University Medical Center, the Netherlands].
Nederlands tijdschrift voor geneeskunde 20031122
-
Involvement of p53 in alpha4beta1 integrin-mediated resistance of B-CLL cells to fludarabine.
Biochemical and biophysical research communications 20031121
-
Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors.
Blood 20031115
-
Role of the TRAIL/APO2-L death receptors in chlorambucil- and fludarabine-induced apoptosis in chronic lymphocytic leukemia.
Oncogene 20031113
-
Ex vivo analysis of topotecan: advancing the application of laboratory-based clinical therapeutics.
British journal of cancer 20031103
-
Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen.
Leukemia 20031101
-
Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression.
Journal of leukocyte biology 20031101
-
Allogeneic stem cell transplantation with reduced-intensity conditioning is potentially feasible as an outpatient procedure.
Bone marrow transplantation 20031101
-
The graft-versus-leukemia effect of nonmyeloablative stem cell allografts may not be sufficient to cure chronic myelogenous leukemia.
Bone marrow transplantation 20031101
-
Lymphocyte depletion with fludarabine in patients with psoriatic arthritis: clinical and immunological effects.
Annals of the rheumatic diseases 20031101
-
Strategies to reduce transplant-related mortality after allogeneic stem cell transplantation in elderly patients: Comparison of reduced-intensity conditioning and unmanipulated peripheral blood stem cells vs a myeloablative regimen and CD34+ cell selection.
Experimental hematology 20031101
-
Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations.
Haematologica 20031101
-
Low risk of graft-versus-host disease with transplantation of CD34 selected peripheral blood progenitor cells from alternative donors for Fanconi anemia.
Journal of pediatric hematology/oncology 20031101
-
Dissociation of putative graft-versus-haematopoiesis and graft-versus-myeloma effects in patients with rapidly progressive multiple myeloma.
British journal of haematology 20031101
-
Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantation.
British journal of haematology 20031101
-
Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20031101
-
Detection of two cell populations corresponding to distinct maturation stages in API-2/MLT-positive mucosa-associated lymphoid tissue lymphoma cells proliferating in pleural effusion.
International journal of hematology 20031101
-
[Successful T-cell-replete peripheral blood stem cell transplantation from an HLA 2 loci mismatched mother to her son with refractory anemia in myelodysplastic syndrome].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20031101
-
Conventional dose fludarabine-based regimens are effective but have excessive toxicity in elderly patients with refractory chronic lymphocytic leukemia.
Leukemia & lymphoma 20031101
-
Appraisal of the MTT-based assay as a useful tool for predicting drug chemosensitivity in leukemia.
Leukemia & lymphoma 20031101
-
Clinical use of rituximab in haematological malignancies.
British journal of cancer 20031020
-
Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.
Cancer chemotherapy and pharmacology 20031001
-
Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemia.
Leukemia research 20031001
-
Application of the CFU-GM assay to predict acute drug-induced neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics.
Toxicological sciences : an official journal of the Society of Toxicology 20031001
-
Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors.
Bone marrow transplantation 20031001
-
Cytomegalovirus infections in allogeneic stem cell recipients after reduced-intensity or myeloablative conditioning assessed by quantitative PCR and pp65-antigenemia.
Bone marrow transplantation 20031001
-
The P2X7 receptor gene polymorphism 1513 A-->C has no effect on clinical prognostic markers, in vitro sensitivity to fludarabine, Bcl-2 family protein expression or survival in B-cell chronic lymphocytic leukaemia.
British journal of haematology 20031001
-
Fludarabine-related myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031001
-
Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy.
Leukemia 20031001
-
Successful engraftment of HLA-haploidentical related transplants using nonmyeloablative conditioning with fludarabine, busulfan and anti-T-lymphocyte globulin.
Leukemia 20031001
-
Allogeneic peripheral blood stem cell transplantation for high-risk non-Hodgkin's lymphoma.
Bone marrow transplantation 20031001
-
Low T-cell chimerism is not followed by graft rejection after nonmyeloablative stem cell transplantation (NMSCT) with CD34-selected PBSC.
Bone marrow transplantation 20031001
-
Fludarabine and once-daily intravenous busulfan for allogeneic bone marrow transplantation for Chediak-Higashi syndrome.
Journal of pediatric hematology/oncology 20031001
-
Minimal GVHD following in-vitro T cell-depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors.
Experimental hematology 20031001
-
Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen.
Experimental hematology 20031001
-
Low-dose total-body irradiation and fludarabine followed by hematopoietic cell transplantation from HLA-identical sibling donors do not induce complete T-cell donor engraftment in most patients with progressive hematologic diseases.
Experimental hematology 20031001
-
Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: effect of interventions on outcome.
Experimental hematology 20031001
-
Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 20031001
-
[Modified FLAG regimen in the management of refractory acute myeloid leukemia].
Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20031001
-
Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20031001
-
Haploidentical stem cell transplantation with purified CD34 cells after a chemotherapy-alone conditioning regimen.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20031001
-
Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20031001
-
Progressive multifocal leukoencephalopathy with detection of JC virus in a patient with chronic lymphocytic leukemia parallel to onset of fludarabine therapy.
Leukemia & lymphoma 20031001
-
Fatal fludarabine-induced extensive bone marrow necrosis in a patient with chronic lymphocytic leukemia.
Leukemia & lymphoma 20031001
-
Fludarabine induced immune thrombocytopenia in a patient with CD5 positive B cell chronic lymphocytic leukemia.
JPMA. The Journal of the Pakistan Medical Association 20031001
-
[Pressure pain in the left epigastrium: blood picture provides diagnosis. Chronic lymphatic leukemia].
MMW Fortschritte der Medizin 20030925
-
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies.
Blood 20030915
-
Fludarabine plus rituximab for untreated B-cell chronic lymphocytic leukemia.
Blood 20030915
-
Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning.
Blood 20030901
-
Amifostine does not reduce the toxicity of the fludarabine and cyclophosphamide regimen in patients with chronic lymphocytic leukemia.
Cancer chemotherapy and pharmacology 20030901
-
Post-transplant interleukin-2 in patients with low-grade lymphoid neoplasms previously treated with fludarabine is limited by hematologic toxicity.
Annals of hematology 20030901
-
Regimen-related toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies.
Bone marrow transplantation 20030901
-
A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantation.
Bone marrow transplantation 20030901
-
A phase II study of DT fusion protein denileukin diftitox in patients with fludarabine-refractory chronic lymphocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 20030901
-
[Chimerism in allogeneic mini-transplantation].
Nihon rinsho. Japanese journal of clinical medicine 20030901
-
[Non-myeloablative or reduced intensity stem cell transplantation preparative regimens].
Nihon rinsho. Japanese journal of clinical medicine 20030901
-
[Mini-transplantation from HLA-mismatched donors].
Nihon rinsho. Japanese journal of clinical medicine 20030901
-
[Mini-transplantation from cord blood].
Nihon rinsho. Japanese journal of clinical medicine 20030901
-
[Reduced-intensity stem cell transplantation (RIST) for lymphoproliferative diseases].
Nihon rinsho. Japanese journal of clinical medicine 20030901
-
[Non-myeloablative stem cell transplantation for non-malignant hematologic disorders].
Nihon rinsho. Japanese journal of clinical medicine 20030901
-
[Gastrointestinal cancer].
Nihon rinsho. Japanese journal of clinical medicine 20030901
-
[Nonmyeloablative allogeneic peripheral blood stem cell transplantation of renal cell carcinoma].
Nihon rinsho. Japanese journal of clinical medicine 20030901
-
The influence of imatinib mesylate (STI571) used alone or in combination with purine nucleoside analogues on the normal and chronic myelogenous leukaemia progenitor cells in vitro.
Leukemia & lymphoma 20030901
-
[Unrelated HLA-mismatched cord blood transplantation using nonmyeloablative conditioning in an adult patient with very severe aplastic anemia].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20030901
-
Durable remissions of myelodysplastic syndrome and acute myeloid leukemia after reduced-intensity allografting.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030815
-
Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation.
Blood 20030801
-
Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells.
Blood 20030801
-
High-dose hydroxyurea in the treatment of poor-risk myeloid leukemias.
Annals of hematology 20030801
-
Bilateral optic disc swelling as the presenting sign of Waldenström's macroglobulinaemia.
Acta ophthalmologica Scandinavica 20030801
-
Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation.
Blood 20030801
-
Allogeneic hematopoietic cell transplantation for paroxysmal nocturnal hemoglobinuria.
European journal of haematology 20030801
-
A novel t(15;17) translocation in acute myeloid leukaemia not associated with PML/RARalpha rearrangement.
Clinical and laboratory haematology 20030801
-
Transfusion-free reduced-intensity conditioned allogeneic stem cell transplantation in a Jehovah's witness.
Bone marrow transplantation 20030801
-
Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 20030801
-
Activation of a p53-mediated apoptotic pathway in quiescent lymphocytes after the inhibition of DNA repair by fludarabine.
Clinical cancer research : an official journal of the American Association for Cancer Research 20030801
-
Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030801
-
Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro.
Haematologica 20030801
-
Rituximab in B-cell chronic lymphocytic leukemia.
Seminars in oncology 20030801
-
Alemtuzumab therapy in B-cell lymphoproliferative disorders.
Seminars in oncology 20030801
-
Nonmyeloablative transplantation for lymphoma.
Current treatment options in oncology 20030801
-
Mantle cell lymphoma.
Current treatment options in oncology 20030801
-
Early reappearance of primary solid cancer in patients treated with purine analogs.
Journal of chemotherapy (Florence, Italy) 20030801
-
[Seventeen cases of nonmyeloablative stem cell transplantation using a conditioning regimen containing fludarabine].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20030801
-
[Comparison of conditioning regimens containing or no fludarabine in nonmyeloablative allogeneic peripheral blood stem cell transplantation].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20030801
-
Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen.
Blood 20030715
-
Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.
Blood 20030715
-
Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030715
-
Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
Transplantation 20030715
-
Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival.
Transplantation 20030715
-
[Current concepts in chronic lymphocytic leukemia. Better chances for young patients].
MMW Fortschritte der Medizin 20030710
-
Advances in the therapy of chronic lymphocytic leukemia.
Current opinion in hematology 20030701
-
Fludarabine plus cyclophosphamide for the treatment of advanced chronic lymphocytic leukemia.
European journal of haematology 20030701
-
Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies.
Bone marrow transplantation 20030701
-
A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors.
Bone marrow transplantation 20030701
-
High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment.
Bone marrow transplantation 20030701
-
Fludarabine versus cyclophosphamide, vincristine, and prednisone in recurrent low-grade lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030701
-
Use of a reduced-intensity conditioning regimen for allogeneic transplantation in patients with chronic myeloid leukemia.
Bone marrow transplantation 20030701
-
Graft-versus-host disease, donor chimerism, and organ toxicity in stem cell transplantation after conditioning with fludarabine and melphalan.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030701
-
Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030701
-
Reduced-intensity allogeneic stem cell transplantation.
Current hematology reports 20030701
-
Role of IMP-selective 5'-nucleotidase (cN-II) in hematological malignancies.
Leukemia & lymphoma 20030701
-
Hepatitis B virus reactivation during fludarabine therapy in non-Hodgkin's lymphoma.
Leukemia & lymphoma 20030701
-
Effects of etoposide and fludarabine in subtoxic doses on karyotype of human malignant lymphoid Namalwa cells.
Bulletin of experimental biology and medicine 20030701
-
Successful allogeneic stem cell transplantation with fludarabine-based conditioning regimen in severe aplastic anemia.
The Journal of the Association of Physicians of India 20030701
-
[Evidence-based therapy for chronic leukemia].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20030610
-
Successful treatment with reduced-intensity stem cell transplantation in a case of relapsed refractory central nervous system lymphoma.
Annals of hematology 20030601
-
Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
Annals of hematology 20030601
-
Decreased transfusion requirements in patients given stem cell allografts using a non-myeloablative conditioning regimen: a single institution experience.
Hematology (Amsterdam, Netherlands) 20030601
-
Feasibility of fludarabine added to VAD during induction therapy in multiple myeloma: a randomised phase II-study.
European journal of haematology 20030601
-
Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases.
Leukemia 20030601
-
Nonmyeloablative allogeneic hematopoietic stem cell transplantation for congenital sideroblastic anemia.
Bone marrow transplantation 20030601
-
Successful T-cell-replete peripheral blood stem cell transplantation from HLA-haploidentical microchimeric mother to daughter with refractory acute lymphoblastic leukemia using reduced-intensity conditioning.
Bone marrow transplantation 20030601
-
Mechanism of action of purine analogues in chronic lymphocytic leukaemia.
British journal of haematology 20030601
-
Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligand.
British journal of haematology 20030601
-
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor.
Bone marrow transplantation 20030601
-
Treatment of Waldenstrom's macroglobulinemia with the combination of fludarabine and cyclophosphamide.
Leukemia & lymphoma 20030601
-
[Current status of reduced-intensity stem cell transplantation; survey in the Kinki area].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20030601
-
Allogeneic haemopoietic stem cell transplantation using non-myeloablative conditioning--a local experience.
The Medical journal of Malaysia 20030601
-
Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030515
-
Waldenstrom's macroglobulinemia: is there a place and time for a cease-fire?
Leukemia research 20030501
-
Successful immunotherapy in early relapse of acute myeloid leukemia after nonmyeloablative allogeneic stem cell transplantation.
Annals of hematology 20030501
-
Treatment of pure red cell aplasia and autoimmune haemolytic anaemia in chronic lymphocytic leukaemia with Campath-1H.
European journal of haematology 20030501
-
Autoimmune thrombocytopenia due to chronic lymphocytic leukemia treated with fludarabine.
The Annals of pharmacotherapy 20030501
-
Monoclonal antibody therapy of chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030501
-
Conformational change and mitochondrial translocation of Bax accompany proteasome inhibitor-induced apoptosis of chronic lymphocytic leukemic cells.
Oncogene 20030501
-
Low-intensity hematopoietic stem-cell transplantation across human leucocyte antigen barriers in dyskeratosis congenita.
Bone marrow transplantation 20030501
-
Regression of an unresectable pancreatic tumor following nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.
Bone marrow transplantation 20030501
-
Epstein-Barr virus-associated B-cell lymphoproliferative disorder in CLL patients after treatment with fludarabine and cyclophosphamide followed by high-dose chemotherapy with autologous stem cell transplantation.
Bone marrow transplantation 20030501
-
Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning.
Leukemia 20030501
-
Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemia.
Leukemia 20030501
-
Hodgkin's type of Richter's syndrome in familial chronic lymphocytic leukemia treated with cladribine and cyclophosphamide.
Leukemia & lymphoma 20030501
-
Allogeneic stem-cell transplantation from related and unrelated donors in older patients with myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030415
-
A substantial level of donor hematopoietic chimerism is required to protect donor-specific islet grafts in diabetic NOD mice.
Transplantation 20030415
-
Liver transplantation followed by adjuvant nonmyeloablative hemopoietic stem cell transplantation for advanced primary liver cancer in humans.
Transplantation 20030415
-
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia.
Cancer 20030401
-
Pentostatin and cyclophosphamide: an effective new regimen in previously treated patients with chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030401
-
Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin's disease: case report and literature review.
American journal of hematology 20030401
-
Chronic but not acute graft-versus-host disease improves outcome in multiple myeloma patients after non-myeloablative allogeneic transplantation.
British journal of haematology 20030401
-
Non-myeloablative stem cell transplantation with low-dose total body irradiation and fludarabine for metastatic renal cell carcinoma.
Haematologica 20030401
-
Bilateral orbital masses in a patient with B-cell chronic lymph.
Haematologica 20030401
-
Impact of graft-versus-host disease in reduced-intensity stem cell transplantation (RIST) for patients with haematological malignancies.
British journal of haematology 20030401
-
FLAG-IDA in the treatment of refractory/relapsed acute myeloid leukemia: single-center experience.
Annals of hematology 20030401
-
Subcutaneous panniculitis-like T-cell lymphoma: complete remission with fludarabine.
Annals of hematology 20030401
-
Mutation of p53 and consecutive selective drug resistance in B-CLL occurs as a consequence of prior DNA-damaging chemotherapy.
Cell death and differentiation 20030401
-
Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Seminars in oncology 20030401
-
Prognostic factors and response to fludarabine therapy in Waldenstrom's macroglobulinemia: an update of a US intergroup trial (SW0G S9003).
Seminars in oncology 20030401
-
Fludarabine in Waldenstrom's macroglobulinemia.
Seminars in oncology 20030401
-
Role for high-dose therapy with autologous hematopoietic stem cell support in Waldenstrom's macroglobulinemia.
Seminars in oncology 20030401
-
Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030401
-
Unrelated umbilical cord blood transplant for beta-thalassemia major.
Journal of tropical pediatrics 20030401
-
Non-myeloablative hematopoietic stem cell transplantation for the treatment of adult T-cell lymphoma in a patient with advanced hepatic impairment.
Leukemia & lymphoma 20030401
-
Remission of follicular non-Hodgkin's lymphoma with denileukin diftitox (ONTAK) after progression during rituximab, CHOP and fludarabine therapy.
Leukemia & lymphoma 20030401
-
Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia.
Blood 20030315
-
Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes.
Statistics in medicine 20030315
-
Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes.
Cancer 20030315
-
Cytotoxic activity of 6-alkynyl- and 6-alkenylpurines.
Bioorganic & medicinal chemistry letters 20030310
-
Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia.
British journal of cancer 20030310
-
Increased CMV infection following nonmyeloablative allogeneic stem cell transplantation: a search for the guilty.
Blood 20030301
-
Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature.
American journal of hematology 20030301
-
Reduced-intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first-donor origin.
American journal of hematology 20030301
-
Leg ulcers associated with cryoglobulinemia: clinical study of 15 patients and response to treatment.
Archives of dermatology 20030301
-
Reduced intensity conditioning and prophylactic DLI can cure patients with high-risk acute leukaemias if complete donor chimerism can be achieved.
Bone marrow transplantation 20030301
-
Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning.
Bone marrow transplantation 20030301
-
Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of Dyskeratosis congenita.
Bone marrow transplantation 20030301
-
Unrelated bone marrow transplantation for beta-thalassemia major: report of the first 2 successful cases in Asia.
Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20030301
-
Comparison of cytotoxicity of 2-chloro- 2'-arabino-fluoro-2'-deoxyadenosine (clofarabine) with cladribine in mononuclear cells from patients with acute myeloid and chronic lymphocytic leukemia.
Haematologica 20030301
-
Low-grade non Hodgkin's lymphomas in the elderly: impact of a low-dose fludarabine-based combination regimen (mini-FLEC).
Haematologica 20030301
-
Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030301
-
Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030301
-
Successful T-cell-depleted, related haploidentical peripheral blood stem cell transplantation in a patient with Fanconi anaemia using a fludarabine-based preparative regimen without radiation.
Bone marrow transplantation 20030301
-
Nongastric mucosa-associated lymphoid tissue lymphomas.
Clinical lymphoma 20030301
-
Purine nucleoside analogues in the treatment of myleoid leukemias.
Leukemia & lymphoma 20030301
-
Combined fludarabine and rituximab for low grade lymphoma and chronic lymphocytic leukemia.
Leukemia & lymphoma 20030301
-
Induction of apoptosis in the human mast cell leukemia cell line HMC-1 by various antineoplastic drugs.
Leukemia & lymphoma 20030301
-
Trisomy 15 as the sole abnormality in myelodysplastic syndromes: case report and review of the literature.
Leukemia & lymphoma 20030301
-
Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases.
Blood 20030215
-
[Clinical significance of formation and conversion of hematopoietic mixed chimerism in nonmyeloablative allogeneic stem cell transplantation].
Zhonghua yi xue za zhi 20030210
-
Successful engraftment and stable full donor chimerism after myeloablation with thiotepa, fludarabine, and melphalan and CD34-selected peripheral allogeneic stem cell transplantation in hemophagocytic lymphohistiocytosis.
American journal of hematology 20030201
-
Advances in the treatment of hairy-cell leukaemia.
The Lancet. Oncology 20030201
-
Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 20030201
-
Neutropenia and anaemia associated with T-cell large granular lymphocyte leukaemia responds to fludarabine with minimal toxicity.
British journal of haematology 20030201
-
The relevance of nonmyeloablative transplants in developing countries: lessons from the UK experience.
Transplantation proceedings 20030201
-
A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211.
Leukemia 20030201
-
CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
Haematologica 20030201
-
Immune thrombocytopenia induced by fludarabine successfully treated with rituximab.
Haematologica 20030201
-
Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma.
Bone marrow transplantation 20030201
-
Fatal EBV-related post-transplant lymphoproliferative disorder (LPD) after matched related donor nonmyeloablative peripheral blood progenitor cell transplant.
Bone marrow transplantation 20030201
-
Rituximab plus chemotherapy in follicular and mantle cell lymphomas.
Seminars in oncology 20030201
-
Rituximab in chronic lymphocytic leukemia.
Seminars in oncology 20030201
-
[Two HLA-loci mismatched sibling cord blood transplantation in a severe beta-thalassemia patient].
Zhongguo shi yan xue ye xue za zhi 20030201
-
Evaluation of thymic output by measurement of T-cell-receptor gene rearrangement excisional circles (TREC) in patients who have received fludarabine.
Leukemia & lymphoma 20030201
-
Massive immune hemolysis after non-myeloablative allogeneic peripheral blood stem cell transplantation with minor ABO-incompatibility.
Leukemia & lymphoma 20030201
-
DAB389IL2 (ONTAK) fusion protein therapy of chronic lymphocytic leukaemia.
Expert opinion on biological therapy 20030201
-
Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia.
Blood 20030115
-
Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase.
Blood 20030115
-
The effects of cladribine and fludarabine on DNA methylation in K562 cells.
Biochemical pharmacology 20030115
-
Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance.
Biochemical pharmacology 20030115
-
Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712).
Blood 20030101
-
Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia.
Cancer 20030101
-
Newer drugs for the treatment of lupus nephritis.
Drugs 20030101
-
Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 20030101
-
Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission.
British journal of haematology 20030101
-
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indications.
Oncology (Williston Park, N.Y.) 20030101
-
Fludarabine in combination with cyclophosphamide decreases incidence of GVHD and maintains effective graft-versus-leukemia effect after allogeneic stem cell transplantation in murine lymphocytic leukemia.
Bone marrow transplantation 20030101
-
Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study.
Bone marrow transplantation 20030101
-
Germ cell damage and Leydig cell insufficiency in recipients of nonmyeloablative transplantation for haematological malignancies.
Bone marrow transplantation 20030101
-
Treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine.
Acta haematologica 20030101
-
Costs of drug delivery for CHOP, COP/CVP, and fludarabine: an international assessment.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20030101
-
Phase I trial of fludarabine and paclitaxel in non-Hodgkin's lymphoma.
Medical oncology (Northwood, London, England) 20030101
-
In AML cell lines Ara-C combined with purine analogues is able to exert synergistic as well as antagonistic effects on proliferation, apoptosis and disruption of mitochondrial membrane potential.
Leukemia & lymphoma 20030101
-
The effect of cyclosporin A used alone and in combination with either 2-chlorodeoxyadenosine or fludarabine on normal and chronic myelogenous leukemia progenitors in vitro.
Archivum immunologiae et therapiae experimentalis 20030101
-
Leukemic and non-leukemic lymphocytes from patients with Li Fraumeni syndrome demonstrate loss of p53 function, Bcl-2 family dysregulation and intrinsic resistance to conventional chemotherapeutic drugs but not flavopiridol.
Cell cycle (Georgetown, Tex.) 20030101
-
New directions in the diagnosis and treatment of chronic lymphocytic leukaemia.
Drugs 20030101
-
[Long-term results of treatment of chronic B-cell lymphoid leukocytes in persons who participated in the elimination of the effects of the nuclear accident at the Chernobyl nuclear station].
Likars'ka sprava 20030101
-
B cells as a therapeutic target in autoimmune disease.
Arthritis research & therapy 20030101
-
Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma.
Urologic oncology 20030101
-
Retreatment with rituximab alone induces sustained remission in a patient with follicular lymphoma with multiple extranodal sites of involvement, relapsing soon after primary treatment with fludarabine-rituximab.
The hematology journal : the official journal of the European Haematology Association 20030101
-
Alemtuzumab.
Drugs 20030101
-
The transplantation of hematopoietic stem cells after non-myeloablative conditioning: a cellular therapeutic approach to hematologic and genetic diseases.
Immunologic research 20030101
-
Oral fludarabine.
Drugs 20030101
-
Oral fludarabine: a viewpoint by Dieter Huhn.
Drugs 20030101
-
Oral fludarabine: a viewpoint by David Oscier.
Drugs 20030101
-
Oral fludarabine: a viewpoint by Bruce D. Cheson.
Drugs 20030101
-
Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed Hodgkin's disease following autologous stem cell transplantation.
Archives of medical research 20030101
-
[Cytogenetic changes in the Namalwa cell line of human malignant lymphoma induced by inhibitors of DNA replication and synthesis].
TSitologiia i genetika 20030101
-
Biology and treatment of chronic lymphocytic leukemia.
Hematology. American Society of Hematology. Education Program 20030101
-
Fludarabine combined with cyclophosphamid is highly effective in the treatment of chronic lymphocytic leukemia.
Neoplasma 20030101
-
Traditional treatment approaches in B-cell non-Hodgkin's lymphoma.
Leukemia & lymphoma 20030101
-
Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis.
Arthritis research & therapy 20030101
-
Graft-vs.-lymphoma effect in various histologies of non-Hodgkin's lymphoma.
Leukemia & lymphoma 20030101
-
Treatment of cutaneous T-cell lymphomas with purine analogues (fludarabine and 2-chlorodeoxyadenosine).
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20030101
-
Erythropoiesis after nonmyeloablative stem-cell transplantation is not impaired by inadequate erythropoietin production as observed after conventional allogeneic transplantation.
Transplantation 20021227
-
Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.
Blood 20021215
-
Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma.
Blood 20021215
-
Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation.
Blood 20021215
-
Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin's lymphoma previously treated with an alkylating agent or alkylator-containing regimen.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021215
-
Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality.
Blood 20021201
-
Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation.
British journal of haematology 20021201
-
A novel DKC1 mutation, severe combined immunodeficiency (T+B-NK- SCID) and bone marrow transplantation in an infant with Hoyeraal-Hreidarsson syndrome.
British journal of haematology 20021201
-
Dose-reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia.
British journal of haematology 20021201
-
Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia.
British journal of haematology 20021201
-
Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality.
British journal of haematology 20021201
-
Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation.
Transfusion 20021201
-
Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?
Bone marrow transplantation 20021201
-
Nonablative hematopoietic cell transplantation for the treatment of metastatic renal cell carcinoma.
Bone marrow transplantation 20021201
-
Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa.
Bone marrow transplantation 20021201
-
Phase I study of bryostatin-1 and fludarabine in patients with chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma.
Clinical lymphoma 20021201
-
Combination of nonmyeloablative stem cell transplantation and Imatinib in accelerated phase CML.
Haematologica 20021201
-
Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for de novo AML patients.
Journal of experimental & clinical cancer research : CR 20021201
-
Relationships of in vitro sensitivities tested with nine drugs and two types of irradiation in chronic lymphocytic leukemia.
Leukemia research 20021101
-
The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation.
Blood 20021101
-
Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia.
Blood 20021101
-
Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders.
Blood 20021101
-
Successful umbilical cord blood transplantation in a child with dyskeratosis congenita after a fludarabine-based reduced-intensity conditioning regimen.
British journal of haematology 20021101
-
Sustained molecular remission in a patient with CML in blastic crisis receiving dose-reduced hematopoietic stem-cell transplantation followed by early withdrawal of cyclosporine and prophylactic use of interferon-alpha.
American journal of hematology 20021101
-
Guillain-Barre' syndrome following Varicella zoster reactivation in Chronic Lymphocytic Leukemia treated with fludarabine.
Haematologica 20021101
-
Reduced intensity preparative regimens for allogeneic hematopoietic stem cell transplantation: a single center experience.
Bone marrow transplantation 20021101
-
Reliable engraftment, low toxicity, and durable remissions following allogeneic blood stem cell transplantation with minimal conditioning.
Experimental hematology 20021101
-
Alloimmunization to RhD antigen in RhD-incompatible haemopoietic cell transplants with non-myeloablative conditioning.
Vox sanguinis 20021101
-
[Multifocal progressive leukoencephalitis in a patient given fludarabine for chronic lymphoid leukemia].
Revue neurologique 20021101
-
[Successful treatment with fludarabine of chronic lymphocytic leukemia associated with nephrotic syndrome].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20021101
-
[Persistent T-cell mixed chimerism in a case of malignant lymphoma after nonmyeloablative allogeneic peripheral blood stem cell transplantation].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20021101
-
Treatment of secondary myelodysplastic syndrome after heart transplantation with chemotherapy and nonmyeloablative stem-cell transplantation.
Transplantation 20021027
-
[Increased response rate with rituximab in relapsed and refractory follicular and mantle cell lymphomas -- results of a prospective randomized study of the German Low-Grade Lymphoma Study Group].
Deutsche medizinische Wochenschrift (1946) 20021025
-
Repeated cycles of alternate administration of fludarabine and Zidovudine plus Didanosine inhibits murine AIDS and reduces proviral DNA content in lymph nodes to undetectable levels.
Virology 20021025
-
The triterpenoid CDDO induces apoptosis in refractory CLL B cells.
Blood 20021015
-
CML after treatment for lymphoid malignancy: Therapy-related CML or coincidence?
American journal of hematology 20021001
-
In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia.
Leukemia 20021001
-
Features of large granular lymphocytes (LGL) expansion following allogeneic stem cell transplantation: a long-term analysis.
Leukemia 20021001
-
Non-myeloablative haematopoietic stem cell transplantation for severe aplastic anaemia with various complications.
Clinical and laboratory haematology 20021001
-
Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome.
British journal of haematology 20021001
-
Chronic lymphocytic leukaemia: only treat when symptomatic.
Prescrire international 20021001
-
The combination of fludarabine and cyclophosphamide results in a high remission rate with moderate toxicity in low-grade non-Hodgkin's lymphomas.
Anti-cancer drugs 20021001
-
Monoclonal antibody therapies in leukemias.
Seminars in hematology 20021001
-
Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes.
Blood 20020915
-
Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia.
Blood 20020915
-
Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020915
-
Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020915
-
Waldenström's macroglobulinaemia.
Blood reviews 20020901
-
Spontaneous and drug-induced apoptosis is mediated by conformational changes of Bax and Bak in B-cell chronic lymphocytic leukemia.
Blood 20020901
-
Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporine.
Molecular pharmacology 20020901
-
Mechanisms of resistance to nucleoside analogue chemotherapy in mantle cell lymphoma: a molecular case study.
Leukemia 20020901
-
Fludarabine treatment of cryoglobulinemic glomerulonephritis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 20020901
-
B-chronic lymphocytic leukemia: practical aspects.
Hematological oncology 20020901
-
In vitro and in vivo characterization of graft-versus-tumor responses in melanoma patients after allogeneic peripheral blood stem cell transplantation.
International journal of cancer 20020901
-
Fludarabine, ara-C, novantrone and dexamethasone (FAND) in previously treated chronic lymphocytic leukemia patients.
Haematologica 20020901
-
Acute myocardial infarction as the presenting symptom of acute myeloblastic leukemia with extreme hyperleukocytosis.
American journal of hematology 20020901
-
Fludarabine-related pulmonary toxicity: a distinct clinical entity in chronic lymphoproliferative syndromes.
Chest 20020901
-
Rapid hematopoietic engraftment following fractionated TBI conditioning and transplantation with CD34(+) enriched hematopoietic progenitor cells from partially mismatched related donors.
Bone marrow transplantation 20020901
-
Partially matched related donor peripheral blood progenitor cell transplantation in paediatric patients adding fludarabine and anti-lymphocyte gamma-globulin.
Bone marrow transplantation 20020901
-
Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma.
Bone marrow transplantation 20020901
-
Full chimerism in nonmyeloablative stem cell transplantation in a beta-thalassemia major patient (class 3 Lucarelli).
Bone marrow transplantation 20020901
-
Eosinophilic pneumonia after administration of fludarabine for the treatment of non-Hodgkin's lymphoma.
Annals of hematology 20020901
-
Prolymphocytic leukaemia and Hodgkin's lymphoma.
European journal of haematology 20020901
-
Severe hypoglycemia in a patient with acute renal failure due to tumor lysis syndrome.
The Israel Medical Association journal : IMAJ 20020901
-
[Whipple's disease as a complication of chronic lymphocytic leukemia treated with fludarabine].
Polskie Archiwum Medycyny Wewnetrznej 20020901
-
Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemia.
Leukemia & lymphoma 20020901
-
Increased apoptosis in B-chronic lymphocytic leukemia cells as a result of cyclin D3 down regulation.
Leukemia & lymphoma 20020901
-
Ex vivo drug resistance profile in childhood acute myelogenous leukemia: no drug is more effective in comparison to acute lymphoblastic leukemia.
Leukemia & lymphoma 20020901
-
Vaccine therapies for non-Hodgkin's lymphoma.
Current treatment options in oncology 20020801
-
Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma.
Blood 20020801
-
Corticosteroid responsive fludarabine pulmonary toxicity.
American journal of clinical oncology 20020801
-
Phase II study of fludarabine combined with interferon-alpha-2a followed by maintenance therapy with interferon-alpha-2a in patients with low-grade non-hodgkin's lymphoma.
American journal of clinical oncology 20020801
-
Bendamustine in the treatment of chronic lymphocytic leukemia: results and future perspectives.
Seminars in oncology 20020801
-
FLAG-IDA regimen (fludarabine, cytarabine, idarubicin and G-CSF) in the treatment of patients with high-risk myeloid malignancies.
Leukemia research 20020801
-
Dendritic cell recovery following nonmyeloablative allogeneic stem cell transplants.
Journal of hematotherapy & stem cell research 20020801
-
Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomas.
Bone marrow transplantation 20020801
-
Dramatic efficacy of fludarabine in the treatment of an aggressive case of splenic lymphoma with villous lymphocytes.
European journal of haematology 20020801
-
Waldenström's macroglobulinemia: a review of therapy.
Leukemia & lymphoma 20020801
-
Segmental coecal cytomegalovirus colitis during fludarabine, cytarabine and mitoxantrone induction chemotherapy for myelodysplastic syndrome.
Leukemia & lymphoma 20020801
-
Haploidentical stem cell transplantation for acute leukemia.
International journal of hematology 20020801
-
Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases.
International journal of hematology 20020801
-
Mini-transplantation strategy for solid tumors.
International journal of hematology 20020801
-
[Clinical pharmacology of nucleoside analogues].
Bulletin du cancer 20020801
-
Evolving role of ribonucleoside reductase inhibitors in hematologic malignancies.
Expert review of anticancer therapy 20020801
-
Inducing tolerance to MHC-matched allogeneic islet grafts in diabetic NOD mice by simultaneous islet and bone marrow transplantation under nonirradiative and nonmyeloablative conditioning therapy.
Transplantation 20020715
-
Resistance to fludarabine-induced apoptosis in Epstein-Barr virus infected B cells.
Oncogene 20020704
-
Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide.
Blood 20020701
-
Safety and efficacy of subcutaneous Campath-1H for treating residual disease in patients with chronic lymphocytic leukemia responding to fludarabine.
Haematologica 20020701
-
The cost of treating relapsed indolent non-Hodgkin's lymphoma in an international setting: retrospective analysis of resource use.
Haematologica 20020701
-
Systemic aspergillosis in a patient with non-Hodgkin's lymphoma developing acute graft-versus-host disease after autologous peripheral blood stem cell transplantation.
Haematologica 20020701
-
Progressive multifocal leukoencephalopathy shortly after the diagnosis of follicular lymphoma in a patient treated with fludarabine.
Haematologica 20020701
-
Continuous complete clinical and molecular remission in two patients with refractory lymphoid malignancies after autografting followed by allogeneic stem cell transplantation with reduced intensity conditioning.
British journal of haematology 20020701
-
Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study.
Cancer chemotherapy and pharmacology 20020701
-
Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide, mitoxantrone, vincristine, and prednisone for low-grade follicular lymphomas.
American journal of hematology 20020701
-
Multiple pulmonary nodules: an unusual presentation of fludarabine pulmonary toxicity: case report and review of literature.
American journal of hematology 20020701
-
Cast nephropathy in a case of Waldenström's macroglobulinemia.
Nephron 20020701
-
Low transplant-related mortality after second allogeneic peripheral blood stem cell transplant with reduced-intensity conditioning in adult patients who have failed a prior autologous transplant.
Bone marrow transplantation 20020701
-
[Chronic myelogenous leukemia treated with non-myeloablative stem cell transplantation after discontinuing myeloablative stem cell transplantation due to mental aberrations].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20020701
-
Severe respiratory syncytial virus pneumonia complicating fludarabine and cyclophosphamide treatment of chronic lymphocytic leukemia.
European journal of haematology 20020701
-
[Experience with fludarabine treatment and review of the literature].
Orvosi hetilap 20020616
-
Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphoma.
British journal of cancer 20020605
-
Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer.
Blood 20020601
-
Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone.
Haematologica 20020601
-
Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course.
Leukemia 20020601
-
Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia.
Leukemia 20020601
-
Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia.
Leukemia 20020601
-
Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models.
Gene therapy 20020601
-
Chronic lymphocytic leukemia.
Current treatment options in oncology 20020601
-
Challenges in treating hematologic malignancies.
Seminars in oncology 20020601
-
Successful treatment of Griscelli syndrome with unrelated donor allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 20020601
-
Troxacitabine-based therapy of refractory leukemia.
Expert review of anticancer therapy 20020601
-
Fludarabine combination therapy for the treatment of chronic lymphocytic leukemia.
Clinical lymphoma 20020601
-
Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.
Clinical lymphoma 20020601
-
Gateways to Clinical Trials. June 2002.
Methods and findings in experimental and clinical pharmacology 20020601
-
Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study.
Blood 20020515
-
Rationale for combination therapy of chronic myelogenous leukaemia with imatinib and irradiation or alkylating agents: implications for pretransplant conditioning.
British journal of cancer 20020506
-
CD80 antigen expression as a predictor of ex vivo chemosensitivity in chronic lymphocytic leukemia.
Leukemia research 20020501
-
HLA-haploidentical blood progenitor cell transplantation in osteopetrosis.
Blood 20020501
-
Epstein-Barr virus-positive B-cell lymphoproliferative disorders arising in immunodeficient patients previously treated with fludarabine for low-grade B-cell neoplasms.
The American journal of surgical pathology 20020501
-
Aggressive growth of epithelial carcinomas following treatment with nucleoside analogues.
American journal of hematology 20020501
-
Progressive multifocal leukoencephalopathy after fludarabine therapy for low-grade lymphoproliferative disease.
American journal of hematology 20020501
-
Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies.
Cancer 20020501
-
Quantitative molecular monitoring of residual tumor cells in chronic lymphocytic leukemia.
Annals of hematology 20020501
-
Fludarabine-induced eosinophilia: case report.
Annals of hematology 20020501
-
Inhibition of nucleotide excision repair by fludarabine in normal lymphocytes in vitro, measured by the alkaline single cell gel electrophoresis (Comet) assay.
Japanese journal of cancer research : Gann 20020501
-
A phase I study of fludarabine combined with radiotherapy in patients with intermediate to locally advanced head and neck squamous cell carcinoma.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20020501
-
Non-myeloablative allogeneic stem cell transplantation in patients with solid tumours and patients with a haematological malignancy.
The Netherlands journal of medicine 20020501
-
Allogeneic stem-cell transplantation of renal cell cancer after nonmyeloablative chemotherapy: feasibility, engraftment, and clinical results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020415
-
Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma: implications for clinical trials in this patient population.
Cancer 20020401
-
Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia.
Leukemia 20020401
-
Significance of the levels of bone marrow lymphoid infiltrate in chronic lymphocytic leukemia patients with nodular partial remission.
Leukemia 20020401
-
Stable mixed chimerism after T cell-depleted allogeneic hematopoietic stem cell transplantation using conditioning with low-dose total body irradiation and fludarabine.
Bone marrow transplantation 20020401
-
Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells.
Journal of hematotherapy & stem cell research 20020401
-
Membranoproliferative glomerulonephritis in association with chronic lymphocytic leukaemia: a report of three cases.
Pathology 20020401
-
The role of mitoxantrone in non-Hodgkin's lymphoma.
Oncology (Williston Park, N.Y.) 20020401
-
Immunochemotherapy in indolent non-Hodgkin's lymphoma.
Seminars in oncology 20020401
-
[Fludarabine as primary therapeutic drug in chronic lymphatic leukemia].
Der Internist 20020401
-
De novo acute myeloid leukemia with multilineage dysplasia: treatment results and prognostic evaluation from a series of 44 patients treated with fludarabine, cytarabine and G-CSF (FLAG).
European journal of haematology 20020401
-
Gateways to Clinical Trials.
Methods and findings in experimental and clinical pharmacology 20020401
-
[Application of FBC conditioning regimen in HLA haplotype peripheral blood stem cell transplantation].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20020401
-
Phase II study of fludarabine, cytarabine (Ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disorders.
Leukemia & lymphoma 20020401
-
Campath-1H and fludarabine in combination are highly active in refractory chronic lymphocytic leukemia.
Blood 20020315
-
Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia.
Blood 20020315
-
Engagement of alpha4beta1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine.
Journal of leukocyte biology 20020301
-
Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease.
Haematologica 20020301
-
High-dose chlorambucil for the treatment of chronic lymphocytic leukaemia and low-grade non-Hodgkin's lymphoma.
British journal of haematology 20020301
-
Hemophagocytosis in a patient with chronic lymphocytic leukemia and histoplasmosis.
Mayo Clinic proceedings 20020301
-
Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage.
American journal of hematology 20020301
-
Allogeneic blood stem cell transplantation following non-myeloablative conditioning for hypereosinophilic syndrome.
Bone marrow transplantation 20020301
-
Efficacy of fludarabine/mitoxantrone/dexamethasone alternating with CHOP in bulky follicular non-Hodgkin's lymphoma.
Clinical lymphoma 20020301
-
Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology 20020301
-
The role of nucleoside analogues in the treatment of chronic lymphocytic leukemia-lessons learned from prospective randomized trials.
Leukemia & lymphoma 20020301
-
Correlation between chromosome damage and apoptosis induced by fludarabine and idarubicin in normal human lymphocytes.
Toxicology 20020227
-
The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction.
Blood 20020201
-
Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen.
Blood 20020201
-
Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia.
Blood 20020201
-
Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro.
Haematologica 20020201
-
Hematopoietic cell transplantation beyond first remission.
Leukemia 20020201
-
Non-myeloablative bone marrow transplantation in an adult with Wiskott-Aldrich syndrome.
British journal of haematology 20020201
-
Rituximab in combination with CHOP or fludarabine in low-grade lymphoma.
Seminars in oncology 20020201
-
Quantitative real-time polymerase chain reaction for monitoring minimal residual disease in patients with advanced indolent lymphomas treated with rituximab, fludarabine, mitoxantrone, and dexamethasone.
Seminars in oncology 20020201
-
Emerging information on the use of rituximab in chronic lymphocytic leukemia.
Seminars in oncology 20020201
-
Cisplatin, fludarabine, and cytarabine: a novel, pharmacologically designed salvage therapy for patients with refractory, histologically aggressive or mantle cell non-Hodgkin's lymphoma.
Cancer 20020201
-
Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT).
Bone marrow transplantation 20020201
-
Fludarabine therapy in Waldenström's macroglobulinemia patients treated previously with 2-chlorodeoxyadenosine.
Leukemia & lymphoma 20020201
-
Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia after treatment with fludarabine.
Leukemia & lymphoma 20020201
-
Large-cell transformation of chronic lymphocytic leukemia and follicular lymphoma during or soon after treatment with fludarabine-rituximab-containing regimens: natural history- or therapy-related complication?
European journal of haematology 20020201
-
Development and rapid dissemination of Merkel-cell carcinomatosis following therapy with fludarabine and rituximab for relapsing follicular lymphoma.
European journal of haematology 20020201
-
Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome.
Blood 20020115
-
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies.
Blood 20020101
-
Hematopoietic stem cell transplantation after reduced-intensity conditioning as treatment of sickle cell disease.
Experimental hematology 20020101
-
Nonmyeloablative allogeneic peripheral blood stem cell transplantation for multifocal extramedullary plasmacytomas progressing after autologous transplantation.
Bone marrow transplantation 20020101
-
Toxoplasmic encephalitis in a non-HIV patient with follicular lymphoma.
International journal of hematology 20020101
-
Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens.
Annals of oncology : official journal of the European Society for Medical Oncology 20020101
-
Cellular and clinical pharmacology of fludarabine.
Clinical pharmacokinetics 20020101
-
Combined use of autografting and non-myeloablative allografting for the treatment of hematologic malignancies and metastatic breast cancer.
Cancer treatment and research 20020101
-
Outpatient allografting in hematologic malignancies and nonmalignant disorders--applying lessons learned in the canine model to humans.
Cancer treatment and research 20020101
-
Immunosuppression with limited toxicity: the characteristics of nucleoside analogs and anti-lymphocyte antibodies used in non-myeloablative hematopoietic cell transplantation.
Cancer treatment and research 20020101
-
Primary treatment of low-grade non-Hodgkin's lymphoma with the combination of fludarabine and mitoxantrone: a phase II study of the Hellenic Cooperative Oncology Group.
Leukemia & lymphoma 20020101
-
Cutaneous pleomorphic T-cell lymphoma coexisting with myelodysplastic syndrome transforming into acute myeloid leukemia: successful treatment with a fludarabine-containing regimen.
European journal of haematology 20020101
-
Relapsing pure red cell aplasia associated with B-cell chronic lymphocytic leukemia successfully treated by intravenous immunoglobulin concentrate.
Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna 20020101
-
A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 20020101
-
Timed sequential chemotherapy with concomitant granulocyte colony-stimulating factor for high-risk acute myelogenous leukemia: a single arm clinical trial.
BMC cancer 20020101
-
Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment.
Health technology assessment (Winchester, England) 20020101
-
[Peripheral blood hematopoietic cell transplant using immunosuppressive chemotherapy without bone marrow destruction: 'minitransplant'].
Gaceta medica de Mexico 20020101
-
Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20020101
-
Current and developing chemotherapy for CLL.
Medical oncology (Northwood, London, England) 20020101
-
Clinical effects of alemtuzumab (Campath-1H) in B-cell chronic lymphocytic leukemia.
Medical oncology (Northwood, London, England) 20020101
-
Future prospects for alemtuzumab (MabCampath).
Medical oncology (Northwood, London, England) 20020101
-
Long-term follow-up of patients with CLL treated with allogeneic hematopoietic transplantation.
Cytotherapy 20020101
-
Phase II study of a moderate-intensity preparative regimen with allogeneic peripheral blood stem cell transplantation for hematologic diseases: the Texas Transplant Consortium experience.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20020101
-
Waldenström's macroglobulinemia.
Clinical journal of oncology nursing 20020101
-
Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: study of pharmacokinetics and early clinical outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20020101
-
The pharmacokinetics and pharmacodynamics of fludarabine phosphate in patients with renal impairment: a prospective dose adjustment study.
Cancer investigation 20020101
-
The role of membrane transporters in cellular resistance to anticancer nucleoside drugs.
Cancer treatment and research 20020101
-
Fatal adenovirus infection during alemtuzumab (anti-CD52 monoclonal antibody) treatment of a patient with fludarabine-refractory B-cell chronic lymphocytic leukemia.
Medical oncology (Northwood, London, England) 20020101
-
High molecular weight DNA fragmentation assay: a sensitive method for monitoring in vivo response to antileukemic chemotherapy.
Anticancer research 20020101
-
[Autologous stem cell transplantation in a patient with diffuse systemic sclerosis].
Reumatismo 20020101
-
Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia.
Annals of hematology 20020101
-
Facial paresis after fludarabine treatment for advanced chronic lymphocytic leukaemia.
Haematologia 20020101
-
Costs of toxicity during chemotherapy with CHOP, COP/CVP, and fludarabine.
The European journal of health economics : HEPAC : health economics in prevention and care 20020101
-
Analysis of recurrent failure times data: should the baseline hazard be stratified?
Statistics in medicine 20011230
-
Comparison of idarubicin + ara-C-, fludarabine + ara-C-, and topotecan + ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts.
Blood 20011215
-
Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings.
Blood 20011215
-
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality.
Blood 20011215
-
Interaction of p53 and DNA-PK in response to nucleoside analogues: potential role as a sensor complex for DNA damage.
Cancer research 20011215
-
Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide.
Blood 20011201
-
Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG +/- Ida) and second allogeneic stem cell transplant.
British journal of haematology 20011201
-
Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study.
British journal of haematology 20011201
-
Nitric oxide enhancement of fludarabine cytotoxicity for B-CLL lymphocytes.
Leukemia 20011201
-
Prophylaxis of hepatitis B reactivation using lamivudine in a patient receiving rituximab.
American journal of hematology 20011201
-
[Allogeneic peripheral blood stem cell transplantation for 3 patients with beta-thalassemia major and 1 patient with congenital idiopathic haemolytic anemia].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 20011201
-
Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation.
British journal of haematology 20011201
-
Stem cell transplantation eliminates alloantibody in a highly sensitized patient.
Transplantation 20011127
-
Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20011115
-
Clinical significance of CD38 expression in chronic lymphocytic leukemia.
Blood 20011101
-
Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease.
Blood 20011101
-
Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation.
Blood 20011101
-
Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
Haematologica 20011101
-
DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine.
Clinical cancer research : an official journal of the American Association for Cancer Research 20011101
-
Progress in CLL, chemotherapy, antibodies and transplantation.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20011101
-
[Chronic lymphocytic leukemias].
Nihon rinsho. Japanese journal of clinical medicine 20011101
-
Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients.
Blood 20011015
-
Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies.
Blood 20011015
-
High-dose chemotherapy in high-risk myelodysplastic syndrome: covariate-adjusted comparison of five regimens.
Cancer 20011015
-
Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia.
Cancer 20011015
-
Phosphodiesterase type 4 inhibitor suppresses expression of anti-apoptotic members of the Bcl-2 family in B-CLL cells and induces caspase-dependent apoptosis.
Leukemia 20011001
-
Early full donor myeloid chimerism after reduced-intensity stem cell transplantation using a combination of fludarabine and busulfan.
Haematologica 20011001
-
Considerations in the selection of an appropriate conditioning regimen for the treatment of rheumatoid arthritis by autologous peripheral blood stem cell transplantation.
The Journal of rheumatology. Supplement 20011001
-
Severe alveolar proteinosis following chemotherapy for acute myeloid leukemia in a lung allograft recipient.
Journal of thoracic imaging 20011001
-
Inhibitors against factor VIII associated with the use of interferon-alpha and fludarabine.
Thrombosis and haemostasis 20011001
-
A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
Bone marrow transplantation 20011001
-
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Bone marrow transplantation 20011001
-
Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis.
British journal of haematology 20011001
-
Fludarabine and mitoxantrone: effective and well-tolerated salvage therapy in relapsed indolent lymphoproliferative disorders.
Annals of oncology : official journal of the European Society for Medical Oncology 20011001
-
The gut mucosa barrier is preserved during allogeneic, haemopoietic stem cell transplantation with reduced intensity conditioning.
Bone marrow transplantation 20011001
-
Successful non-myeloablative stem cell transplantation for a heavily transfused woman with severe aplastic anemia complicated by heart failure.
Bone marrow transplantation 20011001
-
Identification and characterization of human deoxyguanosine kinase cDNA fragments.
Cancer letters 20010920
-
Evaluating treatment strategies in advanced Waldenström macroglobulinemia: use of quality-adjusted survival analysis.
Leukemia 20010901
-
Non-myeloablative conditioning regimen of fludarabine, busulfan, anti-thymocyte globulin, and methylprednisolone for allogeneic peripheral blood hematopoietic cell transplantation.
Haematologica 20010901
-
Improved outcome of alternative donor bone marrow transplantation in children with severe aplastic anaemia using a conditioning regimen containing low-dose total body irradiation, cyclophosphamide and Campath.
British journal of haematology 20010901
-
Cathepsins are upregulated by IFN-gamma/STAT1 in human muscle culture: a possible active factor in dermatomyositis.
Journal of neuropathology and experimental neurology 20010901
-
Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone.
British journal of haematology 20010901
-
Therapeutic options for acute myelogenous leukemia.
Cancer 20010901
-
[Recent progress in the treatment of malignant lymphoma].
Gan to kagaku ryoho. Cancer & chemotherapy 20010901
-
Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant.
Bone marrow transplantation 20010901
-
Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant.
Annals of hematology 20010901
-
Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: case report.
Annals of hematology 20010901
-
Impact of therapy With chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010815
-
Developing a pediatric outpatient transplantation program. The Children's Memorial Hospital experience.
Frontiers in bioscience : a journal and virtual library 20010801
-
Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 20010801
-
Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group.
British journal of haematology 20010801
-
Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen.
Bone marrow transplantation 20010801
-
Reversal of cytosine arabinoside (ara-C) resistance by the synergistic combination of 6-thioguanine plus ara-C plus PEG-asparaginase (TGAP) in human leukemia lines lacking or expressing p53 protein.
Cancer chemotherapy and pharmacology 20010801
-
Reduced intensity conditioning: enhanced graft-versus-tumor effect following dose-reduced conditioning and allogeneic transplantation for refractory lymphoid malignancies after high-dose therapy.
Bone marrow transplantation 20010801
-
Mito-flag as salvage therapy for relapsed and refractory acute myeloid leukemia.
Onkologie 20010801
-
[Drug-induced hemolytic anemia].
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine 20010801
-
Infectious complications of purine analog therapy.
Current opinion in infectious diseases 20010801
-
Will mixed chimerism cure autoimmune diseases after a nonmyeloablative stem cell transplant?
Transplantation 20010727
-
Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010715
-
Imbalanced DNA synthesis induced by cytosine arabinoside and fludarabine in human leukemia cells.
Biochemical pharmacology 20010701
-
Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003).
Blood 20010701
-
Evaluating treatment strategies in chronic lymphocytic leukemia: use of quality-adjusted survival analysis.
Journal of clinical epidemiology 20010701
-
Flavopiridol circumvents Bcl-2 family mediated inhibition of apoptosis and drug resistance in B-cell chronic lymphocytic leukaemia.
British journal of haematology 20010701
-
Successful HLA-identical bone marrow transplantation in a patient with PNP deficiency using busulfan and fludarabine for conditioning.
Bone marrow transplantation 20010701
-
Acute left ventricular failure following melphalan and fludarabine conditioning.
Bone marrow transplantation 20010701
-
Unrelated cord blood transplantation in a Fanconi anemia patient using fludarabine-based conditioning.
Bone marrow transplantation 20010701
-
Failure of sustained engraftment after non-myeloablative conditioning with low-dose TBI and T cell-reduced allogeneic peripheral stem cell transplantation.
Bone marrow transplantation 20010701
-
Lethal adenovirus infection in a patient who had undergone nonmyeloablative stem cell transplantation.
International journal of hematology 20010701
-
Remarkable response to rituximab in a 72-year-old patient with refractory non-Hodgkin's lymphoma and marrow aplasia.
Leukemia & lymphoma 20010701
-
Recent advances in the management of adult myositis.
Expert opinion on investigational drugs 20010701
-
[Chronic lymphocytic leukemia. 2. Therapy].
Deutsche medizinische Wochenschrift (1946) 20010608
-
[Chronic lymphatic leukemia. 3. The concrete case].
Deutsche medizinische Wochenschrift (1946) 20010608
-
UCN-01 induces cytotoxicity toward human CLL cells through a p53-independent mechanism.
Experimental hematology 20010601
-
Nucleoside analogues: mechanisms of drug resistance and reversal strategies.
Leukemia 20010601
-
Paraneoplastic pemphigus: an association with fludarabine?
The British journal of dermatology 20010601
-
Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect.
Annals of the New York Academy of Sciences 20010601
-
Efficacy of fludarabine, intermittent sequential high-dose cytosine arabinoside, and mitoxantrone (FIS-HAM) salvage therapy in highly resistant acute leukemias.
Annals of hematology 20010601
-
Cost of de novo acute myeloid leukemia induction therapy in adults: analysis of EORTC-GIMEMA AML10 and FLANG regimens.
Journal of experimental & clinical cancer research : CR 20010601
-
Non-myeloablative hematopoietic stem cell transplantation.
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine 20010601
-
Combination chemotherapy and rituximab.
Anti-cancer drugs 20010601
-
Nucleoside analogues in the treatment of haematological malignancies.
Expert opinion on pharmacotherapy 20010601
-
Treatment options in Waldenström's macroglobulinaemia: the role of the purine analogues.
Expert opinion on pharmacotherapy 20010601
-
Features of the engraftment of allogeneic hematopoietic stem cells using reduced-intensity conditioning regimens.
Leukemia & lymphoma 20010601
-
[Pneumonia in patients with chronic lymphocytic leukemia. Study of 30 episodes].
Medicina clinica 20010526
-
Novel treatment strategies in chronic lymphocytic leukemia.
Current oncology reports 20010501
-
Fatal legionella pneumonia after fludarabine treatment in chronic lymphocytic leukaemia.
Journal of clinical pathology 20010501
-
Fludarabine pharmacokinetics after subcutaneous and intravenous administration in patients with lupus nephritis.
Pharmacotherapy 20010501
-
A trial of fludarabine and cyclophosphamide combination chemotherapy in the treatment of advanced refractory primary cutaneous T-cell lymphoma.
The British journal of dermatology 20010501
-
Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia?
Leukemia & lymphoma 20010501
-
Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine.
Annals of oncology : official journal of the European Society for Medical Oncology 20010501
-
[Hematopoietic allogeneic transplantation with attenuated conditioning regimen on an outpatient basis. First experience in Spain].
Medicina clinica 20010428
-
[Molecular biology examination in chronic lymphocytic leukemia].
Orvosi hetilap 20010422
-
Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010415
-
Fludarabine for chronic lymphocytic leukemia.
The New England journal of medicine 20010412
-
Fludarabine for chronic lymphocytic leukemia.
The New England journal of medicine 20010412
-
Fludarabine for chronic lymphocytic leukemia.
The New England journal of medicine 20010412
-
Fludarabine for chronic lymphocytic leukemia.
The New England journal of medicine 20010412
-
Clonotypic polymerase chain reaction confirms minimal residual disease in CLL nodular PR: results from a sequential treatment CLL protocol.
Blood 20010401
-
Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens.
American journal of hematology 20010401
-
Fludarabine in the treatment of an active phase of a familial haemophagocytic lymphohistiocytosis.
Archives of disease in childhood 20010401
-
Immunotherapy by non-myeloablative allogeneic stem cell transplantation in multiple myeloma: results of a pilot study as salvage therapy after autologous transplantation.
Leukemia 20010401
-
Fludarabine and cytarabine as a sequential infusion regimen for treatment of adults with recurrent, refractory or poor prognosis acute leukemia.
Leukemia & lymphoma 20010401
-
[Mantle cell lymphoma].
[Rinsho ketsueki] The Japanese journal of clinical hematology 20010401
-
Treatment of aggressive, or progressing indolent peripheral T- and NK-cell neoplasias by combination of fludarabine, cyclophosphamide and doxorubicine.
Onkologie 20010401
-
Double reinforcement with fludarabine/high-dose cytarabine enhances the impact of autologous stem cell transplantation in acute myeloid leukemia patients.
Bone marrow transplantation 20010401
-
Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.
The New England journal of medicine 20010322
-
Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010301
-
Circumvention of ara-C resistance by aphidicolin in blast cells from patients with AML.
British journal of cancer 20010301
-
Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma.
Haematologica 20010301
-
Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B-CLL patients: impact on clonal B-cell apoptosis.
British journal of haematology 20010301
-
New drug combinations for the treatment of murine AIDS and macrophage protection.
European journal of clinical investigation 20010301
-
Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation.
Experimental hematology 20010301
-
Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 20010301
-
Biological and molecular characterization of PNH-like lymphocytes emerging after Campath-1H therapy.
British journal of haematology 20010301
-
Early allogeneic blood stem cell transplantation after modified conditioning therapy during marrow aplasia: stable remission in high-risk acute myeloid leukemia.
Bone marrow transplantation 20010301
-
Effective treatment with rituximab in a patient with refractory prolymphocytoid transformed B-chronic lymphocytic leukemia and Evans syndrome.
Annals of hematology 20010301
-
Fludarabine in alkylator-resistant follicular non-Hodgkin's lymphoma.
Leukemia & lymphoma 20010301
-
Reversal of fludarabine induced testicular damage in a patient with chronic lymphocytic leukaemia (CLL), by suppression of pituitary-testicular axis using gonadotrophin releasing hormone (GnRH).
Leukemia & lymphoma 20010301
-
Cytomegalovirus pneumonia in adults with leukemia: an emerging problem.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010215
-
Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.
Blood 20010201
-
Long-lasting complete remission of hepatitis C virus (HCV) infection and HCV-associated immunocytoma with alpha-interferon treatment.
British journal of haematology 20010201
-
Fludarabine-based stem cell transplantation protocol for Fanconi's anaemia in myelodysplastic transformation.
British journal of haematology 20010201
-
A case of refractory idiopathic pure red cell aplasia responsive to fludarabine treatment.
British journal of haematology 20010201
-
Bilateral breast relapse in acute myelogenous leukemia.
Journal of pediatric hematology/oncology 20010201
-
Reactivation of hepatitis B virus infection during cytotoxic chemotherapy.
The American journal of gastroenterology 20010201
-
Interactions between 2-fluoroadenine 9-beta-D-arabinofuranoside and the kinase inhibitor UCN-01 in human leukemia and lymphoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 20010201
-
Candida tropicalis and Penicillium marneffei mixed fungaemia in a patient with Waldenström's macroglobulinaemia.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20010201
-
Second primary tumors and immune phenomena after fludarabine or 2-chloro-2'-deoxyadenosine treatment.
Leukemia & lymphoma 20010201
-
Cladribine in the treatment of chronic lymphocytic leukemia.
Leukemia & lymphoma 20010201
-
Molecular remission following high-dose hydroxyurea and fludarabine plus cytarabine in a patient with simultaneous acute myeloid leukemia and low-grade lymphoma.
Leukemia & lymphoma 20010201
-
Secondary myelodysplastic syndrome after fludarabine therapy of a low-grade non-Hodgkin's lymphoma.
Leukemia research 20010101
-
Fludarabine, cytarabine and topotecan (FLAT) as induction therapy for acute myeloid leukemia in the elderly: a preliminary report.
Haematologica 20010101
-
Red swollen nail folds and nail deformity as presenting findings in chronic lymphocytic leukaemia.
British journal of haematology 20010101
-
A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation.
British journal of haematology 20010101
-
Modulation of ara-CTP levels by fludarabine and hydroxyurea in leukemic cells.
Leukemia 20010101
-
Prophylactic donor lymphocyte infusions after moderately ablative chemotherapy and stem cell transplantation for hematological malignancies: high remission rate among poor prognosis patients at the expense of graft-versus-host disease.
Bone marrow transplantation 20010101
-
Acute heart failure after allogeneic blood stem cell transplantation due to massive myocardial infiltration by cytotoxic T cells of donor origin.
Bone marrow transplantation 20010101
-
Transplantation of CD34-enriched peripheral stem cells from an HLA-haplotype mismatched donor to a patient with severe aplastic anemia.
Bone marrow transplantation 20010101
-
A fludarabine-based conditioning regimen for severe aplastic anemia.
Bone marrow transplantation 20010101
-
Bone marrow transplantation in a case of severe, type II congenital dyserythropoietic anaemia (CDA II).
Bone marrow transplantation 20010101
-
Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20010101
-
Achieving optimal outcomes in chronic lymphocytic leukaemia.
Drugs 20010101
-
Second allogeneic peripheral blood stem cell transplantation with fludarabine-based low-intensity conditioning regimen for relapsed myelodysplastic syndrome after allogeneic bone marrow transplantation.
International journal of hematology 20010101
-
Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine.
Acta haematologica 20010101
-
Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma.
Journal of cancer research and clinical oncology 20010101
-
Treatment of 'poor risk' acute myeloid leukemia with fludarabine, cytarabine and G-CSF (flag regimen): a single center study.
Leukemia & lymphoma 20010101
-
First line therapy with fludarabine combinations in 42 patients with either post myelodysplastic syndrome or therapy related acute myeloid leukaemia.
Leukemia & lymphoma 20010101
-
Mitoxantrone and fludarabine in the treatment of patients with non-Hodgkin's lymphoma failing primary therapy with a doxorubicinor mitoxantrone-containing regimen.
Leukemia & lymphoma 20010101
-
Fludarabine, arabinosyl cytosine and idarubicin (FLAI) for remission induction in poor-risk acute myeloid leukemia.
Leukemia & lymphoma 20010101
-
A systematic overview of chemotherapy effects in B-cell chronic lymphocytic leukaemia.
Acta oncologica (Stockholm, Sweden) 20010101
-
Application of high-performance, thin-layer chromatography to quality control of antimetabolite analogue infusion bags.
Journal of AOAC International 20010101
-
Alemtuzumab (Millennium/ILEX).
Current opinion in investigational drugs (London, England : 2000) 20010101
-
Autoimmune thrombocytopenia associated with the first cycle of fludarabine therapy in the treatment of relapsed non-Hodgkin's lymphoma.
Clinical oncology (Royal College of Radiologists (Great Britain)) 20010101
-
Cyclophosphamide/fludarabine (CF) is active in the treatment of mantle cell lymphoma.
Leukemia & lymphoma 20010101
-
Carboxyamido-triazole (CAI)--a novel 'static' signal transduction inhibitor induces apoptosis in human B-cell chronic lymphocytic leukemia cells.
Leukemia & lymphoma 20010101
-
Fulminant hepatic failure secondary to adenovirus following fludarabine-based chemotherapy for non-Hodgkin's lymphoma.
Leukemia & lymphoma 20010101
-
Angiogenic growth factors: autocrine and paracrine regulation of survival in hematologic malignancies.
The oncologist 20010101
-
Peripheral blood involvement in a mycosis fungoides patient with limited skin lesions: phenotypical features and homing molecule pattern.
European journal of dermatology : EJD 20010101
-
Chronic lymphocytic leukaemia.
Clinical medicine (London, England) 20010101
-
Chronic lymphocytic leukemia: case-based session.
Hematology. American Society of Hematology. Education Program 20010101
-
Non-myeloablative transplants for malignant disease.
Hematology. American Society of Hematology. Education Program 20010101
-
Ajoene, a garlic-derived natural compound, enhances chemotherapy-induced apoptosis in human myeloid leukaemia CD34-positive resistant cells.
Anticancer research 20010101
-
[Lupus nephritis: treatments for today and tomorrow].
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20010101
-
The bioavailability of oral fludarabine phosphate is unaffected by food.
The hematology journal : the official journal of the European Haematology Association 20010101
-
[Nucleoside analogues--new drugs for the treatment of lymphatic cancers].
Duodecim; laaketieteellinen aikakauskirja 20010101
-
Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
Cytotherapy 20010101
-
In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation.
Cytotherapy 20010101
-
Allogeneic stem-cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH (+/- fludarabine) conditioning combined with post-transplant donor-lymphocyte infusion.
Cytotherapy 20010101
-
[Non-myeloablative therapy and allogeneic hematopoietic stem cell transplantation in hematologic malignancies].
Polskie Archiwum Medycyny Wewnetrznej 20010101